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Abstract 
The rapid development of seriously drug-resistant pathogen strains has created a dangerous 
problem to public health. The discovery of new effective antimicrobials remains an urgent 
task to control microbial resistance. Natural products can offer special stereochemistry and 
unlimited diversity of natural leads which are biologically active or ready for development 
and structure optimization strategies. Four medicinal plants Cylicodiscus gabunensis (CG), 
Pogostemon cablin (PC), Perilla frutescens (PF) and Magnolia biondii (MB) were selected 
for investigation of their phytochemical composition and antiplasmodial and/or antibacterial 
properties. A bioassay guided fractionation method has been followed to characterize the 
antiplasmodial and antibacterial constituents of CG. Flash column chromatography and 
preparative HPLC were used to obtain the bioactive compounds. GC-MS, LC-MS, and NMR 
have been used for chemical analysis purposes. For evaluation of the antibacterial activity, 
disk diffusion assay, alamar blue microplate assay, time kill kinetic and scanning electron 
microscopy (SEM) methods have been used. The work led to the isolation of the most potent 
antiplasmodial fraction of CG with IC50 of 4.7 ?g/ml using Malaria Sybr Green I assay. 
Detailed chemical analysis suggested the presence of conjugates of oligosaccharide with 
gallic acid in this mixture. The active antibacterial compounds of CG were identified as 
benzoic acid derivatives such as ethyl gallate and gallic acid. Several gallate compounds were 
prepared de novo and the results showed that esterification of gallic acid increased both the 
antibacterial and antiplasmodial activities. Furthermore, the extracts of PC, PF and MB 
showed moderate antibacterial activities, whose mechanisms of action have been determined 
by SEM. In particular, patchouli alcohol, the major component of PC showed strong 
antibacterial activity and synergism with gallic acid against Staphylococcus aureus. These 
studies have provided evidences for the traditional use of these plants for the treatment of 
malaria and/or bacterial infections.  
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Chapter 1 : Introduction 
1.1. Discovery of the antibacterial agents 
The discovery of penicillin started the antibiotics era and for over seventy years provide 
huge victory over pathogens, however, the emergence and rapid development of seriously 
drug-resistant pathogens have created the greatest danger to public health and made the 
treatment of infectious diseases ineffective (Oluwatuyi, Kaatz et al. 2004). 
Bacteria can resist antibiotic/s by several means: 1) the modification of protein targets to 
antibiotics; 2) the production of enzymes which can degrade or modify the antibiotic 
structure rendering it unsuccessful in infections treatment; 3) the changes of cell wall 
permeability due to mutations; 4) the use of the pumping system to expel the antibiotic 
molecules (Blair, Webber et al. 2015, Abreu, McBain et al. 2012).  
Based on the various mechanisms of bacterial resistance listed above, resistance modifying 
agents (RMAs) which may address the resistance problem have been explored to modify 
the antimicrobial resistances. The details of resistance modification mechanisms and 
RMAs were reviewed in detail by Abreu (Abreu, McBain et al. 2012).  
1.1.1. Antibacterial resistance  
The emergence of resistant strains to antibacterials was determined by the level of 
exposure of the pathogen to the antibacterial, the biochemical and physiological effects of 
drugs on the microorganisms (pharmacodynamics) and the pharmacokinetic properties of 
the antibiotics (Andersson, Hughes 2010). The use of wrong dosage of antibacterials and 
the general abuse of the antibacterials were the contributing factors of the emergence and 
dissemination of resistance (Maisnier-Patin, Andersson 2004). The resistant microbes do 
not respond to the antibacterials due to either expression of resistance phenotype, or 
inherent resistant genes (Gilbert, Maira-Litran et al. 2002). 
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The multidrug-resistance is more serious than the resistance to a single antibiotic. 
Examples are the methicillin-resistant Staphylococcus aureus (MRSA) and the toughest 
type of S. aureus which also resists vancomycin (Abreu, McBain et al. 2012). These kinds 
of bacteria cause around 25000 deaths annually and cost the European economy more than 
one billion euros (Blair, Webber et al. 2015).    
To control the antibiotic resistant microbes, the discovery of new effective antimicrobials 
with new mechanism of action against bacteria remains an urgent task to control the 
bacterial resistance (Theuretzbacher 2011). WHO adopted several strategies to address the 
resistance problems like using the antibiotics in the right dose and duration of treatment, 
enhancing healthy environment to control transmission of resistant strains and supporting 
the research for finding new antibiotics (WHO 2011). The use of synergism between 
antibiotics is also an important strategy to control drug resistance by targeting more than 
one site of action and increases the bioavailability or the modification of resistance 
mechanisms (Wagner, Ulrich-Merzenich 2009).  
1.1.2. Plants as sources of antibacterials 
Plant extracts have been utilized from ancient times to treat various ailments, particularly 
in Asia. A major ??????????????????????????????????????????????????????????????????????????
for a healthy life (Prabuseenivasan, Jayakumar et al. 2006). In modern drug discovery and 
development processes, phytochemicals play a ???? ????? ??? ???? ?????? ?????? ??? ???????
discovery, i.e. discovery of the bioactive (determined by various bioassays) natural 
molecule, which could be an ideal drug candidate itself or as a lead compound to develop 
for its structural analogues (Sarker 2007, Cowan 1999). 
Some of phytochemicals are utilized by the plants themselves as a defence against many 
invaders, therefore playing a distinctive role as antimicrobials (Simoes, Bennett et al. 
2009).  
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The paucity of infections in wild plants supports the role of innate defence system of plants 
(Hemaiswarya, Kruthiventi et al. 2008). Many researchers have indicated that a broad 
range of plant extracts may act against bacterial resistance mechanisms, and the majority of 
them have now been focused on the combination of plant extracts and antibiotics in order 
to determine the existence and abundance of RMAs (Chlez, Hohmann et al. 2010, Sibanda, 
Okoh 2007).  
Giant companies in the pharmaceutical sector have invested a huge amount of money to 
synthesize chemical compounds but without significant biological activities due to lack of 
special stereochemistry which natural products can offer, therefore an increase in drug 
discovery from nature in the future will be expected (Gibbons 2008). Another important 
motive to discover natural products and produce alternatives to the limited or failed 
therapeutic protocols is the unlimited diversity of natural leads which are biologically 
active or ready for development and structure optimization strategies. In addition to that, 
the toxicity and low margin of safety of some antimicrobials have promoted the interest in 
search for novel antimicrobial products from other sources, particularly plant secondary 
metabolites (phytochemicals) (Gibbons 2008). 
There are different phytochemical approaches to follow when searching for natural 
antimicrobials. The plant species are selected randomly and then their phytochemicals are 
categorized to different chemical groups. The second approach is the random selection of 
plant species followed by antimicrobial assays; the third approach is to follow previous 
reports of researchers.  
The most important approach is the follow-up of ethno-medical or traditional uses of plants 
against microbial infections (Fabricant, Farnsworth 2001). Traditional medicines like 
Ayurveda and Chinese medicine provide information about the medicinal use of plants. 
Information sources may include books, herbals, review articles, notes placed on voucher 
4 
 
herbarium specimens, field work and computer databases, such as NAPRALERT 
(Farnsworth 2015).  
1.1.2.1. Extraction of antibacterial natural products 
To extract the phytochemicals, researchers can use open extraction system or closed 
(continuous) system like refluxing with Soxhlet or Clevenger apparatus. Extraction of 
phytochemicals is carried out, using water or alcohol or other organic solvents like hexane, 
methanol or ethyl acetate under heat or at room temperature. Most of the antimicrobials are 
extracted by an aqueous alcoholic solution which is later dried by rotary evaporator under 
vacuum (Taylor, Edel et al. 1996). 
1.1.2.2. Antibacterial assay methods 
The assays of antibacterials from plants are conducted with crude plant extract (Silva, 
Duarte et al. 1996) and/or pure compounds (Afolayan, Meyer 1997, Batista, Duarte et al. 
1994). Disk or agar well diffusion assay and broth micro or macro dilution assay are the 
most important assays used to evaluate the antibacterial activities (Ayafor, Tchuendem et 
al. 1994, Navarro, Villarreal et al. 1996). The bioautographic method (Rios, Recio et al. 
1988) is another technique used to evaluate the antibacterial effects. 
To detect the antibacterial action, the researchers can use the disk diffusion method, in 
which a paper disk impregnated with the natural extract or pure compound is laid on top of 
an inoculated agar plate. The volume or quantity of the natural material deposited on the 
paper disks, the thickness of the agar layer and whether a solvent is used can affect the 
results considerably between studies. 
In the agar well test when a large number of extracts are to be screened or a large number 
of bacterial isolates need to be tested, the material assayed for antibacterial activity is 
introduced into wells cut into the agar plate (Deans, Simpson et al. 1993, Dorman, Deans 
2000). 
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In broth dilution method, the antibacterial activity such as the minimal inhibitory 
concentrations (MIC) is quantified by measuring the optical density (OD) using an 
automated spectrophotometer, or by counting the viable colonies left after incubating the 
inoculum in the presence of the antibacterial agent for a defined period of time. Although 
this method is accurate, it is a tedious process and requires a longer period of time than OD 
measurement.  
Resazurin (alamar blue) can be used in microplate assay method as a highly sensitive 
indicator, accurately reflect the activity of the bacterial cells (Sarker, Nahar et al. 2007). 
The alamar blue assay method is sensitive enough to be compared with OD measurement 
and viable colonies counting and it is more sensitive than the agar dilution method (Mann, 
Markham 1998).  
The time-kill assay is used to define the time required to reach a bactericidal or 
bacteriostatic level. The time kill kinetic graph is presented by plotting the number of 
viable cells remaining in the broth after addition of the natural extract versus time. The 
destruction of the bacterial cell by antibacterial agent and loss of cellular contents can be 
studied by scanning electron microscopy (SEM) (Skandamis, Nychas 2001, Burt, Reinders 
2003).  
1.1.2.3. Volatile oils as antibacterial agents 
Essential oils (EOs) are chemical compounds also called volatile or ethereal oils (Guenther 
1948). EOs are aromatic and obtained from different plant parts, many methods are used to 
extract EOs; those methods are expression (cold pressing), enfleurage, or extraction by 
organic solvents, hexane for example. Steam distillation is a well-known method used to 
extract volatile oils in industry for the commercial production (Van de Braak, Leijten 
1999). EOs may contain aromatic chemicals derived from shikimate pathway or mainly of 
terpenoids which are derived from methylerythritol phosphate or mevalonate pathways. 
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Some of the volatile oils are composed of the two types, aromatics and terpenoids, and one 
group of those two is predominated over the other (Paul 2009).   
Terpenoids are composed of isoprene/s units, which are linked head to tail as in geraniol, 
farnesol, and geranyl geraniol. Isoprene units also linked tail to tail as in squalene. 
Terpenoids are classified into hemiterpenes composed of five carbon block, monoterpenes 
with C10, sesquiterpenes with C15, diterpenes C20, sesterterpenes C25 and tetraterpenes C40 
(Paul 2009). (Figure 1.1) shows the head to tail and tail to tail linked isoprene units.  
 
Figure ?1.1: the head to tail and tail to tail linked isoprene units. The arrow shows the 
linkage point of tail to tail isoprene units in squalene. 
 
1.1.2.3.1. Historical and current use of essential oils 
However, the use of EOs was not common in Europe until the 16th century, where they 
were sold in London for different purposes such as perfumes, food additives and remedies 
for various ailments (Crosthwaite 1998). The environmental sustainability and 
?????????????? ???? ???????? ???????????? ????? ?????????? ??????????? ?????????? ??? ??????
substances (Nychas 1995, Tuley de Silva 1996). EOs have been shown to have 
antibacterial actions (Deans, Ritchie 1987, Carson, Cookson et al. 1995a, Mourey, Canillac 
2002), antiviral (Bishop 1995), anti-mycotic (Azzouz, Bullerman 1982, Akgul, Kivanc 
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1988, Jayashree, Subramanyam 1999, Mari, Bertolini et al. 2003) and insect killing 
properties (Konstantopoulou, Vassilopoulou et al. 1992).  
EOs, in general, are a good source of antimicrobials (Burt 2004) when used alone or in 
combination with antibiotics to fight multidrug-resistant strains (Langeveld, Veldhuizen et 
al. 2014). The EOs extracted by hexane has been shown to exhibit better antimicrobial 
activity than the corresponding steam distilled EOs (Packiyasothy, Kyle 2002). The 
quantity and quality of the EO and hence its chemical compositions are varied substantially 
depending on the time of collection and geographical area (McGimpsey, Douglas et al. 
1994, Faleiro, Miguel et al. 2002).  
The strongest antimicrobial effects were observed from plants collected directly after their 
flowering (McGimpsey, Douglas et al. 1994). The chemical orientation or stereochemical 
orientation of the EOs components can affect the antimicrobial activity (Lis-Balchin, 
Ochoka et al. 1999). The MIC of EOs is calculated by ?g/ml, however, some researchers 
reported EOs MIC as ?l/ml instead of ?g/ml (Tolossa, Asres et al. 2007).    
Food scientists have found that terpenoids of EOs are useful in the control of Listeria 
monocytogenes (Aureli, Costantini et al. 1992). Basil oil is used to protect lettuce leaves 
from deterioration (Wan, Wilcock et al. 1998). The essential oil of Sweet basil Ocimum 
basilicum L. (Lamiaceae) showed antibacterial activity with MIC against B. cereus = 62.5 
?g/ml, against B. subtilis = 125 ?g/ml, against E. coli = 500 ?g/ml and against P. 
aeruginosa ?????????????(Hossain, Kabir et al. 2010).  
A capsaicinoid alkaloid, capsaicin from chillies was bactericidal to Helicobacter pylori 
(Jones, Shabib et al. 1997) and trichorabdal A, a diterpene from a Japanese herb, could 
directly inhibit H. pylori (Kadota, Basnet et al. 1997). Another hot-tasting diterpene, 
aframodial, from a Cameroonian spice, is a broad-spectrum antifungal (Ayafor, 
Tchuendem et al. 1994).  
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The ethanol-soluble fraction of purple prairie clover yielded a terpenoid petalostemumol 
(Cowan 1999), which showed great activity with MICs of 0.78 ?g/ml and 3.12 ?g/ml 
against B. subtilis and S. aureus, respectively (Hufford, Jia et al. 1993).  
Chrysothol and madreporanone, two terpenoids isolated from Azorella cryptantha (Clos) 
Reiche showed MIC of 50????? ?????? ????????E. coli and Salmonella enteritidis (Lima, 
Sanchez et al. 2015). Another terpenoid (dysidinoid A) isolated from China Sea sponge 
Dysidea ???? ???? ??????? ?? ????? ??????? ????????? ????? ??????? ??? ?? ?????? ?????????????
(Jiao, Li et al. 2014). (Figure 1.2) shows the structures of the terpenoids mentioned above. 
 
 
Figure ?1.2: The structures of some terpenoids mentioned with antibacterial activities. 
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In a recent study (Maree, Kamatou et al. 2014), one hundred and fifty eight EOs were 
tested against the following microorganisms, B. cereus, S. aureus, Enterococcus faecalis, 
E. coli, P. aeruginosa and two yeasts, Candida albicans and Cryptococcus neoformans. 
The results revealed that the essential oils which contained eugenol demonstrated moderate 
activity against the studied cells, eighteen oils have MICs between 250 and 1000 ?g/ml. 
Cistus spp., Eugenia caryophyllata, and Listea cubeba have MIC of 4 ?g/ml against 
Cryptococcus neoformans. EO which consists of ?-pinene, limonene and sabinene showed 
weak antimicrobial activities (Maree, Kamatou et al. 2014). (Figure 1.3) shows the 
structure of eugenol and terpenes mentioned above. 
 
 
Figure ?1.3: ???????????????????????????-pinene, limonene and sabinene. 
 
The compositional analysis of the oil or its headspace is often accomplished by gas 
chromatography mass spectrometry (GC-MS) or thermal-desorption gas chromatography-
mass spectrometry (TD GC- MS) (Salzer 1977, Scheffer, Svendsen 1981, Wilkins, Madsen 
1991, Daferera, Ziogas et al. 2000, Juliano, Mattana et al. 2000).  
There are numerous examples of essential oils studied for antibacterial activities and 
checked by GC-MS to define their metabolites profiles. The volatile oil of Coriandrum 
sativum L. was analyzed by GC-MS coupled with chemometric resolution methods to 
enhance the resolution of peak clusters (Zhou, Chen et al. 2011).  
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The EO of Foeniculum vulgare was analyzed by GC-MS, however, the antibacterial 
activity was found to be weak (Miguel, Cruz et al. 2010). The oil of Piper arborescens 
Roxb studied by GC-MS and showed activity against S. aureus MIC= 250 ?g/ml (Salleh, 
Ahmad et al. 2016). Artemisia stricta Edgew. f. stricta Pamp showed MIC= 1.25 ?g/ml 
against S. aureus and its fraction was analysed using GC-MS to detect its metabolic profile 
(Manika, Chanotiya et al. 2016). In summary, GC-MS is an important tool for essential oils 
characterization. 
1.1.2.3.2. Mode of action and interactions between components of EOs 
The hydrocarbons interact with the nonpolar parts of bacterial cells to exert their 
antibacterial action (Sikkema, De Bont et al. 1995). Bacterial cells contain many targets 
susceptible to the activity of volatile oil (Carson, Mee et al. 2002). The hydrophobicity of 
the oils enables them to partition into the lipids of the bacterial cell membrane, affecting 
their structures and leaving them more permeable (Sikkema, De Bont et al. 1994). Leakage 
of ions and cell materials is the second step (Zhang, Liu et al. 2016). The massive leakage 
of cell contents definitely leads to cell death (Shukla, Majumder et al. 2016).  
Functional groups on the essential oil structures are vital for antibacterial activities; 
hydroxyl groups in carvacrol and thymol play a key role in antimicrobial behaviour (Ultee, 
Bennink et al. 2002). Thymol and carvacrol, were isolated from Thymus vulgaris, they 
increase the outer membrane permeability and assist the penetration of antibiotics in gram 
negative bacteria (Lambert, Skandamis et al. 2001). Acetate moiety increases the 
antibacterial activity of geraniol, where geranyl acetate was found to be more potent than 
geraniol against a range of gram-positive and negative species (Dorman, Deans 2000). 
Structures of carvacrol, thymol and geranyl acetate are shown in (Figure 1.4). 
11 
 
 
Figure ?1.4: Structures of carvacrol, thymol and geranyl acetate. 
  
The functional groups of the EO components may classify their antibacterial activities, 
phenolic materials are the most potent ones followed by alcohols, and esters are less active 
than the previously mentioned compounds while ethers rank among the least potent. 
Hydrocarbons are practically very weak antibacterials or inactive (Ait-Ouazzou, Cherrat et 
al. 2011). The hydrocarbon monoterpenes (?-pinene, camphene, myrcene, ? -terpinene and 
para-cymene) with weak antimicrobial activities can potentiate the antimicrobial effects of 
carvacrol by interaction with the cell membrane to facilitate the penetration of carvacrol 
into the cell (de Azeredo, Stamford et al. 2011).  
Additive effects were observed from a combination of 1,8-cineole (eucalyptol) and 
aromadendrene against MRSA and vancomycin-resistant Enterococci (E. faecalis) by 
using the checkerboard method (Mulyaningsih, Sporer et al. 2010). In conclusion the 
phenolic compounds in the EOs are more effective against bacteria than hydrocarbon 
molecules deprived of oxygen atoms. Structures of compounds from camphene to 
eucalyptol are shown in (Figure 1.5). 
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Figure ?1.5: Structures of some of the hydrocarbon monoterpenes, with weak antibacterial 
activities, 1,8-cineole (eucalyptol) and aromadendrene showed additive effects against 
MRSA and vancomycin-resistant Enterococci (E. faecalis).  
 
1.1.2.4. Phenols and phenolic acids 
Phenols like catechol and pyrogallol showed activity against some microorganisms. For 
example, pyrogallol showed MIC= 2.4-????? ?????? ???? ????????????????? ????? was = 
4.9-?????????????????????????????????????????????????????????????????(Shahzad, Millhouse 
et al. 2015). Taguri (2006) recorded the antibacterial activities of 22 polyphenolic 
structures against several gram positive and gram negative bacteria, the results showed that 
the pyrogallol-based compounds were more potent than others such as catechol or 
resorcinol (Taguri, Tanaka et al. 2006). There was evidence that increased hydroxylation 
of those phenols results in increased toxicity or antimicrobial activities (Geissman 1963). 
The mechanisms of action of simple phenols are probably proceed through interaction with 
sulfhydryl groups in microbial enzymes leading to inhibition of those enzymes or due to 
nonspecific proteins interactions (Mason, Wasserman 1987).  
Some phenolic acids such as caffeic acid have antimicrobial activities. Caffeic acid showed 
weak antibacterial activities, MIC equal to 1600 ?g/ml against S. aureus and E. coli 
compared to ampicillin which showed MIC= 0.1 and 3.2 ?g/ml respectively (Lim, Subhan 
et al. 2016).   
Gallic acid is a phenolic acid showing an effect against E. faecalis (Aires, Marques et al. 
2013). It also showed the greatest effect, among several phenolic compounds, against a 
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group of bacterial strains including P. aeruginosa, S. aureus, Moraxella catarrhalis, E. 
faecalis, S. agalactiae and S. pneumonia (Cueva, Mingo et al. 2012). Gallic acid showed 
good activity against Campylobacter and produced bactericidal activity against two 
Campylobacter coli strains with MIC equal to 61.5-125 ?g/ml (Sarjit, Wang et al. 2015). 
In another study, the antibacterial activities of gallic acid and ferulic acid were detected 
???????? ?????????????????? ?????????????????????? ????????????????? ?????????????????????P.
aeruginosa?? ????? ?????? ????????E. coli?? ????? ?????? ???????? S. aureus ???? ????? ??????
against L. monocytogenes; MIC of f??????? ????? ???? ???? ?????? ???????? E. coli and P.
aeruginosa?? ????? ?????? ???? ????? ?????? ???????? S. aureus and L. monocytogenes, 
respectively. MBCs for both compounds against all microorganisms were 2500-5500 ?g/ 
ml (Borges, Ferreira et al. 2013).  
Gallic acid and ferulic acid affect the bacterial cell wall of S. aureus, E. coli and P. 
aeruginosa, producing local destruction and leakage of cellular contents (Borges, Ferreira 
et al. 2013). 
Wild Polish mushrooms which contained protocatechuic acid, 4-hydroxybenzoic acid, 
vanillic acid, syringic acid, caffeic acids, p-coumaric and ferulic acids, showed 
intermediate antibacterial activities with MIC ranged from 156 to 5000 ?g/ml, against a 
range of gram positive and negative bacteria with a stronger activity against gram-positive 
microorganisms (Nowacka, Nowak et al. 2015). (Figure 1.6) shows the structures of some 
phenols and phenolic acids like pyrogallol and gallic acid.  
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Figure ?1.6: Structures of several phenols and phenolic acids. 
 
Methyl gallate, a major metabolite from Galla rhois an Asian plant collected in Korea 
showed anti-Salmonella behavior against several Salmonella strains with MIC from 3.9 to 
125 ?g/ ml (Choi, Mun et al. 2014). The in vivo therapeutic activity of methyl gallate was 
well proved by the absence of lethargy and liver problems the two common consequences 
of Salmonella in treated mice (Choi, Mun et al. 2014). Methyl gallate demonstrated good 
antibacterial effect against E. coli and Shigella flexneri with MIC= 30 ?g/ml (Madikizela, 
Aderogba et al. 2013). 
Three Potentilla species were found to be rich in hyperoside, (+)-catechin, caffeic acid, 
ferulic acid, rutin and ellagic acid, which were tested for their antimicrobial activities. P. 
fruticosa had the highest effect against gram-positive bacteria, a gram negative bacterium 
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(P. aeruginosa) and a fungus Candida albicans with MIC values of 0.78-6.25 mg/ml 
(Wang, Wang et al. 2013). The structures of the methyl gallate and phenolic compounds 
detected in Potentilla species are shown in (Figure 1.7). 
 
Figure ?1.7: The structures of the methyl gallate and phenolic compounds detected in 
Potentilla species. 
 
Plant polyphenols interact with each other to improve the antibacterial actions (Tomas-
Menor, Barrajon-Catalan et al. 2015). Polyphenolic compounds present in a Cistus 
salviifolius extract showed synergism. Flavonoids in combination with ellagitannins in 
certain percentage showed inhibition against the growth of S. aureus (Tomas-Menor, 
Barrajon-Catalan et al. 2015).  
The combination of isoquercitrin (10 ?g/ml), (Figure 1.8) with gallic acid (10 ?g/ml) was 
successful in inhibiting the growth of S. aureus, while their MICs separately were 10 times 
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more (Soberon, Sgariglia et al. 2014). The ethyl acetate fraction from the ethanol extract of 
Searsia chirindensis was the most active antibacterial fraction, contained methyl gallate, 
myricetin-3-O-arabinopyranoside, myricetin-3-O-rhamnoside, kaempferol-3-O-rhamnoside 
and quercetin-3-O-arabinofuranoside. The MICs of these compounds ranged from 30 to 
250 ?g/ml against Campylobacter jejuni, E. coli, Shigella flexneri, and S. aureus 
(Madikizela, Aderogba et al. 2013). 
 
Figure ?1.8: The structure of isoquercitrin, a compound showed synergism with gallic acid 
against S. aureus.   
The seed kernels of Mangifera induce L. consisted of the following phenolic acids: gallic 
acid, methyl gallate and pentagalloyl glucopyranose. The extract inhibited the growth of 
MRSA, due to the major phenolic component, pentagalloylglucopyranose, which showed a 
synergism with penicillin G against MRSA (Jiamboonsri, Pithayanukul et al. 2011).  
The structures of flavonoid glycosides, ellagitannin and pentagalloyl glucopyranose are 
shown in (Figure 1.9).  
17 
 
 
Figure ?1.9: The structures of some flavonoid glycosides, ellagitannin and pentagalloyl 
glucopyranose. 
 
Some phenolic compounds like hydroquinone, thymol, carvacrol, butylated 
hydroxyanisole, and octyl gallate were assayed against S. aureus. As a result, octyl gallate 
had MIC equal to 21?g/ml; hydroquinone had MIC= ????????????????????????????????????
showed ????????????????????????(Rua, Fernandez-Alvarez et al. 2011).  
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Panduratin A a natural chalcone compound extracted from Kaempferia pandurata Roxb 
had potent activity against S. aureus with MIC equal to 0.06-2 ?g/ml. An interesting study 
of synergism between phenolic materials and penicillins demonstrated the lowering MIC 
of oxacillin around 500 times by epicatechin gallate (Cushnie, Lamb 2011, Rukayadi, Lee 
et al. 2009). The structures of compounds have activity against S. aureus (hydroquinone to 
epicatechin gallate) are shown in (Figure 1.10). 
 
Figure ?1.10: The structures of hydroquinone and other phenolic compounds recorded with 
anti-Staphylococcal activity. 
Acylphloroglucinols (Olympicins A-E) isolated from the aerial parts of the plant 
Hypericum olympicum L. cf. uniflorum were evaluated as antibacterial agents against 
MRSA and multidrug-resistant S. aureus. They were found to be very active. Olympicin A 
had MIC of 0.5-1 ?g/ml; others had MIC between 84 and 128 ?g/ ml against several S.
aureus isolates (Shiu, Rahman et al. 2012). Arzanol, a very strong anti-staphylococcal drug 
19 
 
from Helichrysum italicum subsp. Microphyllum, had MIC equal to 1-4 ?g/ml against 
different S. aureus strains (Taglialatela-Scafati, Pollastro et al. 2013). Potent fraction 
isolated from Hypericum beanie contained two acylphloroglucinols, 1,5-dihydroxy-2-???-
methylpropionyl)-3-methoxy-6-methylbenzene and 1,5-dihydroxy-2-???-methylbutanoyl)-
3-methoxy-6-methylbenzene. This mixture showed MIC equal to 16-32 ?g/ml against 
methicillin-resistant S. aureus (Po Shiu, Gibbons 2006). The structures of those 
acylphloroglucinols are shown in (Figure 1.11).  
 
Figure ?1.11: The structures of acylphloroglucinols.  
  
Catechin gallate, epicatechin gallate and epigallocatechin gallate showed ?-lactamase and 
PBP2a inhibition to potentiate the antibiotic activity against S. aureus and MRSA (Yam, 
Hamilton-Miller et al. 1998, Hu, Zhao et al. 2002, Sudano Roccaro, Blanco et al. 2004). 
Using epigallocatechin gallate (25 ?g/ml) can restore MIC of imipenem to < 4 ?g/ml 
against around 18 MRSA isolates out of 24 isolates (Hu, Zhao et al. 2002). 
Epigallocatechin gallate (50?g/ml) inhibited Tet (K) pump and increased intracellular 
concentration of tetracycline and ultimately its activity (Sudano Roccaro, Blanco et al. 
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2004). Epicatechin gallate decreased the MIC of norfloxacin four times against S. aureus 
with NorA (Gibbons, Moser et al. 2004). Catechins structures are shown in (Figure 1.12). 
 
Figure ?1.12: Structures of three catechins have resistance modification abilities. 
 
Ethyl gallate and other alky gallate caused cell wall disruption of the methicillin sensitive 
S. aureus (MSSA) and MRSA, and potentiated the antibacterial activities of ?-lactam 
antibiotics, probably by inhibition of PBP2a (Shibata, Kondo et al. 2005). Gallic acid 
showed synergism with sulfamethoxazole or tetracycline against several P. aeruginosa 
isolates (Jayaraman, Sakharkar et al. 2010) and with streptomycin against the same gram 
negative isolate (Saavedra, Borges et al. 2010) by disruptions of cell wall integrity. 
1.1.2.5. Quinones
Quinones are responsible for the brown color formed on the fruit and vegetable cut pieces; 
they are also intermediates in the melanin synthesis pathway in human skin (Schmidt 
1988). Quinones are electrophile and react readily with the nucleophile (amino acid) in 
proteins (Stern, Hagerman et al. 1996), leading to inactivation of the protein and loss of 
function. There is more than one mechanism which can illustrate the antimicrobial effects 
of quinones: they can bind to the cell wall polypeptide or membrane-bound enzymes. 
Murrayaquinone A had MIC equal to 50 ?g/ml against S. aureus (Chakraborty, 
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Chakraborty et al. 2014). ?-Hydroxyemodin (Citreorosein) from Cassia alata showed an 
MIC equal to 4 ?g/ml against S. aureus and 8 ?g/ml against B. cereus (Promgool, 
Pancharoen et al. 2014). (Figure 1.13) shows the structures of quinones mentioned in this 
section. 
 
Figure ?1.13: ?????????????????? ?????????????????????-Hydroxyemodin. 
 
1.1.2.6. Flavones and flavonols 
Flavones are phenolic structures with one carbonyl group, the presence of a 3-hydroxyl 
group in flavones yields flavonols (Fessenden, Fessenden 1982). Galangin (3,5,7-
trihydroxyflavone), derived from the perennial herb Helichrysum aureonitens showed 
activity against a wide range of gram-positive bacteria with MICs equal to 100 ?g/ml 
against B. cereus, 500 ?g/ml against B. subtilis, 500 ?g/ml against S. aureus and 100 
?g/ml against Enterobacter cloacae, but it was not active against E. coli (Afolayan, Meyer 
1997). 
The essential role of the hydroxyl groups on the (3-rings) of flavonoids is controversial, a 
research showed that the flavonoids lacking hydroxyl groups on their (3-rings) are more   
active against microorganisms than those with the hydroxyl groups since they are more 
lipophilic (Chabot, Bel-Rhlid et al. 1992). However, other research groups have reported 
the opposite effect, and have found that the more hydroxyl groups present on the 
flavonoids lead the greater antimicrobial activity (Sato, Fujiwara et al. 1996).  
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An isoflavone, 5,7-dihydroxy-2'-methoxy-3',4'-methylenedioxyisoflavanone was extracted 
from Uraria picta and showed MIC equal to 12.5 ?g/ml against S. aureus, 50 ?g/ml 
against B. subtilis, 100 ?g/ml against E. coli, 25 ?g/ml against Proteus vulgaris, 50 ?g/ml 
against Aspergillus niger and100 ?g/ml against candida albicans (Mukhlesur Rahman, 
Gibbons et al. 2007).   
Hydroxygenkwanin-8-C-??-rhamnopyranosyl-??????-?-glucopyranoside, isolated from 
the stem bark of Margaritaria discoidea, showed MICs of 500 ?g/ml against B. subtilis, S. 
aureus, Proteus vulgaris and  P. aeruginosa (Ekuadzi, Dickson et al. 2014). A flavonoid 
artonin I isolated from Morus mesozygia Stapf. showed an ability to block the bacterial 
efflux pump in multidrug-resistant (MDR) S. aureus?? ?????? ???? ???? ??? ?????? ?????
possible application as a resistance modification agent (Farooq, Wahab et al. 2014). All the 
structures of the compounds mentioned here in this section are shown in (Figure 1.14). 
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Figure ?1.14: Structures of flavones and flavonols with some antibacterial activities. 
  
1.1.2.7. Tannins  
Tannins are derived from bark, wood, leaves, fruits and roots. More than one type of 
tannins is available in nature and the hydrolysable tannins (gallic acid ester with D-
glucose) are less frequently found in nature than condensed tannin (proanthocyanidins) 
(Scalbert 1991). The antimicrobial action of tannins was attributed to their inhibition to 
microbial adhesions and complex formation with enzymes, cell envelope transport proteins 
and polysaccharide (Ya, Gaffney et al. 1988).  
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Condensed tannins were determined to bind cell walls of ruminal bacteria, and prevent   
growth and protease activity (Jones, McAllister et al. 1994).   
Corilagin, a compound classified as ellagitannin, showed weak antibacterial activities with 
MICs equal to 1000-2000 ?g/ml against B. subtilis and several gram-negative bacteria like 
E. coli. ????????????????????????????????. Ellagitannins fraction from Acalypha wilkesiana 
var. macafeana hort showed moderate activity against S. aureus and its congener MRSA 
with inhibition zone of 11 and 8 mm respectively. The minimum bactericidal concentration 
against MRSA was 3000 ?g/ml (Din, Jin et al. 2013).  
The proanthocyanidins had stronger antibacterial abilities than catechins (Amarowicz, 
Pegg et al. 2000); they exerted their antibacterial activities by complexing with protein 
structures in the bacterial cells. For example, proanthocyanidins from green tea was shown 
to bind proteins and enzymes in E. coli (Amarowicz, Pegg et al. 2000). (Figure 1.15) 
shows the structure of corilagin and proanthocyanidins.  
 
Figure ?1.15: Structures of corilagin and proanthocyanidins  
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1.1.2.8. Coumarins  
Coumarins are phenolic substances made of fused benzene and ?-pyrone rings 
?????????????????????????. They are responsible for the characteristic odor of hay and 
possess antithrombotic (Thastrup, Knudsen et al. 1985), anti-inflammatory (Piller 1975) 
and vasodilator (Namba, Morita et al. 1988) actions. Estrogenic effect of coumarin has also 
been detected (Soine 1964). Coumarins were found to stimulate macrophages (Casley-
Smith, Casley-Smith 1997), which could have an indirect effect on infections.  
The hydroxylated derivatives of coumarins which are produced in carrots were responsible 
for the antifungal activity (Hoult, Paya 1996). Isomammein from Mammea africana had 
strong antibacterial activities against Campylobacter jejuni, Clostridium difficile, S. 
pneumoniae with MIC of 0.25-0.5 ?g/ml (Canning, Sun et al. 2013). Four coumarin 
derivatives isolated from Arracacia tolucensis var. multifidi: osthole, suberosin, 8-
methoxypsoralen (methoxalen), and herniarin appeared to be active against the bacterium 
causing tuberculosis (Mycobacterium tuberculosis); the best activity was attributed to 8-
methoxypsoralen with its MIC equal to 16?g/ml (Figueroa, Rivero-Cruz et al. 2007).  
Licopyranocoumarin and glycyrin isolated from Glycyrrhiza uralensis showed MIC of 330 
and 42 ?M against Enterococcus faecium, respectively (Eerdunbayaer, Orabi et al. 2014). 
Coumarins structures are shown in (Figure 1.16). 
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Figure ?1.16: Structures of several coumarins recorded with good antibacterial activities. 
 
1.1.2.9. Alkaloids 
Alkaloids are nitrogen containing compounds with basic properties. Tetrandrine isolated 
from Stephania tetrandra S. Moore showed MIC equal to 128 ?g/ml against MRSA (Zuo, 
Li et al. 2011). Two alkaloids from Boophone disticha, buphanidrine and distichamine 
showed antibacterial activities with MIC equal to 63 ?g/ml against S. aureus, E. coli and 
Klebsiella pneumoniae (Cheesman, Nair et al. 2012). Oxyphylline B extracted from 
Zizyphus oxyphylla ???????????????????????????????????????????S. aureus ????????????
against E. coli (Kaleem, Nisar et al. 2012). Tegerrardin A isolated from Zanthoxylum 
zanthoxyloides showed moderate antibacterial effect with MIC equal to 500 ?g/ml against 
S. aureus and its MIC against B. subtilis was = 250 ?g/ml (Wouatsa, Misra et al. 2013).  
Berberine an alkaloid isolated Berberis microphylla G. Forst had MIC equal to 167 ?g/ml 
against S. aureus and S. epidermidis, but it was inactive against B. cereus and B. subtilis 
(Manosalva, Mutis et al. 2016). The structures of alkaloids mentioned in this section are 
shown in (Figure 1.17). 
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Figure ?1.17: Structures of several alkaloids recorded with antibacterial activities. 
  
1.1.2.10. Oligosaccharides 
Oligosaccharides have been detected to have antibacterial activity. Tricolorin A isolated 
from Ipomoea tricolor the Mexican Morning Glory Species showed MICs equal to 16, 8, 8 
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and 4 ?g/ml against S. aureus strains ATCC 25923, XU-212, SA-1199B, EMRSA-15, 
respectively. Orizabin VIII isolated from the same plant showed MIC equal to 4-32 ?g/ml, 
against those strains (Pereda-Miranda, Kaatz et al. 2006). The structures of tricolorin A and 
orizabin VIII are shown in (Figure 1.18).  
 
Figure ?1.18: The structures of two oligosaccharides (tricolorin A and orizabin VIII) have 
antibacterial activities. 
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1.2. Discovery of the antiplasmodial agents  
1.2.1. Malaria and antiplasmodial drugs resistance problem 
Malaria is an infectious disease caused by the protozoa Plasmodium. It is widely spread in 
tropical countries, affecting 214 million persons in 2015, a twenty percentage less than the 
cases recorded in the year 2000 which were around 262 million, with 88% of the cases 
recorded in Africa (World Health Organization 2015). The causative agent of malaria is 
transmitted to the human biological compartments via a certain type of mosquito. There are 
about 3,500 mosquito species and those that transmit malaria all belong to a subset called 
the Anopheles. Approximately 40 Anopheles species are able to transmit malaria, causing 
serious human illness and death.  
The four main parasites species causing malaria in human being are Plasmodium
falciparum, P. vivax, P. ovale, and P. malariae (Grimberg, Mehlotra 2011). The most 
lethal specie is P. falciparum (Grimberg, Mehlotra 2011).  
Phytotherapy plays an important role in the efficient treatment of malaria. The Cinchona 
species are well known for their antimalarial properties due to their bioactive alkaloid 
quinine (White 1985). For the treatment of malaria, quinine was widely used as the major 
antimalarial drug, it was originally isolated in 1820 by the French pharmacists Caventou 
and Pelletier from the bark of Cinchona species (e.g., Cinchona officinalis), which is used 
by Amazon people as antipyretic and in the early 1600s used in Europe for the treatment of 
malaria. 
Quinine is an aryl amino alcohol and is usually kept as the last line in malaria therapy via 
intravenous injection. Doxycycline is usually used concurrently with quinine to increase its 
effect (Grimberg, Mehlotra 2011). The resistance to quinine started in South East Asia and 
South of America in the 1960s. 
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Quinine causes several adverse effects like arrhythmia and hypoglycemia (Schlitzer 2008). 
The mechanism of action of quinine is similar to chloroquine. The transporting proteins 
PfCRT (the chloroquine resistance transporter) and PfMDR1 (the multidrug resistance 
transporter) and PfNHE1 (sodium/hydrogen exchanger 1) are responsible for removal of 
quinine from the parasite and leads to a decrease in its activity (Cheruiyot, Ingasia et al. 
2014). 
In the 1930s, quinine was largely replaced by a series of synthetic drugs including 8-
aminoquinolines (e.g. primaquine), 4-aminoquinolines (e.g. chloroquine, amodiaquine) and 
folic acid synthesis inhibitors (e.g. proguanil, pyrimethamine).  
The resistant strains to chloroquine emerged in the 1950s, just ten years after its launch as 
a drug in the 1940s. The resistance problem began in South East Asia and South of 
America (Grimberg, Mehlotra 2011, Farooq, Mahajan 2004). Chloroquine inhibits the 
formation of haemozoin, the haem polymer. Haem in the un-polymerized form causes 
destruction of the parasite membrane and death (Combrinck, Mabotha et al. 2013). 
Parasites sensitive to chloroquine accumulate chloroquine molecules in the digestive 
vacuole (Krogstad, Gluzman et al. 1987) and the resistance to this drug is attributed to 
change in this property. Transporting proteins PfCRT and PfMDR1 are responsible for 
chloroquine and multidrug resistance respectively (Ding, Beck et al. 2011, Eyasu 2015). 
Structures of the natural compound (quinine), chloroquine and other synthetic 
antiplasmodial drugs are shown in (Figure 1.19). 
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Figure ?1.19: Structures of quinine and some synthetic antiplasmodial compounds. 
 
Resistance emerged in both the vector and the parasite itself; the vector mosquito 
developed resistance to the potent insecticides such as dichlorodiphenyltrichloroethane 
(DDT) and by the early 1980s, several strains of P. falciparum had become multi-drug 
resistant. Decrease the accumulation of drugs in the parasite and affinity to the specific 
drug targets are the two major mechanisms of resistance (White 1999). 
Mefloquine is a 4-aminoquinoline launched in the 1970s to treat chloroquine resistance 
(Schlitzer 2008) and works by prevention of haemozoin accumulation. Unfortunately the 
resistance to this drug was first observed ten years later in the Thai-Cambodian border 
where it was used intensively, in the Amazon and to a less extent in Africa (Farooq, 
Mahajan 2004). An amplified PfMDR1 gene is responsible for the resistance 
(Preechapornkul, Imwong et al. 2009). Artesunic acid in combination with mefloquine was 
used to overcome resistance (Price, Nosten et al. 1995).  
The Plasmodium parasites biosynthesize folate using two enzymes: dihydropteroate 
synthase (DHPS) and dihydrofolate reductase (DHFR) (Dondorp, Fanello et al. 2010). 
Pyrimethamine and cycloguanil inhibit DHFR and interrupt folate synthesis. Sulfadoxine 
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and dapsone block the effect of DHPS (Dondorp, Fanello et al. 2010). Blocking the 
process of folate synthesis in the parasite, will lead to decrease the production of amino 
acids and parasite death (Sibley, Hyde et al. 2001). Fansidar® a drug contains sulphadoxine 
and pyrimethamine successively inhibits DHPS and DHFR (Petersen, Eastman et al. 2011, 
Sridaran, McClintock et al. 2010). 
Mutation in genes responsible for DHPS and DHFR formation leads to decrease of their 
affinity to the drug and new resistance cases to Fansidar® have emerged (Gesase, Gosling 
et al. 2009). To address such resistance problem, a combination of chlorproguanil and 
dapsone was introduced to treat those resistance cases (Sridaran, McClintock et al. 2010). 
Structures of mefloquine, artesunic acid and inhibitors of DHFR and DHPS are shown in 
(Figure 1.20). 
 
Figure ?1.20: Structures of mefloquine, artesunic acid, and inhibitors of DHFR and DHPS. 
 
Artemisinin, a sesquiterpene lactone from Artemisia annua, was a milestone in the 
treatment arsenal of malaria ????????????? ???????? 1989, Wright 2005). It has an 
endoperoxide structure which is important for the antimalarial activities (Klayman 1985). 
Artemisinin is safer than chloroquine and it has a higher chemotherapeutic index. It is 
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effectively applied in the treatment of chloroquine-resistant strains of human malaria 
(Warhurst 1985). A reduction of the lactone ring in artemisinin gives its reduced form 
dihydroartemisinin which is more active than the original molecule (Wright 2005). (Figure 
1.21) shows the structures of artemisinin and dihydroartemisinin.  
 
Figure ?1.21: Structures of artemisinin and its reduced congener dihydroartemisinin 
 
The drug, artemisinin (Grimberg, Mehlotra 2011) acts by alkylating the parasites protein?s 
which leads to their damage (Meshnick, Taylor et al. 1996). The drug appeared to inhibit 
the uptake of radio-active hypoxanthine, indicating a decrease in nucleic acid synthesis 
(Saxena, Pant et al. 2003). The semisynthetic drugs of artemisinin such as artesunic acid 
were combined with mefloquine in order to increase the treatment efficacy and treat the 
condition within three days (Beeson, Boeuf et al. 2015). Despite the effectiveness of 
artemisinin, there have been reports of artemisinin treatment failure in South-East Asia 
(Burrows, Leroy et al. 2011, Grimberg, Mehlotra 2011). The proteins contributing to the 
resistance of artemisinin are PfCRT, PfMDR1 and PfATP6 (P. falciparum calcium-
dependent ATPase) (Zakeri, Hemati et al. 2012).  
1.2.2. Recent advances of antiplasmodial natural compounds from plants 
Mortality rate has been increased due to the emergence and spread of multidrug-resistant 
Plasmodium falciparum parasite to the antiplasmodial compounds (Guantai, Chibale 2011, 
Ginsburg, Deharo 2011), therefore there was an urgent need to identify new drugs for the 
treatment of malaria (Sinha, Medhi et al. 2014). The search for new leads for the 
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development of treatments for malaria is a continuous process, which has drawn attention 
to drug discovery of new medicinal agents (McCracken, Kaiser et al. 2012).  
WHO has established four stages to search for antiplasmodial drugs. The first stage is the 
primary screening of active molecules in order to find which one is active in vitro as 
antiplasmodial. The second step is further evaluation of the extent of activity, analysis of 
the quantity of the effect, and running the experiments required to determine the marginal 
safety of the tested molecule and comparative activities of analogues synthesised from the 
natural lead. The third stage is the study of various parasites (non-human and human) in 
biological systems. The fourth stage is the clinical bio-evaluation step (Mojab 2012).  
Towards the search of new-antiplasmodial drugs, several recent reports have described the 
high throughput screening (HTS) of massive number of natural compounds and the 
identification of novel chemical scaffolds to be taken forward for development (Gamo, 
Sanz et al. 2010).  
Prioritizing these compounds for further exploration of their pharmacokinetic and 
pharmacodynamics properties is essential and has been the focus of several recent 
developments in assay formats, and compounds extracted can be grouped into different 
ranks according to their properties and biological activities (Bahamontes-Rosa, Rodríguez-
Alejandre et al. 2012, Sanz, Crespo et al. 2012).  
Much effort has been made to explore the antimalarial abilities of plants; an important 
research published in (Lloydia) has been done by Spencer CF et al (1947) to reveal the 
antimalarial activities of 600 plants from 126 families, their extracts tested for activities, 
against P. gallinaceum in chickens, P. chatemerium and P. lophurae in ducklings. Thirty 
species yielded extracts which were active against these types of malaria affecting birds 
?????????????????????1989). 
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The natural extracts with moderate activity in vitro or in vivo may have an important role 
in the treatment of malaria in mankind by modifying the disease course; shortening the 
period of illness by reducing anaemia, fever, and pain (Wright 2005). Finally, it is 
important to stress that plant extracts could also be effective against the parasite on hepatic 
stage. The results from in vitro experiments will enable researchers to decide whether the 
natural materials possess promising antiplasmodial activities should be followed by in vivo 
assays or not, however, most in vivo assays use parasites types unusual for the human 
being. The four-day suppressive test with P. berghei in rodents predicts antimalarial 
activity and toxicity in humans (Fandeur, Moretti et al. ??????????????????????????1989). 
1.2.2.1. Antiplasmodial assay methods 
Protozoa are microscopic and single-cell microorganisms that can be free-living or 
parasitic in nature and are able to multiply in humans.  
The methods of in vitro culturing of the parasites causing malaria were developed within 
the last forty years. To test effects of the chemical compounds against Plasmodium species, 
researchers used a method called radiolabelled microorganisms technique where the 
erythrocyte infection was assayed with microtiter dishes (Francois, Ake Assi et al. 1996). 
In this case, [3H (G)]-hypoxanthine monohydrochloride was used to label the parasite 
Plasmodium falciparum (Desjardins, Canfield et al. 1979, Wright 2005).  
A study developed by Makler in 1993 used lactate dehydrogenase (pLDH) assay as an 
alternative to the use of the radioactive material[3H(G)]-hypoxanthine monohydrochloride, 
the results produced were fast and accurate and provided an economic alternative to older 
methods (Makler, Ries et al. 1993, Wright 2005). 
Defining the antiplasmodial mode of activity like the formation of toxic drug-haem 
complex to the parasite has been an achievable task now (Parapini, Basilico et al. 2000). 
For example, the mechanism of action of artemisinin which has an active site consisting of 
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a bridge between two oxygen atoms links to haem and produces free radicals to kill the 
parasites (Wright, Warhurst 2002).     
SYBR Green I method is a reproducible, direct and economic method which can be 
defined as an alternative to the determination of parasite growth using a radioactive 
material. The parasitized erythrocytes are incubated with and without test substances, and 
then the Plasmodium organisms after certain period of incubation with SYBR dye are 
measured quantitatively. The fluorescence energy can be measured and dose- response 
curve to determine the IC50 of the drug can be sketch (Smilkstein, Sriwilaijaroen et al. 
2004). 
There have been different classifications with regard to the potency of the plant extracts 
and pure compounds in the literature. According to the potency of antiplasmodial activity 
in vitro Basco et al. (1994) specified that antiplasmodial compounds with IC50 < 10 ??????
is good; IC50 of 10-??? ??????? ??? ????????? ??? ?????????? IC50 of 50-???? ??????? ??? ???? ???
activity; and IC50 ??????????????????????????????????(Basco, Mitaku et al. 1994, Dolabela, 
Oliveira et al. 2008).  
On the other hand, Muriithi et al. (2002) classified compounds as inactive with IC50 > 100 
????????????????????????????????????IC50 of 1?????????????????????????????????????????????
IC50 of 20???????(Muriithi, Abraham et al. 2002).  
Batista et al. (2009) have been established a new classification of antiplasmodial drugs 
according to in vitro activity, compounds with IC50 ???????????????????????????????????IC50 
of 1-??????????????????????IC50 of 20-???????????????????????????IC50 of 100-????????????
activity; and IC50 ???????????????????(Batista, Silva Ade et al. 2009).  
Recently, plant extracts with antiplasmodial activities are classified on the basis of their 
IC50s to be highly active (? 5 ?g/ml), promisingly active (5-10 ?g/ml), have good activity 
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(10 -20 ?g/ml), moderate activity (20-40 ?g/ml), marginal potency (40-70 ?g/ml), poor or 
??????????????????????(Singh, Kaushik et al. 2015). 
Furthermore, two important indices are used to quantify the resistance and selectivity 
properties of the chemical compounds, the resistance index has been defined as the ratio 
between the IC50 values of a given compound against resistant strain and the sensitive 
strain, while the selectivity index is the ratio of the IC50 value of such substance against 
host normal cell line to that against the target strain.  
Accordingly, a desirable chemotherapeutic lead structure should present both low 
resistance index and high selectivity index (Pedersen, Chukwujekwu et al. 2009).  
In the following sections examples of plant natural compounds with antiplasmodial activity 
in different chemical classes will be discussed. The chloroquine sensitive plasmodium 
strains often used were Plasmodium falciparum MRC2; P. falciparum 3D7; P. falciparum 
D6; P. falciparum CDC1; P. falciparum NF54; P. falciparum D10. The chloroquine 
resistant strains used were P. falciparum RKL9; P. falciparum FCR3; P. falciparum W2; 
P. falciparum K1; P. falciparum FZR-8; and, P. falciparum Dd2. 
1.2.2.2 Alkaloids 
??????????????????????????????????????????????????????????????????????????????????????
defending the human beings against malaria. Quinine is the first member of this family, 
which is discussed extensively above. 
Orthidine F from the New Zealand ascidian Aplidium orthium, showed its IC50 of 0.89 ?M 
against P. falciparum K1 strain (dual drug resistant strain). One of its analogues, 1,14-
spermine-di-(2-hydroxyphenylacetamide) showed higher activities with IC50 of 8.6 nM 
against P. falciparum K1 strain. (Liew, Kaiser et al. 2013). Indolisoquinoline alkaloid, 
cryptolepine isolated from Cryptolepis sanguinolenta showed IC50 of 0.03 ?g/ml (134 
nM). This activity is higher than that of chloroquine against P. falciparum K1 in vitro; 
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however, it has no effect against P. berghei in an in vivo study conducted in mouse (Kirby, 
Paine et al. 1995). Later, a synthetic compound 2, 7-dibromocryptolepine was shown to be 
potent and less toxic than cryptolepine in mouse (Wright, Addae-Kyereme et al. 2001).   
Bisbenzylisoquinoline alkaloids isolated from Stephania erecta were active against 
chloroquine-sensitive P. falciparum. (+)-2-N-methyltelobine showed IC50 of 0.25 ?g/ml 
(444 nM) against P. falciparum W2 strain (Likhitwitayawuid, Angerhofer et al. 1993). 
These alkaloids have one or two N-methyl groups; however the presence of two N-methyl 
groups decreases the antiplasmodial activity against both sensitive and resistant parasites 
(Likhitwitayawuid, Angerhofer et al. 1993). Dehatrine, an alkaloid from Beilschmiedia
madang exerted an antiplasmodial effect with an IC50 equal to 17 ?M against P.
falciparum (Kitagawa, Minagawa et al. 1993). 
Tazopsine a novel morphinan alkaloid extracted from Pseuduvaria setosa showed IC50s 
equal to 4.7 ?M and 5.7 ?M against P. falciparum 3D7 and P. falciparum FCR3, 
respectively (Carraz, Jossang et al. 2006). 8-Acetonyldihydronitidine from Feroniella
lucida showed IC50 equal to 0.336 ?g/ml (0.82 ?M) against P. falciparum K1 (Sripisut, 
Cheenpracha et al. 2011). 2-Hydroxyathersperminine isolated from the stem bark of 
Cryptocarya nigra, showed IC50 of 0.75 ?M against P. falciparum K1 (Nasrullah, Zahari et 
al. 2013). Olivacine isolated from Aspidosperma ulei Markgr, this alkaloid showed a weak 
antiplasmodial activities IC50 4.5 mM against P. falciparum K1 (dos Santos Torres, 
Silveira et al. 2013). 
Pseudopalmatine extracted from Stephania rotunda Lour a climber plant distributed in the 
high mountains of Cambodia showed an IC50 ?????? ??????????????????P. falciparum W2 
(Baghdikian, Mahiou-Leddet et al. 2013). N-methyl-tetrahydrolivacine isolated from
Aspidosperma olivaceum showed an IC50 of 5.7 ?g/ml (20.45 ?M) against P. falciparum 
W2 (Chierrito, Aguiar et al. 2014). 
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(-)-O-O-dimethylgrisabine a bisbenzylisoquinoline alkaloid and (-)-milonine, a 
morphinandienones alkaloid both extracted from the bark of Dehaasia longipedicellata 
showed IC50 equal to 0.031 ?M and 0.097 ?M against P. falciparum K1, respectively. 
(Zahari, Cheah et al. 2014). 
Normelicopidine isolated from Zanthoxylum simullans Hance (a common traditional 
Chinese medicine herb) showed IC50 equal to 21.1 ?g/ml (70.5 ?M)  against P. falciparum 
Dd2 (Wang, Wan et al. 2014). Aspidoscarpine was extracted from Aspidosperma
olivaceum a plant used locally in some regions of Brazil for alleviation of fever. 
Aspidoscarpine showed IC50 equal to 5.4 ?g/ml (14.5 ?M) against P. falciparum W2 
(Chierrito, Aguiar et al. 2014). The structures of alkaloids mentioned in this section are 
shown in (Figure 1.22). 
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Figure ?1.22: Structures of alkaloids with antiplasmodial activities. 
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1.2.2.3. Quassinoids 
Quassinoids are degraded triterpenoids isolated from the plants of Simaroubaceae family. 
Usually their carbon skeletons are C-18, C-19, C-20, C-22 and C-25, with many oxygen 
bearing groups attached (Guo, Vangapandu et al. 2005). Quassinoids have many biological 
activities of which, antineoplastic and antiplasmodial are well reported. Bruceantin and 
bruceine A were isolated from Brucea javanica, and they showed very impressive IC50s of 
0.0008 ?g/ml (0.0014 ?M) and 0.011 ?g/ml (0.021 ?M) against P. falciparum K1 strain 
respectively (Anderson, O'Neill et al. 1991, Sharma, Agarwal 1993). 
Orinocinolide and simalikalactone D isolated from Simaba orinocensis showed very low 
IC50s of 3.27 and 8.53 ng/ml (0.0068 and 0.0177 ?M) against P. falciparum D6, and 3.0 
and 3.67 ng/ml (0.0062 and 0.0075 ?M) against P. falciparum W2, respectively 
(Muhammad, Bedir et al. 2004). Cedronin is a quassinoid isolated from Simaba cedron and 
its IC50 against P. falciparum FZR-8 was 0.25 ?g/ml (0.68?M) (Moretti, Deharo et al. 
1994). A Quassia indica product called samaderine X showed good effect against P. 
falciparum K1 with a low IC50 of 0.015 ?M (Kitagawa, Mahmud et al. 1996).  
In general, the group of quassinoid compounds from plants showed excellent anti-
plasmodial activities. Structures of several quassinoids mentioned above are shown in 
(Figure 1.23).   
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Figure ?1.23: Structures of several quassinoids (potent antiplasmodial compounds) 
 
1.2.2.4. Sesquiterpenes 
The most famous example of sesquiterpene group is artemisinin, a strong antiplasmodial 
compound isolated from Artemisia annua as discussed in details above. 10,12-
peroxycalamenene showed potent effect against P. falciparum K1 with IC50 equal to 2.33 
?M (Thebtaranonth, Thebtaranonth et al. 1995). Neurolenin A isolated from Neurolaena 
lobate showed IC50 equal to 0.92 ?M against P. falciparum NF-54 (Francois, Passreiter et 
al. 1996). Nardoperoxide a compound with Endoperoxide Bridge was extracted from 
Nardostachys chinensis and showed IC50 equal to 1.5 ?M against P. falciparum NF-54 
(Takaya, Kurumada et al. 1998).  
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The sesquiterpene lactone lipiferolide of Liriodendron tulipifera L. showed its IC50 equal 
to 1.8 ?g/ml (5.8 ?M) against P. falciparum D10 and 2.3 ?g/ml (7.5 ?M) against Dd2 a 
chloroquine resistant strain (Graziose, Rathinasabapathy et al. 2011). Urospermal A-15-O-
acetate extracted from Dicoma tomentosa showed a low IC50 of <1 ?g/ml (<3.1 ?M) 
against P. falciparum 3D7 and W2 (Jansen, Tits et al. 2012). The structures of these 
sesquiterpenes are shown in (Figure 1.24). 
 
Figure ?1.24: Structures of some sesquiterpenes with antiplasmodial activities. 
 
1.2.2.5 Triterpenoids 
There are many compounds with antiplasmodial activities reported in the triterpenoid 
group, gedunin is a limonoid closely related to quassinoids, which can produce a 
quassinoid like structure after treatment with base (Bray, Warhurst et al. 1990). Gedunin 
isolated from Azadirachta indica (L) showed IC50 of 0.72 ?g/ml (1.5 ?M) against P.
falciparum K1 (Bray, Warhurst et al. 1990). The reduction of (???-unsaturated) ketone 
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produced dihydrogedunin which had less antiplasmodial activity (IC50 2.62 ?g/ml (5.4 
?M)).  
Betulinic acid extracted from Triphyophyllum peltatum showed an IC50 equal to 10.46 
?g/ml (22.9 ?M) against P. falciparum NF-54 (Bringmann, Saeb et al. 1997). 
Dihydrobruceajavanin A isolated from Brucea javanica had IC50 equal to 2.5 ?g/ml (4.3 
?M) against P. falciparum K1 (Sharma, Agarwal 1993). All of these triterpenes are shown 
in (Figure 1.25). 
 
Figure ?1.25: Structures of some triterpenes with antiplasmodial activities. 
  
1.2.2.6. Flavonoids and their glycosides 
3,7-dihydroxy-??-(4-hydroxy-3-methylbutyl)-??????-trimethoxyflavone and 5,7-dihydroxy-
??-(2-hydroxy-3-methyl-3-butenyl)-??????-trimethoxyflavone isolated from Duranta
repens, showed good antiplasmodial activity against  P. falciparum D6 and W2 with IC50s 
ranging between 6.4 ?M and 7.0 ?M,  respectively (Ijaz, Ahmad et al. 2010).  
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3-O-methylquercetin extracted from Tagetes minuta L. showed IC50 ?????????????? ??????
?M) against P. falciparum D6 (Al-Musayeib, Mohamed et al. 2014).      
Afzelin, quercitrin and myricitrin were extracted from the aerial parts of Euphorbia hirta 
Linn and showed IC50 of to 1.1 (2.5), 4.1 (9.1) and 5.4 (11.6) ?g/ml (?M) against P.
falciparum CDC1, respectively (Liu, Murakami et al. 2007). The structures of flavonoids 
and flavonoid glycosides are shown in (Figure 1.26). 
 
 
Figure ?1.26: The structures of flavonoids and flavonoid glycosides with antiplasmodial 
activities. 
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1.2.2.7. Xanthones 
Gerontoxanthone I, macluraxanthone and formoxanthone C were isolated from Cratoxylum
maingayi and assayed against P. falciparum K1, which showed IC50 equal to 1.68 (4.2), 
1.35 (3.4) and 1.19 (3)  ?g/ml (?M) respectively (Laphookhieo, Maneerat et al. 2009). 
???????? ?????????? ?-mangostin extracted from Garcinia mangostana and its IC50 was 
determined to be 2.2 ?M against P. falciparum K1 (Al-Massarani, El Gamal et al. 2013). 
The structures of these xanthones with antiplasmodial activity are shown in (Figure 1.27).  
 
Figure ?1.27: The structures of xanthones with antiplasmodial activities. 
 
1.2.2.8 Quinones and anthracene 
Quinones like digitolutein and damnacanthal were extracted from Morinda lucida, and 
their IC50 against P. berghei were determined to be 12.92 and 9.2 ?g/ml (48.2 and 32.6 
?M) respectively (Koumaglo, Gbeassor et al. 1992). Plumbagin was isolated from 
Nepenthes thorelii and its IC50 against P. berghei (in vitro) was 0.27 ?M 
(Likhitwitayawuid, Kaewamatawong et al. 1998). Vismione B and vismione F were 
isolated from Cratoxylum cochinchinense and showed IC50 equal to 0.66 ?g/ml and 2.02 
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?g/ml (1.68 and 4.9 ?M) against P. falciparum K1, respectively (Laphookhieo, Maneerat 
et al. 2009). The quinones and anthracene structures are shown in (Figure 1.28).  
 
 
Figure ?1.28: The structures of quinones and anthracene structures with antiplasmodial 
activities. 
In summary, we are living in a crucial time to find new compounds able to fight multi-drug 
resistance pathogens. The plant kingdom is an indispensable source for both antimicrobials 
and resistance modifying agents. Natural products can offer special stereochemistry and 
unlimited diversity of natural compounds leads which are biologically active or ready for 
the development and structural optimization strategies. 
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1.3. Plants used in current research 
1.3.1. Cylicodiscus gabunensis 
Cylicodiscus gabunensis Harms, family Mimosaceae (CG) is a large tree which reaches 60 
m in height, straight cylindrical and 11 m in girth, swollen at the base, natively distributed 
in the rainforests of West and Central Africa (Hutchinson, Daziel 1968). 
The bark of CG used as an analgesic, antipyretic, anti-inflammatory, and for the treatment 
of jaundice and malaria by the Ibibio of Niger Delta region of Nigeria (Okokon, Ita et al. 
2006). For the treatment of malaria, fever and internal abscess a decoction is prepared and 
used of two to three cups per day for 15 days (Ndah, Egbe et al. 2013).  
The blood schizontocidal activities of the stem bark extract of CG was evaluated against 
Plasmodium berghei infection in mice. CG extracts administered orally, at 20?60 
mg/kg/day exhibited a significant (P < 0.05) blood schizontocidal activity in 4-day early 
infection, repository evaluation and in established infection with a significant mean 
survival time comparable to that of the standard drug, chloroquine, 5 mg/kg/day (Okokon, 
Ita et al. 2006). 
The ethyl acetate extract of C. gabunensis showed broad antibacterial activities against 
several clinical isolates (Kouitcheu Mabeku, Kouam et al. 2006). A study was conducted to 
define the toxicity level of CG extract against mice. The LD50 of the alcoholic bark extract 
administered intraperitoneally was 223.6 mg/kg while doses of 250 mg/kg and above were 
found to be lethal to mice (Okokon, Ita et al. 2006).  
There have been a lot of chemical characterizations of C. gabunensis. Urs-12-ene-3,28-
?????? ?-amyrin-n-?????? ??????? ???-hydroxyolean-12-en-??-yl-?-D-galactopyranoside, and 
24-hydroxyolean-12-en-??-yl-?-D-glucopyranoside (structures are shown in Figure 1.29) 
were detected from the stem root of this plant (Mkounga, Tiabou et al. 2010). 
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Figure ?1.29: Structures of compounds isolated from the stem root of Cylicodiscus
gabunensis by Mkounga et al. 2012. 
Five triterpenoid saponins (Tchivounda, Koudogbo et al. 1991), cylicodiscic acid 
(Tchivounda, Koudogbo et al. 1990, Tane, Bergqust et al. 1995), lupeol, betulinic acid and 
cyclodione (Tane, Bergqust et al. 1995) were also isolated and characterized from the bark 
of CG. The structures of cylicodiscic acid, lupeol, betulinic acid and cyclodione are shown 
in (Figure 1.30).  
 
Figure ?1.30: The structures of cylicodiscic acid, lupeol, betulinic acid and cyclodione 
isolated from the bark of Cylicodiscus gabunensis.  
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A triterpenoid glycosides (Gabunoside) or (3-O-??-L-arabinopyranosyl-?????-?-L-
arabinopyranosyl-?????-?-D-glucopyranosyl] maslinic acid-28-?-L-rhamnopyranosyl 
ester), cylicodiscoside, and 3-O-??-L-arabinopyranosyl-?????-?-D-glucopyranosyl] 
cylicodiscic acid were isolated from the stem bark (Tene, Chabert et al. 2011). Despite the 
extensive phytochemical studies of CG, the exact active principles responsible for the 
antiplasmodial and antibacterial activities are yet to be confirmed. The structures of the 
chemical compounds isolated from the stem bark of Cylicodiscus gabunensis by Tene et al, 
2011 are shown in (Figure 1.31).  
 
Figure ?1.31: The structures of the chemical compounds isolated from the stem bark of 
Cylicodiscus gabunensis by Tene et al, 2011. 
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1.3.2. Pogostemon cablin  
Pogostemon cablin (Blanco) Benth, family Lamiaceae (PC) is a traditional Chinese 
medicine used for the treatment of common cold, nausea, diarrhoea, headache and fever 
(Yang, Kinoshita et al. 1999). The chemical composition of the essential oil from 
Pogostemon cablin has been previously characterized using gas chromatography-mass 
spectrometry (GC-MS) (Hu, Li et al. 2006) and GC-MS-MS (Wu, Lu et al. 2004). Many 
terpenes such as patchouli alcohol and pogostone have been discovered in this plant 
(structures are shown in Figure 1.32). 
The essential oil and its constituents showed antibacterial activity against periodontopathic 
bacteria (Osawa, Matsumoto et al. 1990), and antifungal activity against Candida albicans 
(Liu, Luten et al. 2012, Yi, He et al. 2013). Patchouli alcohol from Pogostemon cablin also 
shows dose-dependent activity against anti-influenza virus A/PR/8/34 (H1N1) with an IC50 
value equal to 2.6 ?M (Kiyohara, Ichino et al. 2012). The time kill kinetics of PC main 
constituents (patchouli alcohol and pogostone) against S. aureus and E.coli and SEM study 
of their effects on S. aureus are yet to be known.   
 
Figure ?1.32: Structures of patchouli alcohol and pogostone, the main metabolites of 
Pogostemon cablin. 
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1.3.3. Perilla frutescens  
Perilla frutescens (L.) Britt, family Lamiaceae (PF) is widely used as traditional Chinese 
medicine for the treatment of cold symptoms and as food additive (Qiu, Zhang et al. 2011). 
The volatile constituents of the steam distillate of the green leaves of Perilla frutescens 
showed broad antimicrobial activity (Kang, Helms et al. 1992).  
The extract of Perilla frutescens seeds and a constituent, luteolin, also showed an 
antimicrobial effect against cariogenic streptococci and periodontopathic Porphyromonas 
gingivalis (Yamamoto, Ogawa 2002). Perilla frutescens oil inhibited the production of 
Staphylococcal enterotoxins which may be used as an additive to ?-lactam antibiotics for 
the treatment of S. aureus infections (Qiu, Zhang et al. 2011).  
Its essential oil and perilla ketone also showed significant anti-Bacillus and anti-Shigella 
activity (Lim, Shin 2014). The chemical compositions of the essential oil extracted from 
Perilla  frutescens from different countries has been investigated, in which perillaldehyde; 
???????? ???????? ????????? ???? ?-caryophylline were all found to be the main volatile 
components (Huang, Lei et al. 2011, Liu, Wan et al. 2013, Seo, Baek 2009). (Figure 1.33) 
shows the structures of several metabolites detected in Perilla frutescens. Assaying the 
antimicrobial activity of both the non-polar and polar extracts of Perilla frutescens with a 
broader spectrum of microorganisms and study the effect of PF hexane extract using SEM 
have yet to be carried out. 
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Figure ?1.33: The structures of several compounds detected in Perilla frutescens.  
 
1.3.4. Magnolia biondii  
The flower buds of Magnolia biondii Pamp, family Magnoliaceae are known as Xin-yi in 
the Chinese Pharmacopoeia and are widely used for the treatment of allergic rhinitis, 
sinusitis, nasal congestion and headache (Shen, Li et al. 2008). Extracts and 
phytochemicals of Flos Magnolia biondii showed anti-inflammatory, anti-histamine, and 
anti-hypertensive activities (Shen, Li et al. 2008, Lee, Song et al. 2014). Bacterial infection 
caused by S. aureus in the nasal-sinus mucosa is one of key factors which could cause 
rhinosinusitis (Redinbo 2014), thus it is important to evaluate the antibacterial effect of the 
extracts from Magnolia biondii, which may provide scientific evidence of using Xin-Yi for 
the treatment of rhinosinusitis.   
The essential oil from Magnolia biondii was analysed by gas chromatography-mass 
spectrometry (GC-MS) indicating the presence of eucalyptol, beta-pinene and alpha-
terpineol as the major compounds (Lu, Xu et al. 2008, Zeng, Xie et al. 2011). 
Furthermore, the tetrahydrofurofuran lignans such as fargesin, aschantin, and magnolin, the 
sesquiterpene lactone parthenolide, and the sesquiterpene alcohol oplodiol were isolated 
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and characterized from this plant (Schuhly, Skarbina et al. 2009). (Figure 1.34) shows the 
structure of these lignans.   
 
Figure ?1.34: Structures of lignans, parthenolide and oplodiol isolated from Magnolia 
biondii.  
 
1.4. The aim and objectives of this work are 
The aim of this research is to evaluate the in vitro antiplasmodial and antibacterial 
activities of a native African medicinal plant (Cylicodiscus gabunensis) and identify the 
bioactive compounds, and to evaluate the antibacterial activity of three medicinal plants 
used in Chinese medicine (Pogostemon cablin, Perilla frutescens and Magnolia biondii). 
The knowledge gained here can provide scientific basis for using these plants for 
traditional uses. 
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The objectives are  
1. To evaluate the antibacterial activities of Cylicodiscus gabunensis by disk diffusion 
assay and alamar blue microplate assay; to isolate the active compounds using a 
bioassay-guided extraction technique; to identify the active compounds by Nuclear 
Magnetic Resonance (NMR), Liquid Chromatography-Mass Spectrometry (LC-
MS), Gas Chromatography-Mass Spectrometry (GC-MS); to synthesize the 
derivatives of the bioactive molecule (gallic acid); to study the synergism between 
gallic acid and patchouli alcohol against S. aureus using checkerboard; to study the 
effects of gallic acids and esters of gallic acids on S. aureus using Scanning 
Electron Microscopy (SEM), to study gallic acid esters as possible food 
preservatives and to find the relationship between the structures of benzoic acid 
derivatives and their bio-activities (antibacterial and antiplasmodial).  
2. To evaluate the in vitro antiplasmodial activities of Cylicodiscus gabunensis against 
a chloroquine resistant Plasmodium falciparum Dd2 using Malaria Sybr Green I 
fluorescence assay method; to isolate the active compounds using a bioassay-
guided extraction technique; to identify the active compounds by NMR, LC-MS, 
and GC-MS. 
3. To evaluate the antibacterial activities of the nonpolar and polar extracts and pure 
components of Pogostemon cablin using disk diffusion assay, alamar blue 
microplate assay; to characterize their chemical composition by GC-MS; to study 
the mechanism of action of active compounds using time-kill assay and SEM. 
4.  To evaluate the antibacterial activities of the nonpolar and polar extracts and pure 
components of Perilla frutescens using disk diffusion assay, alamar blue microplate 
assay; to characterize their chemical composition by GC-MS; to study the 
mechanism of action of active extract using SEM. 
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5. To evaluate the antibacterial activity of the essential oil and lignans of Magnolia
biondii, by determination of MIC, SEM and time-kill kinetics. To characterize the 
chemical composition of oil and lignans using GC-MS and NMR techniques. 
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Chapter 2 : Materials and Methods 
2.1. Plants collection and authentication 
The bark of Cylicodiscus gabunensis Harms, family Mimosaceae was collected from the 
South East zone of Nigeria, Imo state, in September 2011. The plant was identified by H. 
Donyeachusim and a voucher specimen (UPH1028) was kept in the herbarium at the 
University of Port Harcourt, Nigeria.  
The stem parts of Pogostemon cablin (Blanco) Benth, family Lamiaceae, and the aerial parts 
of Perilla frutescens (L.) Britt, family Lamiaceae were purchased from a registered pharmacy 
in Chongqing, China. The specimen (each 10 g) of Pogostemon cablin stems (KUISTM002) 
and aerial parts of Perilla frutescens (KUISTM003) were kept in the Institute of Science and 
Technology in Medicine, Keele University. 
Flower buds of Magnolia biondii Pamp, family Magnoliaceae were harvested in Guangxi 
province. They were purchased from Hunan Jinshitang Traditional Chinese Medicine Co Ltd., 
China (2013120101).  A voucher specimen (KUISTM004) has been deposited in the Institute 
of Science and Technology in Medicine, Keele University. All the plant specimens were kept 
in dark glass jars until the time of the study.  
2.2. Grinding of the plant materials 
The plants were cleaned and pulverized separately by mechanical mills for the subsequent 
extraction procedure. 
2.3. Solvents, standards, and other materials 
All the chemicals used in this research are enumerated in (Table 2.1). 
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Table ?2.1: The chemical compounds, standards and solvents used in the current study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
  
Sigma Aldrich o-cymene 
Material name Patchouli oil (density  0.963 g/ml) 
???-Borneol Preparative TLC plates with indicator  
???-Caryophyllene oxide Propyl gallate  
2,4-Di-tert-butylphenol Racemic-menthol 
2,6-Di-tert-butylphenol Trifluoroacetic acid-d 
2-Methyl-1-butanol TWEEN® 20 
2-Methyl-1-propanol Vanillic acid 
3,4-Dihydroxybenzoic acid ?-D-Glucose 
3-Methyl-1-butanol ?-phellandrene 
3-Methyl-2-buten-1-ol ?-pinene 
Acetone-d6 ?-terpineol 
Bis-(2-ethylhexyl) phthalate ?-phellandrene 
BSTFA + TMCS, 99:1 ?-pinene 
Camphene ?-terpinene 
Caryophylline Fischer Scientific  
Chloroform-d  Material name 
D-???-Ribose Acetone 
D-(+)-Mannose Alamar Blue Cell Viability Assay 
Reagent 
D-(+)-Xylose Ampicillin sodium salt  
Ethanol Chloroform 
Ethyl gallate Ethyl acetate  
Eucalyptol Hexane 
Eugenol Isopropanol 
Gallic acid  Methanol 
Gallic acid trimethyl ether  Methanol-d4 
L-(+)-Arabinose Nutrient agar powder Oxoid 
Lauryl gallate  Nutrient broth powder Oxoid 
Limonene Anhydrous pyridine 
Linalool Tetrahydrofuran 
L-menthol Carbosynth Limited 
L-menthone Material name 
L-Rhamnose Patchouli alcohol 
????-Dicyclohexylcarbodiimide Pogostone 
n-alkanes  
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2.4. Extraction of the active constituents 
2.4.1. Extraction of Cylicodiscus gabunensis, Pogostemon cablin and Perilla frutescens  
The powder of CG bark (120 g) was macerated in two liters of hexane in D?????????????????????????
Bottle twice and each for two days. The hexane filtrates were combined and evaporated at 30°C under 
vacuum (Buchi Rotavapor RII) to yield the hexane extract of Cylicodiscus gabunensis (CGH, 0.9 g, 
0.75% w/w). The residue was extracted again by maceration using two liters of 70% ethanol two times 
and each for two days, the ethanol filtrates were combined and dried at 45°C under vacuum to give the 
ethanol extract of Cylicodiscus gabunensis (CGE, 11.3 g, 9.4 % w/w). 
50 g of each of PC and PF powders were macerated (twice and each for two days) in 500 ml 
of hexane in ????????????????????????????????. The hexane extracts were filtered and the 
solvent was removed by evaporation at a temperature not exceeding 30°C under vacuum to 
yield the hexane extracts of Pogostemon cablin (PCH) and Perilla frutescens (PFH), 
respectively. The plant residues were further macerated (twice and each for two days) in 500 
ml of 70% ethanol in water and the ethanol extracts were filtered and evaporated at 45 ºC 
under vacuum to give the ethanol extracts of Pogostemon cablin (PCE) and Perilla frutescens 
(PFE), respectively.  The yields of PCH, PCE, PFH, and PFE were 3.9 %, 5.5 %, 3.3% and 
1.7 % w/w, respectively. Density of PCH was 1.1 g/ml after removal of higher alkanes by 
freezing. 
2.4.2. Extraction of Magnolia biondii 
2.4.2.1. Extraction of the essential oil  
Powdered flower buds of MB (200 g) was immersed in 500 ml of deionized water (deionised 
by water distillator, PURELAB Option-Q, UK) and subjected to steam distillation for 6 hours, 
using a reflux-type apparatus; extraction flask was fed from a side inlet by water when 
required. The oil droplets were extracted from the distillate using 600 ml of hexane, two times 
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and the hexane extracts were combined and dried over sodium sulphate and carefully 
removing the hexane solvent at 30 °C under vacuum, the essential oil (1 ml) of Magnolia
biondii was obtained and kept in a sealed dark glass vial at 4 °C for further chemical analysis 
and antibacterial assays. 
2.4.2.2. Extraction of lignans  
Flower buds of MB (2 g) were crushed and sonicated twice with 100 ml of chloroform for 50 
min. The combined extracts were filtered and the solvent was evaporated under vacuum to 
obtain the chloroform lignan-rich extract of Magnolia biondii (120 mg, 6 % w/w yield).  
2.5. Fractionation of Cylicodiscus gabunensis ethanol extract (CGE) 
Each 5.6 g were dispersed in 350 ml of deionized water and partitioned with 350 ml × 2 of 
ethyl acetate and butanol successively, the ethyl acetate, butanol and aqueous extracts were 
combined separately and evaporated as required yielding the ethyl acetate fraction (CGEEA) 
0.9 g, butanol fraction (CGEBU) 8.3 g and aqueous fraction (CGEAQ) 1.6 g which were kept 
in dark bottles at 4°C for future work. The key aspects of the extraction processes are 
summarized in (Figure 2.1).  
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2.6. Fractionation by Flash Column Chromatography (CC) 
2.6.1. Fractionation of CGEEA 
0.85 g of CGEEA was ran on silica gel (35-???????2.5×50 cm), hexane: ethyl acetate 4:1 with 
increased polarity until washing the column by methanol, 3 ml/ min; RT of each fraction was 
100 ml and 18 fractions were collected; detection of eluates by TLC (SiO2, hexane: ethyl 
acetate 1.5: 1, UVGL-25 compact UV lamp 254/365 nm UV/4- Watt, Iodine vapour). Some 
of fractions were combined and dried using vacuum, yielding 8 fractions. F1, 29 mg; F2, 9.1 
mg; F3, 8.8 mg; F4, 8.9 mg; F5, 450 mg; F6, 130 mg; F7, 72.3 mg and F8, 97.2 mg with 
around 94% of recovery.   
2.6.2. Fractionation of CGEBU 
7 g of CGEBU were ran on silica gel (35-?????????50 cm), CHCl3: MeOH: H2O 10: 1: 0.1 ml 
with increased polarity, 3 ml/min; RT of fractions 1-18 was 100 ml and for fraction 19 was 
200 ml; detection of eluates by TLC (SiO2, CHCl3: MeOH 7:3, UVGL-25 compact UV lamp 
254/365 nm UV/4- Watt, Iodine vapour). Some of fractions were combined and dried using 
vacuum, yielding 10 fractions. F1= 100mg, F2= 95mg, F3= 118mg, F4= 75mg, F5= 90mg, 
????????????????? ???????????????????????????????????????????????????????????? 
2.7. Preparative High Performance Liquid Chromatogarphy (HPLC) 
Agilent 1200 series, preparative system consists of, G2258A DLA Dual Loop Auto-sampler, 
G1361A Preparative pump, X bridge Prep C-18, 5 ?m OBD 19 × 100 mm column from 
Waters, G1315D DAD Diode Array Detector at 254 nm and G1364B Prep FC Fraction 
Collector. Flow rate of solvents (A: 0.1% glacial acetic acid in water, B: 0.1% glacial acetic 
acid in methanol) was 16 ml/ min and max pressure 400 bar. (Table 2.2) shows the % of 
methanol in the solvent system throughout the experiment. 
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Table ?2.2: The percentage concentration (v/v) of solvent methanol (solvent B) during the 
preparative HPLC method. 
Time in min 0 5 25 25.1 31 31.1 32 32.1 
B % 0 % 5 % 60 % 100 % 100 % 5 % 5 % 0 % 
 
2.7.1. Fractionation of CGEEA-F5 by preparative HPLC 
EtOAc fraction 5 or as abbreviated CGEEA-F5 (0.42 g) was fractionated by preparative 
HPLC; twelve fractions were collected according to time intervals and peaks selection. The 
fractions were subjected to decrease their volume by evaporation at 45 °C under vacuum 
evaporator then completely dry by lyophilisation using Modulyo freeze dryer from Edwards. 
F1= 12mg, F2= 2mg, F3= 2mg, F4= 2mg, F5= 2mg, F6= 4mg, F7 16mg, F8= 21 mg, F9= 
??????????????? ????????????????????????????????????????????? 
2.7.2. Fractionation of CGEBU-F10 by preparative HPLC 
n-BuOH fraction 10 or as abbreviated CGEBUF10 (0.350 g) was fractionated by preparative 
HPLC; eight fractions were collected according to time intervals and peaks selection. The 
fractions were subjected to decrease their volume by evaporation at 45 °C using vacuum 
evaporator then completely dry by lyophilisation. F1= 20mg, F2=3.5mg, F3= 1.5mg, F4= 
??????????????????????????????????????????????????????????????????????? 
2.8. Gas Chromatography-Mass Spectrometry (GC-MS) analysis 
The GC-MS system consisted of an Agilent 7890 A gas chromatography system with HP-5ms 
column 5 % phenyl-methylpolysiloxane, 30 m × 0.25 mm× 0.25 ?m (Agilent Technologies, 
USA), coupled to an Agilent MS model 5975C MSD with triple axis detector (Agilent 
Technologies, USA). Front SS Inlet He mode is split and the split ratio is 5:1, thermal Aux 2 
(MSD transfer line) temperature 280 °C for 0 min. 
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2.8.1. Program or method A 
Initial temperature 60°C for 2 min, was elevated to 300°C at 10°C/min, and held at 300°C for 
4 min, (total time 30 min) under a constant pressure (10 psi). Spectral data were picked up at 
m/z range 16-1050. 
2.8.2. Program or method B 
Initial temperature 160°C for 0 min, was elevated to 300°C at 10°C/min, and held at 300°C 
for 6 min, (total time 20 min) under a constant pressure (10 psi). Spectral data were picked up 
at m/z range 16-1050. This method was used in association of method A to run the benzoates 
derivatives synthesized de novo for this research.   
2.8.3. Program or method C  
Initial temperature 60°C for 2 min, was elevated to 300°C at 6°C/min, and held at 300°C for 
18 min, (total time 60 min) under a constant pressure (10 psi). Spectral data were picked up at 
m/z range 16-1050. 
2.8.4. Identification and proportional quantification of the plant metabolites  
The compounds were identified by matching their EI-MS spectra with those in the NIST 2011 
Mass Spectral Library using MSD Chem-Station (Agilent Technologies, USA) with a high 
matching quality (greater than 95 %) and with the retention times of standard compounds 
where available. retention indices (RIs) were calculated utilizing alkanes C8-C20 assayed under 
the same conditions. The relative amount of individual compounds was expressed as a 
percentage of abundance ± standard deviation (SD) of three measurements, n=3. 
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2.8.5. Sample preparation 
2.8.5.1. Preparation and injection of hexane extract and alkane standards  
Hexane extract was prepared as 1mg/ml of anhydrous hexane and directly analyzed, 1 ?l was 
injected into the GC-MS injection port. 1 ?l of n-alkane standard mixture was injected 
directly without dilution into the injection port. 
2.8.5.2. Preparation of polar extract and compounds 
Polar extracts or pure compounds were derivatized to their corresponding trimethyl silyl 
derivatives to increase their volatility. Polar materials are including but not limited to 
alcohols, alkaloids, amines, carboxylic acids, phenols, and steroids were silylated by N,O-
bis(trimethylsilyl) trifluoroacetamide (BSTFA) in the presence of trimethylchlorosilane 
(TMCS) as a silylation catalyst, small quantity of pyridine is essential to dissolve the sample 
(Li, Barz 2006). 
The reaction is simple and direct and it was modified from (Li, Barz 2006), 1mg of extract or 
pure compounds was mixed with 20 ?l of anhydrous pyridine and 50 ?l of BSTFA + TMCS, 
99:1 from Sigma Aldrich, UK. The mixture was incubated in a hybridization oven from 
Hybrid for 30 min at 60 °C to prepare the corresponding trimethyl silyl (TMSi) derivatives 
and 1 ?l was injected into the GC-MS injection port.  
2.8.6. Calculation of Retention indices (RIs)
The serial alkanes were separated into distinct peaks and the following equation was used for 
(RI) calculation. (RI) = 100 × n a1 + 100 × (RT c ? RT a1) / (RT a2 ? RT a1)  
n a1: carbon number of alkane eluted before the tested compound (a1) 
RT c: retention time of the tested compound (c) 
RT a1: retention time of the alkane eluted before the tested compound  
RT a2: retention time of the alkane eluted after the tested compound (a2) 
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2.9. Detection method of the compounds developed on silica gel layer (TLC) 
Application of UV light using UVGL-25 compact UV lamp 254/365 nm UV/4- Watt was 
used to detect the compounds separated by TLC method on TLC plate ALUGRAM 40mm x 
80mm SIL G/ UV254 thickness of silica 0.20mm from Fischer Scientific, UK. Another 
technique was used for the detection of chemical compounds which were separated on TLC, 
was the non-destructive visualization technique using Iodine vapour. 
2.10. Analysis of CGEEA-F5 by HPLC 
CGEEA-F5 was analyzed along with three standards; gallic acid, ethyl gallate and 
protocatechuic acid, using an analytical C-8 column from thermoscientific (5 ?m; 250×4.6 
mm), methanol/water as the solvent system. 1 ml/min, UV-detector 218 nm, (Table 2.3) 
shows the % of methanol in the solvent system throughout the experiment. 
 
Table ?2.3: The percentage concentration (v/v) of solvent methanol (solvent B) during the 
analytical HPLC of CGEEA-F5. 
 
Time in min 0 5 25 25.1 31 31.1 32 32.1 
B % 0 % 5 % 60 % 100 % 100 % 5 % 5 % 0 % 
 
2.11. Analysis of CGEEA-F5-8 by HPLC 
CGEEA-F5-8 was ran on C18 analytical column from Thermo Scientific (5 ?m; 250× 4.6 
mm), methanol/water. 1 ml/min, UV-detector 218 nm, along with ethyl gallate and then we 
spiked the fraction by few crystals of ethyl gallate to notice the change in magnitude of ethyl 
gallate peak. (Table 2.4) shows the % of methanol in the solvent system throughout the 
experiment. 
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Table ?2.4: The percentage concentration (v/v) of solvent methanol (solvent B) during the 
analytical HPLC of CGEEA-F5-8. 
 
Time in min 0 25 25.1 35 35.1 
B % 10 % 70 % 100 % 100 % 10 % 
 
2.12. Accurate mass Liquid Chromatography-Mass Spectrometry TOF (LC-MS) 
Infinity 1260 series system consists of G4225A Hip Degasser, G1312B Binary Pump, 
G1329B ALS Auto sampler, G1316A TCC Thermostated Column Compartment,  Column 
50x2.1mm 5 ?m HyPURITY C8 from Thermo Fisher Scientific, UK and 6530 Accurate Mass 
Q-TOF as detector, qualitative analysis mass hunter work station software, ion Source Dual 
ESI, Ion Polarity positive, Mass range 100-1700 m/z Detector. Flow rate of solvent A: 0.1% 
Formic acid in water, B: acetonitrile, flow rate 0.5 ml/ min and max pressure 600 bar, the 
concentration of sample prepared was 100 ?g/ml. (Table 2.5) shows the % of acetonitrile in 
the solvent system throughout the experiment. Analysis of the samples was done by Dr. Falko 
Drijfhout, Chemical Sciences Research Centre, Keele University. 
 
Table ?2.5: The percentage concentration (v/v) of solvent acetonitrile (solvent B) during the 
Accurate mass TOF LC-MS. 
 
Time in min 0 10 18 18.1 
B % 5 % 95 % 95 % 5 % 
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2.13. Acidic hydrolysis and anomerisation of sugars 
2.13.1. Acidic hydrolysis 
CGEBU-F10-7, was hydrolysed as described in   (Aires, Marques et al. 2013, Tene, Chabert 
et al. 2011) with modifications, 2 mg of the extract were mixed with 2 ml of 2 M HCl in 50 % 
methanol and heated in ultrasonic bath at 50 °C for 4 hours and incubated overnight in oven at 
90 °C. After centrifugation at 10000 rpm for 10 min using Eppendorf Centrifuge 5418R, the 
supernatant was dried and1 mg was mixed by BSTFA and pyridine to prepare the TMSi 
derivatives and checked by GC-MS. 
2.13.2. Anomerisation of sugars 
Standard sugars were supplied by Sigma Aldrich UK, aldohexoses like ?-D-g???????? ?-D-
galactose and D-(+)-mannose, in addition to some aldopentoses like L-(+)-arabinose, (+)-
xylose and ???-ribose and one deoxy sugar, L-rhamnose, 1 mg of each standard sugar was 
dissolved in 150 ?l of deionized water and kept overnight in an oven at 100 °C, water was 
removed by rota-vapour at 45 °C and the residue was derived into its trimethyl silyl 
derivatives according to the method mentioned in section 2.8.5.2., then 1 ?l was injected into 
the GC system after dilution with sufficient quantity of chloroform.  
2.14. Nuclear Magnetic Resonance (NMR) spectroscopy 
1H NMR Spectroscopy of the extracts and pure materials was recorded on a Bruker DPX 300 
MHz spectrometer and 13C NMR spectroscopy of the extracts and pure materials was 
recorded on a Bruker DPX 101 MHz spectrometer, 10 mg of material was dissolved using 0.6 
ml of d-chloroform or d4-methanol as solvent. 1H NMR spectrum of CGEBU-F10-7 was 
recorded on a Bruker 700 MHz instrument, 4 mg was dissolved in 0.6 ml of 
(CD3COCD3:D2O (1:1))  . NMR data were analysed using ACD/Labs 12 software.  
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2.15. Bacterial isolates  
The bacterial colonies were supplied by the National Collection of Industrial and Marine 
Bacteria NCIMB Ltd, Aberdeen, Scotland. Bacillus cereus NCIMB 9945, Bacillus subtilis 
NCIMB 3610, Staphylococcus aureus NCIMB 11832, Staphylococcus epidermidis NCIMB 
8853, Enterobacter cloacae NCIMB 10101, Escherichia coli NCIMB8277, Alcaligenes 
faecalis NCIMB 8156, Pseudomonas aeruginosa NCIMB 10848 and Enterococcus faecalis 
NCIMB 2707. 
2.15.1. Preparation of bacterial inoculum 
2.15.1.1. Preparation of the broth media  
Nutrient broth from Thermo Scientific, UK was prepared according to the manufacturer 
directions, by the addition of 13g to 1 litre of distilled water.  Then we mixed the suspension 
well using a magnetic bar until complete solubility. The resulted solution was distributed into 
volumes of 5ml and 20 ml in glass bottles with cap, those bottles were sterilised by 
autoclaving at 121°C for 15 minutes, then kept at 4 ºC for further study.  
2.15.1.2. Preparation of the primary inoculum 
Three to five single colonies were selected from the agar plate using a sterile poly styrene 
inoculating loop from Fischer Scientific, UK and transferred into 20 ml sterilized glass tube 
with cap contained 5 ml of broth media, vortexed for one min using Fisons Whirlimixer 
vortex stirrer. Cultures were incubated at 37 °C in a Thermo / Lab-Line / Barnstead MAX Q 
4000 Benchtop Shaker from Thermo Scientific, USA at 225 rpm for 2-6 hr. 
2.15.1.3. Calibration of growth density 
One ml of the bacterial culture was transferred into a cuvette macro disposable polystyrene 
4.0ml capacity 10mm light path from Fischer Scientific, UK and the absorbance was read 
against the absorbance of broth media as a blank, using Genesys 10 S UV-VIS 
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Spectrophotometer at 625nm. A visible turbidity that is equal to the turbidity of a McFarland 
Standard 0.5 should be optimised and this can be verified by recording absorbance of 0.08?
0.13 which indicates the presence of approximately 1-2×108 Colony Forming Unit/ml 
(CFU/ml). 
2.15.2. Preparation of the agar plates 
Nutrient agar from Thermo Scientific, UK was prepared according to the manufacturer 
directions, 28 g were suspended in 1 litre of distilled water, heated until boiling to ensure 
complete solubility with the aid of stirring using a magnetic bar, and then we sterilised the 
solution by autoclaving at 121°C for 15 minutes. The agar was cooled down to about 50 °C 
and distributed into  cell culture dishes diameter 100 mm × 20 mm height, 60.8 cm2 from 
Thermo Scientific, UK,  about 15 ml of agar was distributed into each plate, agar plates let to 
cool down completely and kept at 4 °C in a cold room until future work.  
2.15.3. Preparation of the purity plate and control plate 
Using the streak method, both the control plate and purity plate were prepared to ensure the 
standardisation of the assay. Control plate was necessary to check the sensitivity of the 
bacterial isolate to the drug used as a control which was Ampicillin here; the control plate 
should be prepared concurrently with each test set. An important step in the bioassay is to 
guarantee the purity of the culture cells and this has been done by the addition of ???l of a 
bacterial inoculum in to an agar plate, a serial streaking of the inoculum into an agar plate in 
order to obtain individual colony forming units, after the procedure was completed the agar 
plate was incubated at 37 °C for the appropriate amount of time (usually 20-24 h) and 
colonies were inspected for uniformity.  
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2.16. Disk diffusion assay (DDA) 
Antimicrobial susceptibility testing (Bukvicki, Gottardi et al. 2012, Matuschek, Brown et al. 
2013) disk diffusion method was initially used to assess the antimicrobial activities of the 
plant extracts.  100 ?l of 0.5 McFarland inoculum suspensions were uniformly spread on the 
agar plate. The plant extracts were prepared in four concentrations of 12.5, 25, 50 and 100 
mg/ml in DiMethyl SulfOxide (DMSO) and 20 ?l dispensed to Whatman sterile filter paper 
disks with diameter of 6 mm from Fischer Scientific, UK, two controls were used in the study 
one for the solvent DMSO and the second one was Ampicillin in a concentration of 10 or 2 ?g 
per disk, the disks were applied firmly to the surface of the inoculated agar plate. The plates 
were inverted and incubated at 37 °C using LMS series 4 cooled incubators.  
Inhibition zone (IZ) is an indication of the antibacterial activities and it is increased as the 
potency of the compound increased. The diameters of the IZs were measured to the nearest 
millimetre with a ruler and the inhibitory zone sizes of three plates were prepared for each 
isolate on three different days, the standard deviation (SD) of the readings were calculated.  
In case of detection of colonies growth throughout the IZ, the infiltrate colonies were checked 
on different plate for purity if the colonies were pure then the zone recorded as not detected or 
(ND), if the infiltrate colonies were contaminated then redoing the test was essential. 
2.17. Determination of MICs using microplate alamar blue assay 
2.17.1. Technical steps  
MIC of the plant extracts and pure materials were determined using microplate alamar blue 
assay (Collins, Franzblau 1997, Kumar, Khan et al. 2005, Leonard, Coronel et al. 2008). 
alamar blue is ready to use reagent gave rapid assay results and gave us a real quantification 
of microbial cell viability, it is usually added as 10 % of the growth medium, for example 20 
?l into 200 ?l well volume.  
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The recommended final inoculum size for broth dilution is 5 × 105 CFU/ml. The bacterial 
isolates were adjusted to McFarland standard 0.5 (1-2 ×108 CFU/ml), and diluted by a factor 
of 1:100 by addition of  0.2 ml bacterial suspension to 19.8 ml sterile broth medium to give a 
bacterial concentration of 1× 106 CFU/ml. The plant extracts and pure compounds were 
dissolved in 3% DMSO, or 0.5% Tween 20 in broth media for use. Black Microplate 
FluoroNunc 96 well flat bottom polystyrene not treated from Fischer Scientific, UK was used 
for the assay. 
100 ?l of nutrient broth were distributed into all wells except wells 10, to which 100 ?l of 3% 
DMSO or 0.5% Tween 20 were added.  100 ?l of the extracts or pure compounds were 
distributed into wells 1A to 1H and mixed well with the broth, to made a serial dilution (two 
folds dilution) until wells 8, then 100 ?l of bacterial broth containing 1 × 106 CFU/ ml were 
distributed into wells 1-10. Wells 9 were the growth control which contained broth media and 
bacteria and wells 10 were the solvent control which contained either 3% DMSO or 0.5% 
Tween 20 and bacteria, the growth in wells nine and ten must not much different, and they 
form the growth control average. Wells 11 were used as the sterility control and wells 12 were 
contained a serial dilution of Ampicillin as drug control from 12A- 12H as 128-0.5 ?g/ml. 
After incubation at 37 °C for 18-24 hours, 20 ?l of Alamar blue from Fischer Scientific, UK 
were added to each well followed by further incubation for 1-4 hours. The fluorescence units 
(FU) were read in GloMax-plus® Multi Detection System, using filter at excitation 
wavelength of 525 nm and emission wavelength of 580-640nm. 
2.17.2. Calculation 
The following equations were used to calculate the percentage of inhibition for each drug 
used. To ensure the reproducibility of the assay the experiment has been done four times on 
two days, duplicate on each day. The background effect must be excluded by subtraction from 
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each reading, percent inhibition was defined as [1 ? (FU test well ? FU SC well) / (FU GC 
well ? FU SC well)] × 100.   
FU test well: Mean of fluorescence in test wells 
FUSC well: Mean of fluorescence in sterility control 
FUGC well: Mean of fluorescence in growth controls  
The lowest extracts/pure compounds concentration effecting an inhibition growth of 90% was 
considered as the MIC (Collins, Franzblau 1997). MICs could be further verified visually as 
the lowest concentration of extracts/pure compounds that prevented a blue-to-pink alamar 
blue colour change.  
2.18. Time Kill assay 
Time-kill assay was performed according to guideline M26-A of the National Committee for 
Clinical Laboratory standards (Karkare, Adou et al. 2007, McKay, Beaulieu et al. 2009), with 
the following modifications: polypropylene 96-well plates were used for time-kill assays with 
S. aureus and E. coli.  
Exponential-phase bacteria were diluted to 5 × 105 - 1 × 106 CFU/ml and exposed to the drug 
over a 24 h period. Eight wells were dedicated for each plant extract or pure compound used 
in the study. The drug used was distributed into three different concentrations ½ MIC of the 
drug used, MIC and 2 MIC levels of the plant extract or pure compound and 0 (control) when 
no drug was used. 100 ?l Specimens were withdrawn and diluted up to 10-7 in some heavy 
growth wells and 100 ?l cell cultures were seeded on agar growth media at different time 
slots, 0, 3, 6 and 24 hr in duplicates. The average of cell density (CFU/ml) was calculated 
based on the viable cell counting and the killing kinetics of the drug was determined. The 
74 
 
bactericidal effect was achieved when the drug caused a 3-Log reduction in bacterial counts 
which equates to a 99.9% reduction in microorganisms. 
2.19. Scanning Electron Microscopy (SEM) 
Eppendorf tubes each containing 3 ml of S. aureus NCIMB 11832 at a cellular density of (108 
CFU/ml) were prepared for this experiment (Monson, Stringham et al. 2010). Tube A was 
kept as a control where 3 ml of 6% DMSO in broth media were added. 3 ml of plant extract or 
pure compound were prepared in 6% DMSO at their 2 MIC level and were added to tube B. 
After one hour the tubes were centrifuged at 16000 rpm using an Eppendorf centrifuge 5418R 
for 10 min. The supernatant liquid was removed carefully to avoid disturbing the cellular 
pellets to which 2.5% glutaraldehyde in a buffer containing 0.1 M sodium cacodylate and 
2mM calcium chloride was added and left standing for 2 h. This was the primary fixation step 
followed by buffer removal and addition of 1% osmium tetroxide in (buffer), which kept for 
one hour. After centrifugation, the sample pellets were cleaned with the buffer three times and 
dried by ethanol with increased concentration (70 to 100 %) and anhydrous 100% ethanol. 
The cells were distributed into 10 ?l of hexamethyldisilazane, and spread onto a glass 
coverslip attached to carbon tab 12 mm in diameter PK100 from Agar Scientific, Hitachi, 
which was placed on the surface of aluminum stubs 15mm × 6 mm from Agar Scientific, 
Hitachi.  The samples were left to dry in air overnight, and then coated by gold using 
Emscope FD 500 sputter coater. The examination was performed using scanning electron 
microscope (Model S-4500, Hitachi, Japan). Scanning of the specimens by SEM was 
performed by Ms. Karen Walker, Electron Microscope Unit/ Keele University.  
2.20. Study the synergism between gallic acid and patchouli alcohol
Checker board was used to evaluate the synergism between gallic acid and patchouli alcohol; 
checker board is a two dimensions assay where two agents were mixed in each well at 
different dilutions prepared previously for the study (Eliopoulos, Eliopoulos 1988). A1 well in 
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the plate was used as growth control where just the bacterial cells were added without the 
drug and H12 used as sterility control where just the broth solution has been added. 
Column one was used to determine the MIC of drug B, double dilution concentrations starting 
from H1 to B1 wells 100 ?l each, for determination of drug A MIC we were used row A 
starting from A12 to A2 wells 100 ?l each. The wells used to mix the two drugs together were 
containing 50 ?l from each drug in a concentration corresponding to the concentration in the 
column or row used to determine the MIC of the drug as shown in (Table 2.6). To calculate 
the fractional inhibitory concentration and define the type of interaction whether it is 
synergism or not we need to do the following calculations. Fractional inhibitory concentration 
(FIC) A= MIC A in combination/ MIC A alone; FIC B= MIC B in combination/ MIC B 
alone; ??????????FIC A + FIC B; Synergism X ?????; Indifference 0.5 < X ???; Antagonism 
X ???.  
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2.21. Malaria Sybr Green I fluorescence assay method 
????????????????????????????????????????????????????????????????????????????????????????
all the laboratory experimental evaluation of the anti-malarial activities. To evaluate the 
anti-malarial activities of the plant extracts at three different concentrations and to 
determine the IC50 of the plant extracts or pure compounds against P. falciparum Dd2, the 
group used a fluorescent dye called Sybr Green l Fluorescence dye (5000X concentration) 
from Sigma Aldrich, UK. The stain was utilised here to stain double-stranded DNA in 
parasite.  
Sybr Green-conjugated DNA emits a fluorescent light which can be quantified using a blue 
fluorescent filter (excitation 490 nm, emission 510-570 nm) and a GloMax-plus® Multi 
Detection System.  
Stock solution was prepared at 1 mg/ml in DMSO for plant extract and 10 mM in DMSO 
for pure compounds. The drug solutions prepared were used immediately or stored at 4°C 
for not longer than one month before use. The stock solutions were diluted to the desired 
solutions in ?g/ml for extracts and ?M for the pure compounds using Roswell Park 
Memorial Institute (RPMI) 1640 Medium from Fischer Scientific, UK.  
100 ?l of re-suspended parasite culture were transferred into a Black Microplate 
FluoroNunc 96 well flat bottom polystyrene not treated from Fischer Scientific, UK. Wells 
containing no drug but the parasite culture were included on each plate as control. 
Chloroquine was used as a control and the IC50 of Chloroquine against P. falciparum Dd2 
was 0.171 ?M.  
The plate was placed in a modular incubator chamber and gassed (gas contains 92.5% N2, 
5.5% CO2, 2% O2). The chamber was placed in an incubator set at 37ºC for 72 hours. 
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Laboratory reference clones, P. falciparum Dd2, regarded as chloroquine resistance were 
assayed periodically as internal control.  
For the outcomes measurements, 100 ?l of MSF lysis buffer (200mM Tris HCl PH 7.5, 
50mM EDTA, 0.08% Saponin and 0.8% Triton X100) supplemented with 1X Sybr Green I 
dye was added and mixed by pipetting. The plate was covered with aluminium foil and 
incubated at room temperature in the dark for at least two hours. After the incubation, the 
fluorescence of the samples was measured (Smilkstein, Sriwilaijaroen et al. 2004). 
Determination of 50% inhibitory concentration (IC50) were carried out using a serial two 
folds dilution method to provide a log-concentration response curve analysed using graph 
prism software (v6.0). 
2.22. Synthesis of alkyl and alkenyl 3,4,5-trihydroxybenzoates  
??? ?? ????????? ??? ??????? ????? ?????? ?????? ??? ???????? ??????? ????? ?? ???? ??? ????
anhydrous alcohol (4.00 mmol) in THF (6 ml) were mixed in 50 ml dry flask and cooled in 
???? ????? ??? ?? ???? ??? ?????? ?? ????????? ??? ? ????-dicyclohexylcarbodiimide (DCC) (3.50 
?????? ??????????????????????????????????????????l). The mixture was stirred for 24 
h; the reaction vessel was connected to a vacuum evaporator to evaporate the solvent, 
yielded dark yellow residue. The product extracted by cold ethyl acetate three times and 
filtered. The filtrate combined and evaporated to dryness. 
List of alcohols used 
1- 2-methyl-1-propanol; MW 74.122 g mol-1; density 0.803 g ml -1, amount used was 
????????? 
2- 2-methyl-1-butanol; MW 88.15 g mol-1; density 0.809 g ml -1, amount used was 
???????? 
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3- 3-methyl-2-buten-1-ol; MW 86.13 g mol-1; density 0.848 g ml-1, amount used was 
?????????? 
4- 3-methyl-1-butanol; MW 88.15 g mol-1; density 0.809 g ml-1, amount used was 436 
?l. 
5- Isopropanol; MW 60.10 g mol-1; density 0.785 g ml-1, amount used was 306 ?l. 
2.23. Purification of the synthesised esters 
The synthesised esters were purified by column chromatography, the dried product was ran 
on silica gel (35-?????????????????????????ethyl acetate 7: 3, isocratic, 3 ml/min, detection 
of eluates by TLC (SiO2, hexane: ethyl acetate 7: 3, UVGL-25 compact UV lamp 254/365 
nm UV/4- Watt, Iodine vapour). 
2.24. Analysis of Alkyl and alkenyl 3,4,5-trihydroxybenzoate by HPLC 
Compounds synthesized in the laboratory were run on C18 analytical column from Thermo 
Scientific (5 ?m; 250× 4.6 mm), methanol/water, UV-detector 254 nm. (Table 2.7) shows 
the % of methanol in the solvent system throughout the experiment. 
Table ?2.7: The percentage concentration (v/v) of solvent methanol (solvent B) during the 
analytical HPLC of synthesised esters. 
 
Time in min 0 25 25.1 35 35.1 
B % 10 % 70 % 100 % 100 % 10 % 
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Chapter 3 : Results and discussion of antibacterial 
and antiplasmodial activities of CG 
3.1. Results  
3.1.1. Antibacterial effects of Cylicodiscus gabunensis extracts 
3.1.1.1. Disk diffusion assay 
IZs in mm of CGH and CGE against a panel of bacteria were recorded three times, on three 
different plates according to section 2.16 and the results are shown in (Table 3.1), the 
effect of CGE against S. epidermidis is displayed in (Figure 3.1). (Table 3.2) shows the IZ 
in mm and MIC in ?g/ml of ampicillin against several bacterial isolates recorded according 
to sections 2.16 and 2.17 respectively.  
                                
Figure ?3.1: The effect of CGE against Staphylococcus epidermidis (8853) growing at 37 
°C, A: concentration of CGE 2mg/disk, B: 1mg/disk, C: 0.5 mg/disk, and D: 0.25 mg/disk. 
The test has been done in triplicate, n=3 according to section 2.16. 
IZ 
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Table ?3.1: Antibacterial activity of Cylicodiscus gabunensis, hexane extract (HE) and 
ethanol extract (EE). The test has been done in triplicate, n=3 according to section 2.16. 
 
Neg.: negative result, NC: IZ not calculated due to the growth of some colonies throughout the IZ. 
 
 
 
Bacteria strain 
(gram stain) 
Extracts Mean diameter of  IZ mm ± SD (n =3) 
2 mg/disk 1 mg/disk 0.5 mg/disk 0.25 mg/disk 
Staphylococcus 
aureus (+) 
HE 7.5 ± 0.5 7.0 ± 0.4 NC NC 
EE 16.5 ± 0.5 12.0 ± 1.0 10.5±0.5 7.5±0.6 
Staphylococcus 
epidermidis (+) 
HE Neg. Neg. Neg. Neg. 
EE 19.5 ±1.0 14.5±0.5 13.5±0.5 10.0±1.0 
Bacillus cereus 
(+) 
HE Neg. Neg. Neg. Neg. 
EE 12.5±0.6 11.0±1.0 10.0±0.5 8.0±1.0 
Bacillus subtilis 
(+) 
HE Neg. Neg. Neg. Neg. 
EE 10.6±0.5 8.5±0.5 7.0±0.5 Neg. 
Streptococcus 
(Enterococcus) 
faecalis  (+) 
HE Neg. Neg. Neg. Neg. 
EE 10.5±0.5 8.0±0.5 7.0±0.5 Neg. 
Escherichia coli  
(-) 
HE Neg. Neg. Neg. Neg. 
EE Neg. Neg. Neg. Neg. 
Enterobacter 
cloacae  (-) 
HE Neg. Neg. Neg. Neg. 
EE Neg. Neg. Neg. Neg. 
Pseudomonas 
aeruginosa  (-) 
HE Neg. Neg. Neg. Neg. 
EE Neg. Neg. Neg. Neg. 
Alcaligenes 
faecalis  (-) 
HE 9.5 ± 0.5 7.5 ± 0.5 Neg. Neg. 
EE 17.0 ± 2.0 15.6 ± 1.4 15.0 ± 1.0 11.0 ±2.0 
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Table ?3.2: Antibacterial activity of ampicillin using disk diffusion assay in triplicate n=3, 
and alamar blue microplate assay in quadruplicate, n=4. The test has been done according 
to section 2.16 and 2.17 respectively. 
 
Bacteria strains 
(gram stain) 
Mean diameter of IZ  mm ± SD (n =3)  
Ampicillin  
10 ?g/disk 
Ampicillin  
2 ?g/disk 
MIC ?g/ml 
Staphylococcus aureus (+) na 32±3.0 ????? 
Staphylococcus epidermidis (+) na 36±2.5 ????? 
Bacillus cereus (+) Neg. na ?64 
Bacillus subtilis (+) na 28±1.0 ????? 
Streptococcus faecalis (+) na 24±2.0 ????? 
Escherichia coli  (-) 22±2.0 16±1.0 ????? 
Enterobacter cloacae  (-) 24±1.0 17±1.5 ????? 
Pseudomonas aeruginosa  (-) na na na 
Alcaligenes faecalis  (-) 10±1.0 na 16 
na: not assayed 
 
3.1.1.2. Partition of CG ethanol extract 
Previous results showed that CGE is more active than CGH against most of the sensitive 
bacterial isolates used. CGE was fractionated according to section 2.5. Three fractions 
were separated, butanol fraction CGEBU 77% w/w, ethyl acetate fraction 8% w/w and 
aqueous fraction CGEAQ 15% w/w.    
3.1.1.3. Disk diffusion assay of ethanol fractions 
IZ in mm of CGEEA, CGEBU, and CGEAQ against S. aureus, S. apidermidis, B. cereus 
and Alcaligenes faecalis were calculated according to section 2.16, and the results are 
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shown in (Table 3.3). The selected bacterial isolates were showed sensitivity to CGE as it 
is clear from (Table 3.1).    
Table ?3.3: Antibacterial activity of Cylicodiscus gabunensis, ethanol fractions, the test has 
been done in triplicate, n=3 according to section 2.16.  
Bacterial strain 0.5 mg/disk IZ ± SD (n =3)  
Staphylococcus aureus  CGEEA 14.0±0.4 
 
CGEBU 11.5±1.5 
 
CGEAQ 7.5±0.4 
Staphylococcus epidermidis  CGEEA 15.0±1.0 
 
CGEBU 10.5±0.6 
 
CGEAQ 11.5±0.6 
Bacillus cereus  CGEEA 11.0±0.4 
 
CHEBU 8.0±0.5 
 
CGEAQ 8.5±0.5 
Alcaligenes faecalis  CGEEA 16.0±1.0 
CGEBU 13.0±0.5 
CGEAQ 11.5±1.0 
 
CGEEA: CG ethanol ethyl acetate; CGEBU: CG ethanol butanol; CGEAQ: CG ethanol aqueous, 
IZ by mm, SD: Standard deviation, n= number of assay replication 
3.1.1.4. CGEEA fractionation  
CGEEA was separated into eight fractions using column chromatography according to 
section 2.6.1. The fractions were prepared for alamar blue microplate assay according to 
section 2.17.    
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3.1.1.5. MICs of CGEEA fractions  
Eight fractions, CGEEA-F1-8 were prepared in eight different concentrations 8-1024 
?g/ml in 3% DMSO according to section 2.17. The results are shown in (Table 3.4).  
Fraction five (CGEEA-F5) showed higher activities than the other fractions with the best 
effect against S. epidermidis with MIC of 128 ?g/ml, S. aureus with MIC of 256 ?g/ml and 
Alcaligenes faecalis with MIC of 256 ?g/ml, CGEEA-F6 also showed some activities 
against the three isolates mentioned above, other fractions showed ???? ?? ????? ???ml 
against all bacterial isolates. 
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Table ?3.4: MIC results in ?g/ml of CG ethanol ethyl acetate fractions CGEEA-F5, 
CGEEA-F6, and Ampicillin. The test has been done in quadruplicate, n= 4 according to 
section 2.17. 
 
 
 
 
 
 
 
 
 
 
 
 
                                         
 
 
 
 
 
 
 
 
Name of Bacteria  CGEEA-F5 CGEEA-F6 Ampicillin  
Bacillus cereus 1024 > 1024 ?64 
Bacillus subtilis  > 1024 > 1024 ???? 
Escherichia coli  1024 > 1024 ???? 
Enterobacter cloacae  1024 > 1024 ???? 
Enterococcus faecalis  1024 > 1024 ???? 
Staphylococcus aureus  256 512 ???? 
Staphylococcus epidermidis 128 256 ???? 
Pseudomonas aeruginosa 1024 > 1024 Not assayed 
Alcaligenes faecalis  256 1024 16 
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3.1.1.6. Preparative HPLC of CGEEA-F5 
CGEEA-F5 was fractionated by preparative HPLC according to section 2.7.1, twelve 
fractions were collected according to time intervals, and (Figure 3.2) shows the HPLC 
chromatogram. 
 
 
Figure ?3.2: Preparative HPLC of CGEEA-F5. ethyl acetate fraction five, fractions were 
collected according to defined time intervals. The separation has been done according to 
section 2.7.1. 
 
3.1.1.7. MICs CGEEA-F5 fractions 
Twelve fractions, CGEEA-F5 (1-12) were prepared in eight different concentrations 4-512 
?g/ml in 3% DMSO according to section 2.17 to calculate their MIC against three bacterial 
isolates. Small fractions were checked only against S. epidermidis, the results are shown in 
(Table 3.5). The results revealed that fraction 8, CGEEA-F5-8 was the most potent fraction 
and its MIC was 64 ?g/ml against S. epidermidis and the MIC against each of S. aureus 
and Alcaligenes faecalis was 128?g/ml, however it showed moderate activity against E. 
coli.  
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Table ?3.5: MIC (?g/ml) of fractions CGEEA-F5 (1-12) and Ampicillin. The test has been 
done in quadruplicate, n= 4 according to section 2.17. 
 
Fraction 
Bacterial isolate 
S. aureus  S. epidermidis E. coli A. faecalis  
CGEEA-F5-1 ?512 ? 512 ?512 ?512 
CGEEA-F5-2 na ?512 na na 
CGEEA-F5-3 na ?512 na na 
CGEEA-F5-4 na ?512 na na 
CGEEA-F5-5 na ?512 na na 
CGEEA-F5-6 na ?512 na na 
CGEEA-F5-7 256 256 ?512 512 
CGEEA-F5-8 128 64 512 128 
CGEEA-F5-9 256 128 ?512 512 
CGEEA-F5-10 ?512 512 512 ?512 
CGEEA-F5-11 ?512 ?512 512 ?512 
CGEEA-F5-12 ?512 ?512 ?512 ?512 
Ampicillin ???? ???? ???? 16 
n: Number of assay replication, n=4; na= Not assayed. 
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3.1.1.8. The effects on S. aureus cell wall integrity 
Scanning electron microscopy was used to study the effect of gallic acid and ethyl gallate 
on S. aureus cell wall integrity according to the method mentioned in section 2.19. Several 
images of cells from the control and after exposure to gallic acid and ethyl gallate were 
taken and here we present the results of both side by side for comparison purposes, (Figure 
3.3) shows the SEM results of gallic acid and ethyl gallate against S. aureus. 
  
 
Figure ?3.3: Electron scanning micrographs (SEM) of S. aureus NCIMB 11832 exposed to 
ethyl gallate and gallic acid.  A: SEM of S. aureus shows the electron micrograph of 
control after 1 hr, arrows pointing to the division of cells. B: SEM of S. aureus after 
exposure to 2MIC level of ethyl gallate for 1 hr, arrows pointing to the leakage of cell 
contents in addition to the collapse of some cells. C: SEM of S. aureus after exposure to 
2MIC level of gallic acid for 1 h, arrows pointing to doughnut shape cells and lysed cells. 
The test has been done according to section 2.19. 
To summarize the bioassay-guided separation process, (Figure 3.4) shows all the steps of 
separation and bioactivity evaluation of the antibacterial activities.   
 
A B C 
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Figure ?3.4: Schematic diagram illustrating key aspects of the bioassay guided fractionation 
of Cylicodiscus gabunensis. The solvents used in the initial separation steps are indicated 
using italics, biological replicates of disk diffusion assay =3 and alamar blue microplate 
assay =4 to detect the IZ in mm and MIC in ?g/ml respectively. Different kinds of 
chromatography have been used for separation purposes. CGEEA: CG ethanol ethyl 
acetate; CGEBU: CG ethanol butanol; CGEAQ: CG ethanol aqueous.  
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3.1.2. Chemical analysis of the active antibacterial fractions 
3.1.2.1. Analysis of CGEEA using GC-MS 
3.1.2.1.1. Calculation of RIs
Retention indices are important as an assistant of the compounds identity confirmation; n-
alkanes were used for calculation of RI, according to section 2.8.  (Table 3.6) mentions the 
RT of alkane?? standard C8-20 ran in two different conditions (method A section 2.8.1) and 
(method C section 2.8.3), (Figure 3.5) shows a graph represents the linear relationship 
between RT of alkanes and their carbon number. 
 
Table ?3.6: ????????? ????????? ??-C20 ran in two different conditions, RT in min. The 
analysis has been done in triplicate, n=3 according to sections 2.8.1 and 2.8.3. 
 
 
 
 
 
 
 
 
 
 
 
Alkane Carbon number  RT Method A RT Method C 
Octane 8 3.14±0.002 2.96±0.121 
Nonane 9 4.59±0.120 4.54±0.054 
Decane 10 6.31±0.021 6.75±0.001 
Undecane 11 8.03±0.067 9.26±0.301 
Dodecane 12 9.68±0.214 11.84±0.023 
Tridecane 13 11.22±0.170 14.39±0.143 
Tetradecane 14 12.67±0.310 16.66±0.005 
Pentadecane 15 14.03±0.009 18.83±0.080 
Hexadecane 16 15.31±0.101 20.89±0.090 
Hepatdecane 17 16.54±0.210 22.86±0.124 
Octadecane 18 17.68±0.167 24.73±0.134 
Nonadecane 19 18.79±0.223 26.53±0.020 
Eicosane 20 19.83±0.243 28.25±0.090 
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Figure ?3.5: The linear relationship between ??????????????????????????????Alkanes were 
run under different temperatures in a GC-MS system. The analysis has been done in 
triplicate, n=3 according to sections 2.8.1 and 2.8.3. 
 
 
 
 
92 
 
3.1.2.1.2. Chemical composition of CGEEA 
After derivatisation of CGEEA to its corresponding silylated derivatives according to the 
procedure mentioned in section 2.8.5.2, the derived fraction was run by method A section 
2.8.1. (Figure 3.6) presents the GC-MS chromatogram and (Table 3.7) shows the 
compounds detected in CGEEA. 
Several benzoic acid derivatives were detected in CGEEA, those benzoic acid derivatives 
were represented  a clear characteristic of this fraction, carboxylic acids and some fatty 
acids were also detected in the ethyl acetate fraction.  
 
 
Figure ?3.6: GC-MS chromatogram of Cylicodiscus gabunensis CGEEA. The analytes are 
derived according to section 2.8.5.2 and analysed according to section 2.8.1 in triplicate, 
n=3. 
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3.1.2.2. Chemical composition of CGEEA-F5 
This fraction was derived to its TMSi-derivative according to section 2.8.5.2 and was run 
by method A section 2.8.1. (Figure 3.7) shows the GC-MS chromatogram and (Table 3.8) 
shows the compounds detected in this fraction.  
 
 
Figure ?3.7: GC-MS chromatogram of Cylicodiscus gabunensis CGEEA-F5. The analytes 
are derived according to section 2.8.5.2 and analysed according to section 2.8.1 in 
triplicate, n=3. 
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Ten compounds were detected. Several benzoic acid derivatives represented about 68% of 
the detected compounds like 4-hydroxy benzoic acid, protocatechuic acid; syringic acid, 
gallic acid and ethyl gallate were detected from CGEEA-F5. Fatty acids abundance is 17% 
compared to more than 60% in CGEEA.  
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3.1.2.3. Analysis of CGEEA-F5 by HPLC 
To confirm the presence of gallic acid, protocatechuic acid and ethyl gallate, the three 
standards were run on analytical C-8 column, according to section 2.10, (Figure 3.8) shows 
the HPLC chromatogram.  
 
 
Figure ?3.8: Analytical HPLC of CGEEA-F5 (blue line).Standards from left to right (red 
line) 1: gallic acid, RT 5.8 min; 2: protocatechuic acid, RT 10.5 min; 3: ethyl gallate, RT 
19.5 min. The analysis has been done according to section 2.10, in triplicate, n=3.  
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3.1.2.4. Chemical composition of CGEEA-F5-8 
3.1.2.4.1. GC-MS 
Checking the most active fraction from CGEEA-F5 by GC-MS using method A section 
2.8.1, showed three benzoic acid derivatives; syringic acid, gallic acid and ethyl gallate 
(Figure 3.9 and Figure 3.10).   
 
Figure ?3.9: GC-MS chromatogram of CGEEA-F5-8.1: syringic acid-TMSi; 2: ethyl 
gallate-TMSi; 3: gallic acid-TMSi. The fraction was derived according to section 2.8.5.2 
and analyse according to section 2.8.1 in triplicate, n=3. 
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Figure ?3.10: EI-Mass spectra of compounds detected in CGEEA-F5-8. A: syringic acid-
TMSi; B: ethyl gallate- TMSi; C: gallic acid-TMSi. 
100 
 
3.1.2.4.2. HPLC 
CGEEA-F5-8 ran according to section 2.11 on C18 analytical column and then we spiked 
the fraction by few crystals of ethyl gallate to notice the change in the magnitude of ethyl 
gallate peak (Figure 3.11).  
 
 
Figure ?3.11: Analytical HPLC of CGEEA-F5-8.Cylicodiscus gabunensis ethanol ethyl 
acetate fraction 5-8 (red), the blue coloured chromatogram is representing CGEEA-F5-8 
spiked with ethyl gallate. The black arrow refers to ethyl gallate. The analysis has been 
done according to section 2.11 in triplicate, n=3. 
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3.1.2.4.3. TOF LC-MS 
CGEEA-F5-8 ran by LC-MS as discussed in section 2.12., (Figure 3.12) shows the 
extraction of ethyl gallate peak which constitutes about 63% of CGEEA-F5-8 and the 
electrospray ionization mass spectrometry (ESI-MS). (Table 3.9) shows all the masses 
detected from this active fraction. 
 
Figure ?3.12: A: LC-MS chromatogram of CGEEA-F5-8. B: positive ESI-MS of Ethyl 
gallate MW: 198.0603 g/mol. Both acquired from qualitative analysis mass hunter work 
station software. The analysis has been done according to section 2.12, n=3. 
A 
B 
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Table ?3.9: Molecular masses of compounds pooled in CGEEA-F5-8 detected using LC-
MS. 
Formula Score Mass m/z RT Vol % 
C7 H4 O4 99.81 152.011 153.0183 2.356 1.91 
C7 H6 O5 99.91 170.0214 171.0287 2.363 3.01 
C9 H10 O5 99.84 198.0528 199.0603 2.364 63.23 
C15 H12 O6 97.5 288.0635 289.0706 2.926 1.45 
C22 H18 O8 99.88 410.1001 411.1074 3.448 2.45 
C20 H22 O9 99.83 406.1265 407.1338 3.072 4.78 
C22 H26 O13 99.81 498.1373 499.1446 3.438 1.31 
C37 H30 O14 99.42 698.1639 699.1713 3.677 6.83 
C37 H30 O15 99.85 714.1585 715.1658 3.719 2.26 
- - 834.2151 835.2223 3.862 3.61 
- - 850.2104 851.2177 3.673 6.22 
- - 1002.2222 1003.2294 3.864 2.62 
 
The positive ESI-MS of the twelve compounds masses detected are shown in appendix A 
as (Figure A-1). 
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3.1.3. Antiplasmodial effects of Cylicodiscus gabunensis extracts 
3.1.3.1. Antiplasmodial activity of CGH and CGE 
CGH and CGE were prepared in DMSO as 100, 33 and 11 ?g/ml and checked for 
antiplasmodial activity according to section 2.21. (Figure 3.13) shows the % of untreated 
control (live cells) versus drug concentration. The IC50 of CGE and CGH are shown in 
(Figure 3.14).  
 
 
Figure ?3.13: The % of untreated P. falciparum Dd2 cells versus three concentrations of 
CG plant extracts (100, 33.3, and 11.1 ?g/ml). Extracts used are Cylicodiscus gabunensis 
ethanol (CGE) and hexane (CGH), n=3. The assay has been done according to section 
2.21. 
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Figure ?3.14: IC50 of Cylicodiscus gabunensis ethanol (CGE) and hexane extract (CGH) 
against P. falciparum Dd2, n=3. The IC50 of Chloroquine against P. falciparum Dd2 was 
0.171 ?M. The assay has been done according to section 2.21. 
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3.1.3.2. Antiplasmodial activity of CGE fractions  
CGEEA, CGEBU and CGEAQ were prepared in DMSO, a dilution of 100, 33 and 11 
?g/ml were checked for antiplasmodial  activity according to section 2.21, (Figure 3.15) 
describes the antiplasmodial  potentials of CGE fractions and (Figure 3.16) shows their 
(IC50)s. The results revealed that CGEBU fraction was more active than CGEEA and 
CGEAQ.  
 
 
 
Figure ?3.15: The % of untreated P. falciparum Dd2 cells versus three concentrations of 
CGEEA, CGEBU and CGEAQ plant extracts (100, 33.3, and 11.1 ?g/ml). Extracts used 
are C. gabunensis ethanol ethyl acetate fraction (CGEEA), ethanol butanol fraction 
(CGEBU), ethanol aqueous fraction (CGEAQ), n=3. The assay has been done according to 
section 2.21. 
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Figure ?3.16: IC50 of Cylicodiscus gabunensis CGEBU, CGEEA and CGEAQ against P.
falciparum Dd2, n=3.The IC50 of Chloroquine against P. falciparum Dd2 was 0.171 ?M. 
The assay has been done according to section 2.21. 
107 
 
3.1.3.3. Fractionation of CGEBU by Column Chromatography  
CGEBU was separated into ten fractions over silica gel column according to the method 
mentioned in section 2.6.2.  
3.1.3.4. Antiplasmodial activity of CGEBU-F1-10 
Butanol fractions CGEBU-F (1-10) were prepared in DMSO as 100, 33, and 11 ?g/ml and 
checked for antiplasmodial activity according to section 2.21. (Figure 3.17) shows the 
antiplasmodial effect of the ten fractions. (Figure 3.18)   shows the IC50 6.5 ?g/ml of the 
more potent fraction CGEBU-F10.  
 
 
Figure ?3.17: The % of untreated P. falciparum Dd2 cells versus three doses of CGEBU 
fractions  (100, 33.3, and 11.1 ?g/ml). Extracts used are Cylicodiscus gabunensis ethanol 
butanol fractions (CGEBU-F1-10), n=3. The assay has been done according to section 
2.21. 
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Figure ?3.18: The dose-response curve shows the IC50 of the most active fraction from 
butanol extract (CGEBU-F10).The IC50 of Chloroquine against P. falciparum Dd2 was 
0.171 ?M. The assay has been done according to section 2.21, n=3. 
3.1.3.5. Preparative HPLC of CGEBU-F10 
The most active fraction from butanol extract (CGEBU-F10) was separated into eight 
fractions using preparative HPLC column according to section 2.7.2, The HPLC 
chromatogram is shown in (Figure 3.19).  
 
Figure ?3.19: Preparative HPLC of CGEBU-F10. The fractionation has been done 
according to section 2.7.2. 
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3.1.3.6. Antiplasmodial activity of CGEBU-F10 (1-8) 
Butanol fractions (CGEBU-F10 (1-8)) were prepared in DMSO as 50, 10, and 2 ?g/ml 
according to the method mentioned in section 2.21, for the evaluation of their 
antiplasmodial activities. (Figure 3.20) shows the effect of the butanol fractions (CGEBU-
F10 (1-8)) against P. falciparum Dd2. (Figure 3.21) shows the dose-response curve of the 
most active fraction (CGEBU-F10-7), IC50 4.694 ?g/ml.  
 
 
 
Figure ?3.20: The % of untreated P. falciparum Dd2 cells versus three doses of CGEBU-
F10 subfractions (50, 10, and 2 ?g/ml). Extracts used are Cylicodiscus gabunensis 
CGEBU-F10 fractions (1-8), n=3. All the fractions causing complete eradication of the 
parasites at concentration 50 ?g/ml. The assay has been done according to section 2.21. 
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Figure ?3.21: The Dose- response curve shows the IC50 of the most active fraction from 
butanol fraction 10 (CGEBU-F10-7). The IC50 of Chloroquine against P. falciparum Dd2 
was 0.171 ?M. The assay has been done according to section 2.21, in triplicate n=3. 
3.1.4. Chemical analysis of the active antiplasmodial compounds 
3.1.4.1. Analysis of CGEBU, CGEAQ and CGH 
The trimethyl silyl derivatives of CGEBU and CGEAQ were prepared according to section 
2.8.5.2 and CGH dissolved in hexane according to section 2.8.5.1 to check by GC-MS 
according to method A described in section 2.8.1. (Table 3.10) shows the metabolites 
detected from CGEBU and (Figure 3.22) shows the GC-MS total ion chromatogram TIC. 
(Table B-1) and (Figure B-1) show the compounds detected and TIC of CGEAQ 
respectively. (Table B-2) and (Figure B-2) show the compounds detected and TIC of CGH 
respectively. (Figure B-3) shows the EI-Mass spectrometry of Lup-20(29)-en-3-one, a 
compound detected from CGH (Appendix-B).  
11
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Figure ?3.22: GC-MS chromatogram of Cylicodiscus gabunensis butanol fraction, CGEBU. 
According to section 2.8.1 in triplicate, n=3.  
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3.1.4.2. 1H NMR of CGEBU-F10-7 
Four mg of CGEBU-F10-7 was prepared for 1H NMR according to section 2.14; (Figure 
3.23) shows the NMR spectrum of CGEBU-F10-7. 
 
 
Figure ?3.23: 1H NMR spectrum of CGEBU-F10-7 in CD3COCD3:D2O (1:1), section 2.14. 
 
3.1.4.3. Acid hydrolysis and GC-MS assay of CGEBU- F10-7 
Two mg of CGEBU-F10-7 hydrolysed according to the procedure specified in section 
2.13. (Figure 3.24) shows the GC-MS chromatogram of the hydrolysed fraction CGEBU-F 
10-7. 
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Figure ?3.24: GC-MS chromatogram of hydrolysed CGEBU-F10-7 after TMSi derivation.  
?????? ????? ????? ??? ?????? ???? ???? ?-L-arabinose-?????? ???? ?-L-rhamnose-?????? ???? ?-L-
arabinose-TMSi; ?????-L-rhamnose-???????????-D-glucose-???????????-D-glucose-TMSi; 
G: gallic acid-TMSi. The assignment of these peaks was based on the NIST library and 
comparison with standard compounds. The derivatives were prepared according to section 
2.8.5.2 and analysed according to section 2.8.1, in triplicate n=3.  
 
CGEBU-F10-7 apparently composed of oligosaccharides units attached to either gallic acid 
or other molecules as confirmed from the results of LC-MS which showed high molecular 
weights of the compounds detected from this fraction. (Figure A-2) in appendix A shows 
the positive ESI-MS of five compounds picked as masses from CGEBU-F10-7 by 
qualitative analysis mass hunter work station software. Masses detected were 1: 
1260.5497; 2: 1436.6116 and 1406.6074; 3: 1044.5522; 4: 1244.5487. 
115 
 
3.1.4.4. Mass spectrometry of the anomerised sugars 
Sugar molecules were identified by running standard sugars and do anomerisation of 
sugars according to section 2.13.2, then confirm the identity of the sugar molecules 
detected from the hydrolysed CGEBU-F10-7 fraction with those standards through 
matching of EI-MS spectrum and RT. (Figures 3.25, 3.26, and 3.27) are show the TIC, EI-
MS of the monosaccharides detected from the hydrolysed CGEBU-F10-7 fraction.  
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Figure ?3.25: GC-MS chromatogram (TIC) and EI-MS of the anomerised glucose. A: TIC 
of glucose shows two peaks of alpha and beta-glucose. B and C: EI-MS of ?-glucose from 
the standard and the anomerised sample respectively. D and E: EI-MS of beta-glucose 
from the standard and the anomerised sample respectively.  
 
A) 
B) C) 
D) E) 
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Figure ?3.26: GC-MS chromatogram (TIC) and EI-MS of anomerised rhamnose. A: TIC of 
rhamnose shows two peaks of alpha and beta-rhamnose. B and C: EI-MS of alpha-
rhamnose from the standard and the anomerised sample respectively. D and E: EI-MS of 
beta-rhamnose from the standard and the anomerised sample respectively.  
 
 
A) 
B) C) 
D) E) 
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Figure ?3.27: GC-MS chromatogram (TIC) and EI-MS of anomerised arabinose. A: TIC of 
arabinose shows two peaks of alpha and beta-arabinose. B and C: EI-MS of alpha-
arabinose from the standard and the anomerised sample respectively. D and E: EI-MS of 
beta-arabinose from the standard and the anomerised sample respectively. 
 
A) 
B) C) 
D) E) 
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(Figure 3.28) mentions the bioguided extraction scheme of Cylicodiscus gabunensis to 
identify its antiplasmodial compounds. 
 
Figure ?3.28: Schematic diagram illustrating key aspects of the bioassay guided 
fractionation of Cylicodiscus gabunensis bark. Indicating key fractionation methods and 
the phytochemical identified. The solvents used in the initial separation steps are indicated 
using italics, with the IC50 in ?g/ml of derived fractions indicated below each (mean from 
n=3 biological replicates).  
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3.2. Discussion 
3.2.1. Antibacterial activities of Cylicodiscus gabunensis  
The choice of the appropriate solvent for extraction of compounds from natural sources is 
essential for obtaining fractions with high antibacterial activity (Feng, Xu 2014). To extract 
the non-polar and polar compounds of CG, we used hexane and aqueous ethanol 
respectively. Phenolics were extracted efficiently with polar solvents, as aqueous ethanol 
was ranked in the best solvents set for extraction of phenolic compounds and hexane the 
least (Feng, Xu 2014). More phenolic materials were detected in ethanol than other 
solvents of extraction like chloroform and ethyl acetate (Al-Dabbas, Suganuma et al. 
2006); CG bark was rich in phenolic materials which were extracted efficiently by aqueous 
ethanol.  
3.2.1.1. Disk diffusion assay 
The agar diffusion method or disk diffusion assay is not a quantitative but a qualitative 
technique (Rios, Recio et al. 1988).  The extracts showing IZ above 9 mm were selected as 
good antibacterial agents (Michielin, Salvador et al. 2009). 
CGE showed potent activity against gram positive bacterial isolates used in this study 
compared to the weak antibacterial activity of CGH. On some plates the IZs were not 
recorded due to the growth of bacterial colonies throughout the IZ. 
The highest effect of CGE recorded against S. epidermidis IZ= 19.5 ±1.0 mm, and against 
S. aureus IZ= 16.5± 0.5 mm. S. aureus can cause skin abscess, sinusitis, and food 
intoxication. S. aureus is extremely prevalent in atopic dermatitis patients (NHS Choices 
2015). S. epidermidis is one of causes of the biofilms formation, because the bacterial cells 
can stack all over to make a multilayer biofilm (Otto 2009). CGE showed moderate effect 
against B. cereus, which contaminates the food and causes food poisoning, nausea, 
vomiting and diarrhea (Asaeda, Caicedow et al. 2005, Ehling-Schulz, Fricker et al. 2004). 
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Ethyl acetate extract of CG showed moderate activities against several isolates of bacteria, 
however, the active compounds have not been revealed yet (Kouitcheu Mabeku, Kouam et 
al. 2006). The ethyl acetate extract prepared and assayed against S. aureus. 2.5 mg/disk 
showed IZ 8-20 mm, those results were in agreement with our results (Kouitcheu Mabeku, 
Kouam et al. 2006). 
3.2.1.2. Partition of CGE  
The compounds which were extracted using aqueous ethanol were semi-polar or polar, 
hence the partition of these compounds was dependent on their solubility behaviour in 
ethyl acetate, butanol and deionized water. The sum of butanol and aqueous fractions was 
about 92% w/w of the total ethanol extract, indicating the high polarity properties of the 
chemical compounds isolated from the ethanol extract.   
CGEEA, CGEBU and CGEAQ were showed good antibacterial activities against the gram 
positive isolates used in this study. CGEEA was more potent than the other fractions.  
3.2.1.3. Antibacterial effect of CGEEA fractions 
There is no clear cut to compare the antibacterial activities of the plant extracts with those 
of standard antibiotics or pure compounds, however there was a classification system of 
natural antibacterials based on their MICs which generally classified natural extracts as 
strong when MIC are less than 500 ?g/ml, moderate 600-1500 ?g/ml and weak with MIC 
above 1600 ?g/ml (Duarte, Leme et al. 2007, Michielin, Salvador et al. 2009).  
Disk diffusion assay revealed that CGEEA was more active than CGEBU and CGEAQ, 
therefore the active fraction CGEEA was separated further into eight fractions over silica 
gel column. The most potent fraction was CGEEA-F5 collected near the end of 
chromatography indicating the semi polar to polar nature of active materials. The fraction 
was rich in benzoic acid derivatives.  
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Gallic acid, protocatechuic acid and ethyl gallate in CGEEA-F5 were eluted together and 
detected using analytical HPLC, which were in agreement with GC-MS results. 
Preparative HPLC was used to separate the CGEEA-F5 into 12 fractions. Fractions 7, 8 
and 9 were eluted in the middle of chromatography. Microdilution assay defined CGEEA-
F5-8 as the most potent fraction against S. epidermidis, S. aureus, Alcaligenes faecalis and 
E. coli; but this fraction was not separated further due to a low quantity and very similar 
elution properties of its individual components.  
The most active fraction CGEEA-F5-8 was derivatized to its corresponding trimethyl silyl 
derivatives and checked by GC-MS; as a result, three benzoic acid derivatives were 
detected. Analysis of CGEEA-F5-8 by TOF LC-MS showed the presence of twelve 
molecules with higher molecular weight than 500 Dalton.   
Ethyl gallate formed about 63% of this fraction, and the antibacterial activities are due to 
synergistic interaction between the components present in this fraction as roughly 
estimated from the higher MIC of each of these compounds when used alone against the 
bacterial isolates compared to the MIC of the total fraction (results will be presented in 
Chapter IV). 
Succinic acid detected in CGEEA is used as an acidity regulator in some pharmaceutical 
preparation. Fatty acids represent a major percentage of the extract; hexadecanoic acid 
(Palmitic acid), (Z,Z)-9,12-octadecadienoic acid (linoleic acid), octadecanoic acid (stearic 
acid), eicosanoic acid (arachidic acid), and 11-trans-octadecenoic acid (vaccenic acid) are 
used in the production of soaps and detergents.  
Free fatty acids have general antimicrobial activity and can control the fungal cells and 
bacterial isolates effectively. The petroleum ether extract of Pleurotus eous containing 
fatty acids esters such as 7,10-octadecadienoic acid, methyl ester and 16-methyl-
heptadecanoic acid methyl ester, showed good antibacterial effects with MIC of 4.4 ?g/ml 
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against S. aureus, 3.1 ?g/ml against B. subtilis, 4.2 ?g/ml against B. cereus, 8.8 ?g/ml 
against P. aeruginosa, 3.1 ?g/ml against E. coli and 4.4 ?g/ml against K. pneumoniae 
(Suseem, Saral 2013). Fatty acids can inhibit the biofilms formation and cease the 
production of toxins and harmful enzymes from the bacterial cells; they can be used as 
antibacterial agents where antibiotic are undesirable or forbidden (Desbois 2012). 
CGEEA contains several benzoic acid derivatives like 4-hydroxy benzoic acid, 3-methoxy-
4-hydroxybenzoic acid or vanillic acid, 3,4-dihydroxybenzoic acid or protocatechuic acid, 
3,5-dimethoxy-4-hydroxybenzoic acid or syringic acid, 3,4,5-trihydroxybenzoic acid ethyl 
ester or ethyl gallate, and 3,4,5-trihydoxy benzoic acid or gallic acid, which were reported 
previously with antibacterial activity. 
Wild mushrooms contain several phenolic acids which have a moderate antibacterial 
activity against methicillin sensitive and resistant S. aureus (MSSA and MRSA), S. 
epidermidis and Enterococcus faecalis. 4-hydroxybenzoic acid had MIC ?1000 ?g/ml 
against all of the microorganisms used in the study, while its 3-methoxy derivative 
(vanillic acid) performed a better antibacterial role with MIC of 500 ?g/ml against MRSA 
and >1000 ?g/ml against other bacterial isolates, 3,4-dihydroxybenzoic acid or 
protocatechuic acid showed MIC 1000 ?g/ml against both MRSA and MSSA and >1000 
?g/ml against the other two types of bacteria. 3,5-dimethoxy-4-hydroxybenzoic acid or 
syringic acid showed MIC of 500 ?g/ml against MRSA and >1000 against the other three 
isolates, and gallic acid showed MIC >1000 ?g/ml against all of the four bacteria (Alves, 
Ferreira et al. 2013).   
Caffeic acid, protocatechuic acid and chlorogenic acid are three phenolic compounds 
isolated from Coffea arabica. They showed MIC of 2000 ?g/ml against Streptococcus
mutans a gram positive bacterial isolate responsible for tooth decay (Almeida, Naghetini et 
al. 2012). Other study showed that caffeic, vanillic and protocatechuic acids showed MIC 
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of 300 ?g/ml against two gram negative bacteria E. coli and K. pneumoniae (Aziz, Farag et 
al. 1998). 
Several phenolic acids from wine, like gallic acid, ethyl gallate, and caffeic acid showed 
the greatest antimicrobial activity against S. aureus ATCC25923 with IC50 18.9, 257, 319 
?g/ml, respectively. Their IC50 against Enterococcus faecalis V583 were 440, 484 and 975 
?g/ml respectively. E. faecalis, a gram positive lactobacillus, can cause dangerous 
infections to patients in hospital wards (Cueva, Mingo et al. 2012).  
Gallic acid found naturally abundant in beer at a concentration of 0.6 mg/kg and 35 mg/ kg 
of wine  is  used in food industry as food additive or flavoring agent from 1- 500 mg/kg 
and maximum 5-2000 mg/kg because of its ability to inhibit the growth of S. aureus 
([EFSA] European Food Safety Authority 2010).  
3.2.1.4. SEM results
Gallic acid and ethyl gallate were tested for their effects on S. aureus cell wall. Double 
concentration of MIC of these two compounds was used here and the fixation process 
started within the first hour of incubation with the antibacterial agents, the reason for this is 
the quick and complete destruction of cells within 3 hours of incubation, indicating the 
necessity for fast fixation to follow the effect of antibacterials against S. aureus. 
Gallic acid and ethyl gallate increase the permeability of the cell wall and enhance the 
leakage of cell contents to end with collapsed cells; gallic acid activity was more 
prominent than ethyl gallate ability within the first hour of incubation.  
Previous study on mechanism of action of gallic acid showed that gallic acid increased the 
cell wall permeability, decreased the negative surface charge and formed pores in the cell 
wall of S. aureus, indicating that gallic acid might link several targets in the bacterial cell 
wall (Borges, Ferreira et al. 2013). Those results were agreed with our results, as we have 
observed the roughness on S. aureus cell wall and leakage of cell contents. 
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3.2.2. Antiplasmodial activities of Cylicodiscus gabunensis  
In order to identify the antiplasmodial compounds from CG bark we used hexane and 70 % 
ethanol to extract the non-polar materials and polar components, respectively, butanol 
fraction had most of the materials from the ethanol extract around 77% w/w, except 
benzoic acid derivatives which were extracted efficiently by ethyl acetate. Hexa- and 
octadecanoic acids represented about 40% of this fraction. Plants with possible anti-
malarial activities are usually extracted by ethanol (Okokon, Ita et al. 2006, Vale, Vilhena 
et al. 2015). The results indicated that the ethanol extract has more potent activity over the 
hexane extract, which comes in agreement with the previous research which used an 
ethanolic extract of CG in an in vivo study in mice infected with P. berghei (Okokon, Ita et 
al. 2006). 
Several phenolic acids in fractions of CGEBU and CGEEA detected by GC-MS analysis 
were assayed for their antiplasmodial activities, and the results indicated that they 
contributed to the antiplasmodial activity of these fractions, those results will be discussed 
in details in Chapter IV.  
Bioassay guided fractionation gave an HPLC fraction (CGBU-F10-7) which was the most 
active and ranked as a highly active extract. Plant extracts with possible anti-malarial 
activities were classified to highly active with IC50 ?????????????????????????????????-10 
?g/ml, good activity 10.1-20 ?g/ml, moderate activity 20.1-40 ?g/ml, marginal potency 
40.1-??????????????????????????????????????????????????(Singh, Kaushik et al. 2015).  
Although different columns such as C8 and amino-derived columns have been tried to 
isolate single pure components for structural elucidation and evaluation its biological 
activity, unfortunately this was not successful probably because  those components may 
have very close physiochemical properties. Therefore we had to characterize the most 
active fraction CGEBU-F10-7 as a mixture. 
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LC-MS of CGEBU-F10-7 indicated the presence of higher molecular weight compounds 
between 1000 and 1500 Da. After acid hydrolysis and TMSi derivation, GC-MS analysis 
indeed revealed that the presence of gallic acid and several monosaccharides (D-glucose, 
L-arabinose, and L-rhamnose), where the peaks for glucose is apparently higher than other 
sugars peaks.  
High resolution 1H NMR indicated the presence of sugar and aromatic protons as well as 
aliphatic protons.  These results suggested that conjugates of oligosaccharide with gallic 
acid or terpenoids might be present in this mixture. However, the exact linkage between 
the monosaccharides and gallic acid is unknown. Previously an oligosaccharide derivative 
(a resin glycoside, crypthophilic acid C) from Scrophularia cryptophila showed potent 
antiplasmodial activity against P. falciparum with IC50 (4.2 ?g/ml) (Tasdemir, Brun et al. 
2008). 
Ellagic acid (a dimer of gallic acid) and a galloyl glycoside from Tristaniopsis calobuxus 
bark extract had very potent antiplasmodial  activities against P. falciparum IC50 values of 
0.5 and 3.2 ?M, respectively (Verotta, Dell'Agli et al. 2001). 1-O-galloyl-6-O-luteoyl-?-D-
glucose from Phyllanthus niruri also showed very low IC50 (1.4 ?g/ml) against P. 
falciparum  (Subeki, Matsuura et al. 2005). All these indicate that galloyl moiety plays an 
important role in the inhibition of P. falciparum. The structures of crypthophilic acid C and 
1-O-galloyl-6-O-luteoyl-?-D-glucose are shown in (Figure 3.29).  
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Figure ?3.29: The structures of crypthophilic acid C and 1-O-galloyl-6-O-luteoyl-?-D-
glucose. 
 
Furthermore, HR LC-MS showed presence of a mass of 1044.5522 which matched to the 
molecular mass (calcd. 1044.5505) of a known gabunoside, 3-O-??-L-arabinopyranosyl-(1-
2)-?-L-arabinopyranosyl-(1-3)-?-D-glucospyranosyl] maslinic acid-28-?-L-rhamnosyl 
ester from CG (Tene, Chabert et al. 2011). However, further confirmation using the 
standard sample is needed.  
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Chapter 4 : Results and discussion of the 
antibacterial and antiplasmodial activities of 
several benzoic acid derivatives. 
4.1. Results 
4.1.1. Synthesis of alkyl and alkenyl 3,4,5-trihydroxybenzoates 
Initially, chemical screening using GC-MS was applied to both CGEEA and CGEBU 
fractions (Chapter III, 3.1.2.1.2 and 3.3.2.1.) in order to quickly identify the possible 
antibacterial and antiplasmodial compounds. As a result, 3,4,5-trihydroxybenzoic acid 
(gallic acid) and several fatty acids were detected in both CGEEA and CGEBU. In 
addition, 4-hydroxybenzoic acid, 3-methoxy-4-hydroxybenzoic acid (vanillic acid), 3,4-
dihydroxybenzoic acid (protocatechuic acid), syringic acid, and 3,4,5-trihydroxybenzoic 
ethyl ester (ethyl gallate) were detected from CGEEA. 
Benzoic acid derivatives may play an important role in the antibacterial and antiplasmodial 
activities of Cylicodiscus gabunensis, here we prepared de novo several 3,4,5-
trihydroxybenzoates for this study and several benzoic acid derivatives were available 
from commercial sources to test for antibacterial and antiplasmodial  activities. The 
possible application of those materials as food preservatives and antibiotic resistance 
modification agents will be discussed.  
Five alkyl or alkenyl 3,4,5-trihydroxybenzoates were synthesized according to section 2.22 
and purified according to section 2.23. White crystals were collected for all compounds 
with yields exceeding 80%. The yields were as follows 583 mg (85%) of 2-methylpropyl 
3,4,5-trihydroxybenzoate, 1; 597 mg (82%) of 2- methylbutyl 3,4, 5-trihydroxybenzoate, 
2; 606 mg (84%) of 3-methylbut-2-en-1-yl 3,4,5-trihydroxybenzoate, 3; 604 mg (83%) of 
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3-methylbutyl 3,4,5-trihydroxybenzoate,4; 534 mg (83%) of propan-2-yl 3,4,5-
trihydroxybenzoate, 5. The molecular weights of the synthesised esters were 226, 240, 238, 
240, and 212 g/mol respectively.  
4.1.2. NMR, positive-ion TOF LC-MS and GC-MS of the synthesised benzoate 
derivatives 
The aromatic type structures of the synthesised 3.4.5-trihydroxybenzoates (1-5) were 
established by spectroscopic analysis. NMR experiments were conducted according to 
section 2.14. The compounds were prepared in d4-methanol according to section 2.14. 
 
  
 
 
 
 
 
1: 2-methylpropyl 3,4,5-trihydroxybenzoate 
1H NMR (300MHz, METHANOL-d4????????????????????-2, 6), 4.02 (2H, d, J = 6.6 Hz, H-
8, 8), 2.04 (1H, m, H-9), 1.03 (6H, d, J = 6.6 Hz, H-10, 11). 
 
13C NMR (101MHz, METHANOL-d4??????????????-7), 145.1 (C-3, 5), 138.3 (C-4), 120.3 
(C-1), 108.6 (C-2, 6), 70.3 (C-8), 27.8 (C-9), 18.1 (C-10, 11). 
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2: 2- methylbutyl 3,4,5-trihydroxybenzoate 
1H NMR (300MHz, METHANOL-d4????????????????????-2, 6), 4.02 - 4.16 (2H, m, H-8, 8), 
1.79 - 1.87 (1H, m, H-9), 1.45-1.55 (1H, m, H-10), 1.26 - 1.34 (1H, m, H-10), 1.02 (3H, d, 
J = 6.8 Hz, H-12), 0.95 (3H, t, J=7.45 Hz, H-11).  
13C NMR (101MHz, METHANOL-d4??????????????-7), 145.1 (C-3, 5), 138.3 (C-4), 120.3 
(C-1), 108.6 (C-2, 6), 68.8 (C-8), 34.3 (C-9), 25.8 (C-10), 15.5 (C-12), 10.3 (C-11). 
 
 
 
 
 
 
3: 3-methylbut-2-en-1-yl 3,4,5-trihydroxybenzoate 
1H NMR (300MHz, METHANOL-d4??????????? ?????????-2, 6), 5.45 (1H, m, H-9), 4.74 
(2H, d, J = 7.2 Hz, H-8, 8), 1.79 (3H, s, H-11), 1.82 (3H, s, H-12). 
13C NMR (101MHz, METHANOL-d4?? ?? ?? ?????? ??-7), 145.1 (C-3, 5), 138.6 (C-10), 
138.3 (C-4), 120.4 (C-1), 118.7 (C-9), 108.6 (C-2, 6), 61.0 (C-8), 24.5 (C-12), 16.7 (C-11). 
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4: 3-methylbutyl 3,4,5-trihydroxybenzoate 
1H NMR (300MHz, METHANOL-??????????????????????-2, 6), 4.27 (2H, t, J = 6.6 Hz, H- 
8,8), 1.64 (2H, q, J = 6.7 Hz, H-9), 1.25 (1H, m, H-10), 0.99 (6H, d, J = 6.6 Hz, H-11, 12).  
13C NMR (101MHz, METHANOL-????????????????-7), 145.1 (C-3, 5), 138.3 (C-4), 120.3 
(C-1), 108.6 (C-2, 6), 62.8 (C-8), 37.3 (C-9), 25.0 (C-10), 21.5 (C-11, 12). 
 
 
 
 
  
5: propan-2-yl 3,4,5-trihydroxybenzoate 
1H NMR (300MHz, METHANOL-d4????????????????????-2, 6), 5.09 - 5.17 (1H, m, H- 8), 
1.34 (6H, d, J = 6.4 Hz, H-9, 10).  
13C NMR (101MHz, METHANOL-d4??????????????-7), 145.0 (C-3, 5), 138.2 (C-4), 120.8 
(C-1), 108.6 (C-2,6), 67.8 (C-8), 20.8 (C-9,10). 
The positive-ion TOF LC-MS was done according to section 2.12. The positive-ion ESI-
MS of 3.4.5-trihydroxybenzoates (1-5) generated the following pseudo-molecular [M+H]+ 
ions at m/z: 227.0917, 1; 241.1073, 2; 239.0922, 3; 241.1071, 4, [M+Na] + ion at m/z: 
235.0576, 5. 
Using GC-MS, samples were prepared according to section 2.8.5.2 and analyzed according 
to section 2.8.1. The molecular peaks of the trimethylsilyl derivatives of the synthesized 
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compounds were detected at m/z: 442.3, 1-TMSi; 456.3, 2-TMSi; 454.2, 3-TMSi; 456.3, 
4-TMSi; and 428.2, 5-TMSi. 
 (Figures C1-C10) in Appendix C show the 1H and 13C NMR data with detailed structures 
of compounds (1-5). (Figure A-3) in appendix A shows the positive mode ESI-MS of the 
synthesized compounds. (Figure A-4) in appendix A shows the EI-MS of compounds (1-5) 
trimethylsilyl derivatives. The esters synthesized were run on C18 column according to 
section 2.24 and RT recorded. (Table 4.1) shows the RT of those compounds in three 
different systems, TOF LC-MS, HPLC, and GC-MS. 
 
 
Table ?4.1: The retention time in min of the five synthetic benzoate esters in three different 
columns using three different techniques, LC-MS, HPLC and GC-MS. Analysis has been 
done in triplicate, n=3 according to sections 2.12, 2.24, and 2.8.1 respectively.  
 
 
4.1.3. Antibacterial activity of gallic acid and other structurally related molecules 
To study the effects of carboxylic acid esterification, O-methylation and dehydroxylation 
of gallic acid on the antibacterial activities of this phenolic acid detected in CGEEA, 
section 3.1.2.1.2., five phenolic esters (2-methylpropyl 3,4,5-trihydroxybenzoate, 1; 2- 
methylbutyl 3,4,5-trihydroxybenzoate, 2; 3-methylbut-2-en-1-yl 3,4, 5-trihydroxybenzoate, 
3; 3-methylbutyl 3, 4, 5-trihydroxybenzoate, 4; propan-2-yl 3,4,5-trihydroxybenzoate, 5), 
Compound RT using LC-MS  RT using HPLC RT using GC-MS 
1 4.245 22.409 20.592 
2 4.980 25.368 21.440 
3 4.523 23.353 21.798 
4 5.007 25.346 21.396 
5 5.720 18.107 19.141 
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in addition to seven phenolic acids and esters of phenolic acids available from commercial 
sources (3,4,5-trihydroxybenzoic acid, 6; 3,4-dihydroxybenzoic acid, 7; 4-hydroxy-3-
methoxybenzoic acid, 8; 3,4,5- trimethoxybenzoic acid, 9;  Ethyl 3,4,5-trihydroxybenzoate, 
10; Propyl 3,4,5-trihydroxybenzoate, 11; and Dodecyl 3,4,5-trihydroxybenzoate, 12) were 
prepared in 3% DMSO, dodecyl 3,4,5-trihydroxybenzoate was prepared in 0.5 % Tween 
20, at eight different double diluted concentrations 1000-8 ?g/ml and MICs of those 
compounds against several bacterial isolates were determined according to section 2.17, 
(Table 4.2) shows the MIC of several phenolic compounds. The structures and IUPAC 
names of the synthesized compounds (1-5) and of compounds (6-12) available from 
commercial sources are shown in (Figure 4.1).  
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4.1.4. Effects of 2-methylpropyl 3, 4, 5-trihydroxybenzoate and propan-2-yl 3,4,5-
trihydroxybenzoate on S. aureus cell wall 
Compounds 2-methylpropyl 3,4,5-trihydroxybenzoate, (1) and propan-2-yl 3,4,5-
trihydroxybenzoate, (5) were selected as the least active compounds of the synthesised 
esters against S. aureus. They were tested for their effects on S. aureus cell wall and their 
effects studied using SEM according to the method mentioned in section 2.19. Compounds 
2-methylpropyl 3,4,5-trihydroxybenzoate, (1) and propan-2-yl 3,4,5-trihydroxybenzoate, 
(5) have prominent effects on S. aureus cell wall integrity as displayed in (Figure 4.2).  
 
Figure ?4.2: The effects of 2-methylpropyl 3,4,5-trihydroxybenzoate, (1) and propan-2-yl 
3,4,5-trihydroxybenzoate , (5) against S. aureus. A: S. aureus control, arrows pointing to 
the cell divisions; B and C: micrography shows the effects of 1 on S. aureus cell wall, 
arrows pointing to the collapsed cells and leakage of cellular contents; D: micrography 
shows the effects of 5 against S. aureus, arrows pointing to the exudates from the bacterial 
cell walls. The assay has been done according to section 2.19. 
C 
B 
D 
A 
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4.1.5. Antiplasmodial activities of gallic acid and other structurally related molecules 
Several benzoic acid derivatives (1-12) which were mentioned in section 4.1.2 were tested 
for their antiplasmodial activity according to method mentioned in section 2.21, the dose-
response curves were sketched using Graph pad prism 6 and IC50 s were calculated in ?M 
and ?g/ml. (Table 4.3) shows the antiplasmodial potentials of several benzoic acid 
derivatives and (Figures 4.3-4.4) show the dose-response curve of several benzoic acid 
derivatives against P. falciparum Dd2. 
Table ?4.3: The antiplasmodial activities of several benzoic acid derivatives. IC50 (mean ± 
SD from n=3 biological replicates. Commercially sourced compounds or those synthesized 
for this study (marked with*). The IC50 of Chloroquine against P. falciparum Dd2 was 
0.171 ?M. The assay has been done according to section 2.21. 
 
 
Compound name IC50 ± SD in ?g/ml (?M) 
2-methylpropyl 3,4,5-trihydroxybenzoate (1)* 3.8  ± 0.5 (16.9 ± 2.3) 
2- methylbutyl 3,4,5-trihydroxybenzoate (2)* 2.8 ± 0.3 (11.8 ± 1.2) 
3-methylbut-2-en-1-yl 3,4, 5-trihydroxybenzoate (3)* 4.1 ± 0.5 (17.5 ± 2.2) 
3-methylbutyl 3, 4, 5-trihydroxybenzoate (4)* 2.1 ± 0.4 (8.8 ± 1.5) 
propan-2-yl 3,4,5-trihydroxybenzoate (5)* 3.0 ± 0.4 (13.9 ± 1.8) 
3,4,5-trihydroxybenzoic acid (6) 4.5 ± 0.7 (26.8 ± 4.4) 
3,4-dihydroxybenzoic acid (7) 12.9 ± 1.5 (83.4  ± 10.0) 
4-hydroxy-3-methoxybenzoic acid (8) 11.97 ± 1.8 (71.2  ± 11.0) 
3,4,5- trimethoxybenzoic acid (9) 23.8 ± 3.2 (112.3 ± 15.2) 
Ethyl 3,4,5-trihydroxybenzoate (10) 1.8  ± 0.6 (9.3 ± 3.1) 
Propyl 3,4,5-trihydroxybenzoate (11) 5.2  ± 0.6 (24.5 ± 2.9) 
Dodecyl 3,4,5-trihydroxybenzoate (12) 0.7 ± 0.1 (2.2 ± 0.2) 
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Figure ?4.3: Dose-response curve of antiplasmodial activity against P. falciparum Dd2, 
compounds (1-6). 2-methylpropyl 3,4,5-trihydroxybenzoate, 1; 2- methylbutyl 3,4,5-
trihydroxybenzoate, 2; 3-methylbut-2-en-1-yl 3,4,5-trihydroxybenzoate, 3; 3-methylbutyl 
3,4,5-trihydroxybenzoate,4;propan-2-yl 3,4,5-trihydroxybenzoate,5;3,4,5 
trihydroxybenzoic acid, 6. The assay has been done according to section 2.21, in triplicate 
n=3. Chloroquine IC50= 0.171 ?M. 
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Figure ?4.4: Dose-response curve of anti-malarial activity against P. falciparum Dd2, 
compounds (7-12). 3,4-dihydroxybenzoic acid,7; 4-hydroxy-3-methoxybenzoic acid, 8; 
3,4,5-trimethoxybenzoic acid,9; ethyl 3,4,5-trihydroxybenzoate, 10; propyl 3,4,5-
trihydroxybenzoate, 11; and dodecyl 3,4,5-trihydroxybenzoate, 12. The assay has been 
done according to section 2.21, in triplicate n=3. Chloroquine IC50= 0.171 ?M. 
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4.2. Discussion 
4.2.1. Synthesis of alkyl and alkenyl 3,4,5-trihydroxybenzoates 
Benzoates can be synthesised from 3,4,5-trihydroxybenzoyl chloride, the procedure was 
utilized excess of thionyl chloride. Production yields for esters from primary and 
secondary alcohols were 72% and 55%, respectively (Khatkar, Nanda et al. 2013). The 
other method is by heating gallic acid with nine times excess of alkanol with sulphuric 
acid, and the yield was 77% (Khatkar, Nanda et al. 2013).  Esters can be synthesised using 
a coupling reagents like N,N'-dicyclohexylcarbodiimide  (DCC), and this reaction needs 
some base as a catalyst (Gilles, Vieira et al. 2015).  
Kubo et al. (2002) synthesized esters of gallic acid utilizing 4 mM of DCC as a coupling 
agent and 1 mM of each gallic acid and alcohol, however, the purification steps were very 
tedious and contained many step of washing with citric acid, alkali and water before using 
the column chromatography (Kubo, Xiao et al. 2002).  
The synthetic approach we adapted here was a modified sequence of steps, which used 
excess of alcohol (4 mmol), 3 mmol of gallic acid and 3.5 mmol of DCC. This 
combination enabled us to avoid the unnecessary excess of coupling reagent which 
complicated the purification steps as we noticed from our synthesis. 
Our procedure did not use several washing steps. Column chromatography using an 
isocratic solvent system of a mixture of ethyl acetate and hexane was used for the 
purification of products; the yields were high and exceeded 80% for all derivatives even 
for propan-2-yl 3,4,5-trihydroxybenzoate compared to the 55% yield when using 3,4,5-
trihydroxybenzoyl chloride (Khatkar, Nanda et al. 2013).  
Using a coupling agent in the presence of a base was reported; the proposed mechanism is 
the formation of acid anhydride by the effect of coupling reagent and base (Gilles, Vieira et 
al. 2015). (Figure 4.5) shows the mechanism of ester formation via acid anhydride, 
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modified from (Gilles, Vieira et al. 2015). In our synthesis scheme we did not use a base; 
we speculate that the conversion of two moles of gallic acid into one mole of gallic acid 
anhydride is spontaneous in the presence of DCC and excess amount of alcohol, however, 
detailed study of all the products and intermediates is essential to confirm this.    
 
Figure ?4.5: Mechanism of benzoate ester formation. Modified from (Gilles, Vieira et al. 
2015). Compounds are gallic acid, 1; DCC, 2; dicyclohexylurea, 3; gallic anhydride, 4; 
alcohol, 5; benzoate esters, 6.    
142 
 
4.2.2. NMR 
n-heptyl gallate, n-nonyl gallate, n-decyl gallate, and n-undecyl gallate were synthesised 
before and their 1H NMR showed a chemical shift = 7.07 ppm for the two aryl protons (H-
2,6) (Shibata, Kondo et al. 2005) which was in agreement with our results. The 1H NMR 
spectra of 2-methylpropyl 3,4,5-trihydroxybenzoate were in good agreement with the 1H 
NMR of isobutyl benzoate, recorded on Varian T-60 spectrometer and CCl4 as a solvent. 
Isobutyl benzoate was showed proton chemical shifts as follows ? 0.97 (d, J = 6.7 Hz, 6 
H), 2.02 (m, 1 H), 4.10 (d, J = 6.7 Hz.2 H), 7.4 (m, 3 H), 8.0 (m, 2 H) (Rossi, De Rossi 
1974), supported the characterization of 2-methylpropyl 3,4,5-trihydroxybenzoate. The 
structures of isobutyl benzoate and 2-methylpropyl 3,4,5-trihydroxybenzoate are shown in 
(Figure 4.6).  
 
Figure ?4.6: The structures of isobutyl benzoate and 2-methylpropyl 3,4,5-
trihydroxybenzoate. 
 
For 3-methylbut-2-en-1-yl 3,4,5-trihydroxybenzoate (3), the proton (H-9) attached to C-9 
appeared at ? = 5.45 ppm (m, H-9) instead of doublet, due to two types of coupling; a 
coupling with the two geminal protons (CH2-8), and a long range coupling with the six 
protons of the two methyl groups (CH3-11/12). In return, the six protons attached to carbon 
number 11 and 12 appeared as two adjacent singlets ??= 1.79 (3H, s, H-???????= 1.82 (3H, 
s, H-12) instead of one singlet, reflecting the different chemical environments of these two 
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methyl groups in the molecule. The structure of 3-methylbut-2-en-1-yl 3,4,5-
trihydroxybenzoate is shown in (Figure 4.7).  
 
 
 
 
Figure ?4.7: The structure of 3-methylbut-2-en-1-yl 3,4,5-trihydroxybenzoate.  
 
Interestingly, 13C NMR of 3-methylbut-2-en-1-yl 3,4,5-trihydroxybenzoate (3) shows the 
different chemical shifts for CH3-12 (24.5 ppm) and CH3-11 (16.7 ppm) probably due to 
their different chemical environments resulted from the alkene preventing the free rotation 
around the bond. 
4.2.3. Antibacterial activity of several benzoic acid derivatives 
Foodstuffs are targets to many pathogenic bacteria like S. aureus, E. coli, B. cereus and 
Pseudomonas spp. which are the major causes of food poisoning. S. aureus gastroenteritis 
is one of the major food hygiene problems (Seo, Boach 2007); dairy products inoculated 
with Shiga toxin producers (E. coli) present another problem in food preservation and 
probably cause an outbreak of infection between people (Nataro, Bopp et al. 2007). Food 
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packaging companies are seeking new kinds of preservatives to improve the products 
safety and phenolics are kinds of promising food preservatives.  
Phenolic compounds have antibacterial activities with more effectiveness against gram 
positive than gram negative bacteria (López-Malo Vigil, Palou et al. 2005). One of those 
phenolic acids detected in CGEEA and CGEBU (Chapter III, 3.1.2.1.2 and 3.3.2.1.) is 
gallic acid which has MIC equal to 100-1600 ?g/ml against different S. aureus strains 
(Gutiérrez-Larraínzar, Rúa et al. 2012). 
Phenolics are antioxidants and their hydroxyl number, arrangement and structural 
conjugation determine antioxidant abilities (Rice-Evans, Miller et al. 1996), those effects 
give them advantage as possible food additives. Previous studies showed that antibacterial 
activity increases with degree of hydroxylation on the ring, however, this assumption is not 
always true (Cowan 1999). Several benzoates are approved to use in Europe as food 
additives due to their antioxidant activities, like propyl gallate, octyl gallate, and dodecyl 
gallate which were coded as E310, E311, and E312 respectively (Gov.UK 2016).  
The results showed that esterification of gallic acid with alkyl or alkenyl group with four 
carbons or more increased the antibacterial activity against B. cereus and B. subtilis 
compared to gallic acid (MIC 1000 ?g/ml). The most prominent anti-bacillus agent was 
lauryl gallate (MIC 31.25 ?g/ml). The effect of the esterified gallic acid was more 
pronounced on both Staphylococcus species used in this research.  S. epidermidis was more 
liable to the compounds used, the order of activity was as following gallic acid, 
protocatechuic acid, vanillic acid, and 3,4,5-trimethoxybenzoic acid< ethyl gallate, propyl 
and isopropyl gallate < lauryl gallate and other esters used. Lauryl gallate showed potent 
effect against S. aureus and S. epidermidis (?????????????).  
The results showed that the phenolic hydroxyls are essential for antibacterial activities as 
we can see from the decrease in activity against S. aureus and S. epidermidis by the 
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methylation of phenolic hydroxyls. Saturation of the double bond in 3-methylbut-2-en-1-yl 
3,4,5-trihydroxybenzoate, 3; compared to 3-methylbutyl 3,4,5-trihydroxybenzoate, 4, leads 
to a two-fold increase of the antibacterial effect against E. coli, B. cereus and B. subtilis .  
The results indicated that the esterification of carboxyl moiety increased the activity 
against E. coli, however this increment in antibacterial activity is limited to a short chain of 
alkyl group attached to the carboxyl group, the most potent compounds against E. coli 
were propan-2-yl 3,4,5-trihydroxybenzoate and ethyl gallate (MIC 62.5 ?g/ml), both of 
these compounds were more active than their corresponding acidic molecule gallic acid 
which showed MIC of 1000 ?g/ml being half of MIC of propyl gallate.  
Propan-2-yl 3,4,5-trihydroxybenzoate (isopropyl gallate, 5) characterized by the three 
carbon chain unit attached to the carbonyl moiety as isopropyl group, showed a more 
potent anti E. coli effect with MIC of 62.5 ?g/ml than that (125 ?g/ml) of propyl 3,4,5-
trihydroxybenzoate (propyl gallate). The increase in such activity may be owed to the 
geometry of the side chain in the molecule. Interestingly, compound 5 showed less 
inhibition against S. aureus with its MIC 1000 ?g/ml than  propyl gallate with MIC of 500 
?g/ml.   
Dodecyl gallate lost completely the activity against E. coli; this could be attributed to the 
nature of E. coli cell wall composed of an outer membrane containing lipopolysaccharides, 
a periplasmic space with a peptidoglycan layer which may prevent penetration of the 
highly non-polar molecules.  
Gram negative bacteria have impermeable outer cell wall which prohibits many molecules 
to go through and the membrane bound efflux proteins which expels many intruders 
outside the cells. These make the finding of strong anti-gram negative agent a big 
challenge and needs great attention (Gibbons 2008). Gallic acid and lauryl gallate showed 
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weak activity against A. faecalis (MIC 1000 ?g/ml) while other compounds were more 
potent with MIC of 250-500 ?g/ml.  
Alkyl gallates at concentrations lower than MIC effectively reduced the MIC of oxacillin 
against MRSA (Shibata, Kondo et al. 2005), because the amphiphilic properties of alkyl 
gallates enable them to interact with S. aureus cell wall (Shibata, Kondo et al. 2005). The 
galloyl moiety plays a key role in beta lactam activity intensification rather than the alkyl 
group which increases the anti-staphylococcal activity of benzoic acid derivatives (Shibata, 
Kondo et al. 2005). The structure of the alkyl gallates enables them to interact with many 
targets in the bacterial cell wall, which disrupt the structure of the cell wall and render the 
process of cell wall synthesis inefficient (Shibata, Kondo et al. 2005). 
3,4,5-trihydroxybenzoic acid showed weak antifungal activity against Saccharomyces  
cerevisiae ???????????????????????????. The esterification of gallic acid increased the 
antifungal effects with MIC of 12.5 ?g/ml for dodecyl gallate, which showed that both the 
alkyl group and catechol or pyrogallol groups are essential for the antifungal activity 
(Kubo, Xiao et al. 2002).   
The SEM micrography pictures indicate that alkyl gallates synthesised here are important 
antibacterial candidates which effectively disrupt the cell wall integrity of S. aureus and 
could offer a synergistic activity with some antibiotics against resistant bacterial cells with 
impermeable cell wall or efflux pump proteins.  
4.2.4. Antiplasmodial activity of several benzoic acid derivatives 
Evaluation of the antiplasmodial activity of several phenolic acids indicated that the free 
hydroxyl groups on the aromatic ring for gallic acid and gallate esters are essential for 
antiplasmodial effect.  
Gallic acid has been detected in the active fraction of butanol CG extract. Gallic acid and 
protocatechuic acid from Chrozophora senegalensis aqueous extract showed moderate 
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antiplasmodial activities against chloroquine-resistant P. falciparum strain W2-Indochina 
(Garcia-Alvarez, Moussa et al. 2013). Ethyl gallate from Talisia nervosa showed a weak 
antiplasmodial effect in vitro against P. falciparum W2 Indochina with IC50 of 9 - 35 ?M 
(Calderón, Romero et al. 2006, Ramanandraibe, Grellier et al. 2008).  
These results were in agreement with our findings. Furthermore, alky gallates, in particular 
lauryl gallate, are more potent antiplasmodial compounds than gallic acid itself. 
Esterification of the acidic group in gallic acid increases the antiplasmodial activity.  
Addition of one methyl group to the alkyl side chain of 2-methylpropyl increased the effect 
and decreased the IC50 from 3.8 to 2.8 ?g/ml; the attachment of methyl group to position 3 
instead of position 2 increased the antiplasmodial  effect more, while unsaturation of the 
side chain decreased the effect. The results suggest that there is an increase in 
antiplasmodial activity of benzoic acid derivatives by esterification of the carboxylic acid 
group and the free hydroxyl groups on the aromatic ring are essential for anti-malarial 
effect. 
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Chapter 5 : Results and discussion of antibacterial 
activity of Pogostemon cablin 
5.1. Results 
5.1.1. Antibacterial effects of PC 
5.1.1.1. Disk diffusion assay 
The hexane (PCH) and ethanol (PCE) extracts of Pogostemon cablin (PC) were tested for 
their antibacterial activities according to section 2.16. (Table 5.1) shows the DDA results. 
Table ?5.1: Antimicrobial activity of the hexane and ethanol extracts PC in disk diffusion 
assay. +/-: indicates Gram positive and negative staining; NC: Not calculated due to the 
growth of some colonies throughout the IZ; Neg: negative. Section 2.16, n=3. 
Microorganism 
strain 
Extracts Mean diameter of inhibition zone (IZ) ± SD (n =3) (mm) 
2 mg  1 mg  0.5 mg  0.25 mg  
S. aureus (+) PCH 11.5 ± 0.6 8.5 ± 0.5 8.0 ± 0.6 NC 
PCE 10.5 ± 0.5 8.0 ± 0.5 NC NC 
S. epidermidis (+) PCH 12.5 ± 0.5 10.5 ± 0.4 8.5 ± 0.6 NC 
PCE 10.5 ± 0.6 Neg. Neg. Neg. 
B. cereus (+) PCH 8.5 ± 0.5 7.0 ± 0.6 Neg. Neg. 
PCE NC Neg. Neg. Neg. 
B. subtilis (+) PCH 8.0 ± 0.5 6.5 ± 0.4 Neg. Neg. 
PCE NC Neg. Neg. Neg. 
E. faecalis (+) PCH 8.5 ± 0.5 7.0 ± 0.4 Neg. Neg. 
PCE Neg. Neg. Neg. Neg. 
E. coli (-) PCH 11.0 ± 0.4 10.0 ± 0.6 8.5 ± 0.5 8 ± 0.5 
PCE 7.0 ± 0.5 6.5 ± 0.4 6.0 ± 0.5 Neg. 
E. cloacae (-) PCH Neg. Neg. Neg. Neg. 
PCE NC NC NC NC 
P. aeruginosa (-) PCH Neg. Neg. Neg. Neg. 
PCE Neg. Neg. Neg. Neg. 
A. faecalis (-) PCH 14.5 ± 0.5 10.0 ± 0.5 7.5 ± 0.5 7.0 ± 0.4 
PCE 11.5 ± 0.5 9.0 ± 0.4 7.0 ± 0.5 Neg. 
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5.1.1.2. MIC of the extracts
Given the broad antibacterial activity of the PCH, the MIC was determined, along with an 
ampicillin control, against a panel of bacteria shown to be inhibited in the previous disk 
diffusion assay using the alamar blue microdilution method according to section 2.17, the 
MIC of PCH, and the essential oil of PC (Sigma Aldrich, UK) are listed in (Table 5.2). 
PCH generally are more potent than PC oil against most of the bacteria tested. 
  
Table ?5.2: MICs in ?g/ml and ?l/ml of the hexane extract of PC and PC oil against the 
growth of eight bacteria.na: not assayed. Assay according to section 2.17, n=4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In order to identify which compounds in PCH are likely to contribute to the antibacterial 
activities of the whole extracts against these bacterial strains, the principal components 
identified by GC-MS and components reported in the literature to be antibacterials were 
selected for testing. The MICs of those components against several isolates of bacteria 
were determined and are shown in (Table 5.3).  
Microorganism 
strain 
PCH P. cablin oil Ampicillin 
 ?g/ml ?l/ml ?g/ml ?l/ml ?g/ml 
S. aureus (+) 256 0.23 1024 1.06 ???? 
S. epidermidis (+) 128 0.12 512 0.53 ???? 
B. cereus (+) 16 0.01 256 0.27 ?64 
B. subtilis (+) 16 0.01 128 0.13 ???? 
E. faecalis (+) 1024 0.93 ?2048 ?2.12 ???? 
E. coli (-) 512 0.47 2048 2.12 ???? 
E. cloacae (-) 2048 1.86 ?2048 ?2.12 ???? 
P. aeruginosa (-) na na na na na 
A. faecalis (-) 512 0.47 2048 2.12 16 
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Table ?5.3: MIC in ?g/ml of several metabolites detected in PCH and PC oil (na: not 
assayed). Assay according to section 2.17, n=4. 
 
 
5.1.1.3. Time Kill assay 
PCH showed promising antibacterial activity. Patchouli alcohol and pogostone, the two 
key compounds of PCH were prepared for the killing kinetics and assayed according to 
section 2.18 against S. aureus and E. coli; the results are shown in (Figure 5.1) and (Figure 
5.2).  
Patchouli alcohol against S. aureus achieved bactericidal level at 2 MIC concentration with 
in the first 3 hours of experiment, the drug at concentration of MIC failed to kill 99.9 % of 
S. aureus cells, ½ MIC produced inhibition of cells with in the first 3 hours then the 
division of cells reactivated again. On E. coli the story showed some differences in the 
antibacterial ability of the drug at ½ MIC the microorganism achieved a high population 
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S. aureus 512 256 >2048 >2048 >2048 1024 ???? 
S. epidermidis 256 128 >2048 >2048 >2048 512 ???? 
E. faecalis 512 1024 >2048 >2048 >2048 1024 ???? 
E. coli 256 512 256 2048 >2048 1024 ???? 
E. cloacae >2048 512 >2048 >2048 >2048 >2048 ???? 
A. faecalis >2048 >2048 64 256 >2048 >2048 16 
B. subtilis 64 128 >2048 >2048 >2048 >2048 ???? 
B. cereus 256 512 >2048 >2048 >2048 >2048 ?64 
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number reaching 370 times the initial population compared to 41 times of S. aureus initial 
population, at MIC level the drug killed about 90 % of the initial cells number within 3 
hours and 98% at the end of experiment course. Patchouli alcohol at 2 MIC level kill all 
the E. coli cells within 3 hours (Figure 5.1).  
Pogostone at ½ MIC concentrations showed a delay in growth for three hours, followed by 
rapid growth of the bacterial population to 496 times the initial population of E. coli and 
103 times the initial population of S. aureus. 2 MIC of pogostone achieved bactericidal 
level after 3 hours on E. coli and 6 hours on S. aureus, indicating a slow onset of action of 
pogostone against S. aureus (Figure 5.2).   
.  
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Figure ?5.1: Time-kill kinetics of patchouli alcohol against S. aureus (A) and E. coli (B) , 
MIC of patchouli alcohol against S. aureus and E. coli are 512 and 256 ?g/ml respectively. 
The assay has been done in duplicate, n=2 according to section 2.18.  
 
 
 
B) 
A) 
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Figure ?5.2: Time-kill kinetics of pogostone against S. aureus (A) and E. coli (B)  , MIC of 
pogostone against S. aureus and E. coli are 256 and 512 ?g/ml respectively. The assay has 
been done in duplicate, n=2 according to section 2.18. 
 
 
 
 
A) 
B) 
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5.1.1.4. Scanning Electron Microscopy (SEM) 
(Figure 5.3 (A-E)) shows the SEM images of S. aureus after exposure to medium (control) 
and 2MIC of PCH, patchouli alcohol, and pogostone for 1h according to section 2.19.  
 
Figure ?5.3: SEM images of S. aureus  after exposure to medium as control (A), PCH (B), 
patchouli alcohol (C), and pogostone (D) for 1h at a concentration of 2 MIC level; 
Structures of patchouli alcohol and pogostone (E). The assay is according to section 2.19. 
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5.1.1.5. Synergism studies 
Previous studies showed that gallic acid exerted its antibacterial action by increasing the 
bacterial cell wall permeability and pores formation, section 3.2.4. (Borges, Ferreira et al. 
2013). The main sesquiterpene metabolite of PC, patchouli alcohol showed great affinity 
for the two key enzymes of bacterial biosynthesis pathways; PBPs and dihydrofolate 
synthase (DHFS) using the molecular docking technology (Yang, Zhang et al. 2013). In 
this section we tried to design a suitable combination of two molecules detected as main 
active constituents from two different medicinal plants and targeting two different sites of 
action in S. aureus. 
Patchouli alcohol as drug A and gallic acid as drug B were prepared in double dilution sets 
in ?g/ml. Evaluation of the interaction between them against S. aureus has been done 
according to procedure mentioned in section 2.20. (Figure 5.4) shows blue wells in which 
the bacteria have been inhibited and red wells in which bacterial growth has occurred. 
(Table 5.4) shows the interpretation of interaction between patchouli alcohol and gallic 
acid against S. aureus. 
Patchouli alcohol and gallic acid are probably working on different targets in bacterial cells 
and they showed good synergism versus S. aureus over variable concentrations range. The 
best synergism between patchouli alcohol and gallic acid, ???????????????.265 when 125 
?g/ml or one quarter the MIC of patchouli alcohol interact with 31.25 ?g/ml of gallic acid 
which is just 1.5 % of its MIC. 
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Figure ?5.4: Plate to assay synergism between patchouli alcohol and gallic acid against S.
aureus. Patchouli alcohol (Drug A) concentrations set from 2000 ?g/ml (A12) to 1.95 ?g/ 
ml (A2). Gallic acid (Drug B) concentrations set from 2000 ?g/ml (H1) to 3.9 ?g/ml (B1). 
Two black arrows refer to MIC of patchouli alcohol and gallic acid against S. aureus, n=3. 
Assay has been done according to section 2.20.  
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Table ?5.4: Interpretation of the interaction between patchouli alcohol and gallic acid 
against S. aureus , data evaluated, IND as Indifference, PSYN as partial synergism and 
SYN as synergism.  
 
 
 
 
Well 
With no 
growth 
Patchouli 
alcohol 
 Gallic 
acid 
 ??????
FIC 
A+FIC B 
Interpretation 
 Con. ?g/ 
ml 
FIC of A Con. 
?g/ml 
FIC of B   
A10 500 MIC of 
A 
0 MIC of 
A 
MIC of 
A 
MIC of A 
B10 500 1 31.25 0.015 1.015 IND 
B9 250 0.5 31.25 0.015 0.515 PSYN or IND 
B8 125 0.25 31.25 0.015 0.265 SYN 
C8 125 0.25 62.5 0.03 0.28 SYN 
D8 125 0.25 125 0.06 0.31 SYN 
E8 125 0.25 250 0.125 0.375 SYN 
F7 62.5 0.125 500 0.25 0.375 SYN 
G6 31.25 0.06 1000 0.5 0.56 PSYN or IND 
G5 15.62 0.03 1000 0.5 0.53 PSYN or IND 
G4 7.8 0.015 1000 0.5 0.515 PSYN or IND 
G3 3.9 0.0078 1000 0.5 0.507 PSYN or IND 
G2 1.95 0.0039 1000 0.5 0.503 PSYN or IND 
H1 0 MIC of B 2000 MIC of B MIC of B MIC of B 
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5.1.2. GC-MS 
PCH and PC oil were prepared according to section 2.8.5.1.  PCE was prepared according 
to section 2.8.5.2.  Samples were injected according to method mentioned in section 2.8.1 
method A. (Table 5.5) mentions the compounds detected in PCH and (Figure 5.5) shows 
the GC-MS chromatogram. (Table 5.6) and (Figure 5.6) shows the compounds detected in 
PC oil and GC-MS chromatogram respectively. 
Table ?5.5: Compounds detected in PCH using GC-MS, according to section 2.8.1, n=3. 
  
 
no. RT (min) Compound name percentages ±SD (n=3) RI 
1 5.25 ?-pinene 0.15±0.02 939 
2 6.01 ?-pinene 0.39±0.06 982 
3 9.29 Endo-borneol 0.17±0.03 1176 
4 10.62 1,3-Bis(1,1-dimethylethyl)-benzene 2.73±0.60 1359 
5 12.67 ?-patchoulene 1.29±0.15 1400 
6 13.20 ?-caryophyllene 0.54±0.06 1439 
7 13.40 ?-guaiene 5.43±0.51 1454 
8 13.58 Seychellene 4.76±0.42 1467 
9 13.76 ?-Patchoulene 2.81±0.37 1480 
10 14.04 Pentadecane 1.74±0.09 1501 
11 14.12 ?-Selinene 0.49±0.05 1508 
12 14.28 2,4-Bis(1,1-dimethylethyl)-phenol 5.41±1.43 1520 
13 14.33 ?-Bulnesene 1.76±0.21 1524 
14 15.16 Cashmeran 2.26±0.09 1588 
15 15.41 Caryophyllene oxide 2.21±0.19 1608 
16 15.80 (-)-Spathulenol 1.52±0.09 1640 
17 16.46 Patchouli alcohol 27.74±0.80 1694 
18 16.96 Pogostone 35.95±4.85 1738 
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Figure ?5.5: GC-MS chromatogram of compounds of the PCH. Two principal components 
(patchouli alcohol (17) and pogostone (18)) are shown in the inset and number bearing of 
peaks refers to (Table 5.5). The analysis has been done according to section 2.8.1, n=3. 
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Table ?5.6: Compounds detected in PC oil using GC-MS, section 2.8.1, n=3. 
 
RT = Retention time in min, SD= Standard deviation, n= Number of experiment replication, RI= Retention 
index. 
 
 
 
 
no. RT (min) Compound name Averages percentages± SD (n=3) RI 
1 12.50 ?-Copaene 0.09±0.01 1390 
2 12.60 ?-patchoulene 2.65±0.05 1400 
3 12.70 ?-elemene 1.11±0.20 1401 
4 13.17 ?-caryophylline 4.96±0.56 1439 
5 13.40 ?-Guaiene 15.06±2.20 1454 
6 13.60 Seychellene 7.07±0.70 1467 
7 13.70  ?-caryophyllene (Humulene) 0.81±0.03 1475 
8 13.80 ?-patchoulene 5.40±0.27 1480 
9 13.81 ?-Elemene 1.83±0.31 1481 
10 14.10 D-Germacrene 0.26±0.07 1506 
11 14.12 ?-Gurjunene 0.58±0.01 1507 
12 14.20 Cedrene-V6 3.99±0.05 1513 
13 14.30 ?-Bulnesene 17.48±3.23 1524 
14 14.50 (+)-epi-Bicyclosesquiphellandrene 0.40±0.08 1537 
15 15.10 Cashmeran 0.62±0.10 1588 
16 15.40 Caryophyllene oxide 0.78±0.15 1608 
17 15.50 2-methyl-3-methylene- 
Cyclopentanecarboxaldehyde 
0.05±0.01 1615 
18 16.30 epi-?-Selinene 1.82±0.48 1680 
19 16.50 Patchouli alcohol 31.50±5.29 1694 
20 16.90 pogostone 1.07±0.34 1737 
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Figure ?5.6: GC-MS chromatogram of compounds of the PC oil. The analysis has been 
done according to section 2.8.1, n=3. 
 
 
Nine compounds were detected in both PCH and PC oil, the percentage of those 
compounds were different in extracts, (Figure 5.7) shows the difference in compounds 
abundance in PCH and PC oil. It is clear that pogostone quantity, one of the main 
compounds of PC is very low in PC oil compared to its quantity in PCH.  
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Figure ?5.7: Comparison of the relative quantity of nine compounds detected in PCH and 
PC oil. 
 
Appendix D shows the GC-MS data obtained from PCE, (Table-D1) shows the compounds 
detected in PCE. (Figure-D1) shows the GC-MS chromatograms of PCE. 
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5.2. Discussion 
5.2.1. Disk diffusion assay 
A general outlook about the results of DDA revealed that PCH is a promising antibacterial 
extract and hexane was more efficient than ethanol in extraction of the active antimicrobial 
compounds from Pogostemon cablin.  
In all experiments, as expected, decreasing the quantity of the extracts tested resulted in the 
reduction of diameter of IZ. The extracts showed no or little inhibitory effect against E. 
facecalis and the two gram negative bacteria P. aeruginosa and E. cloacae.  
5.2.2. MIC of PCH and Patchouli oil 
The MICs of PCH, and patchouli oil along with ampicillin as a control, were recorded 
against the bacteria, which were shown to be inhibited by DDA. Pseudomonas aeruginosa 
was not tested here because it showed no sensitivity to PCH or PCE. The essential oil of 
patchouli extracted by destructive distillation was included in this experiment to study the 
effect of the extraction method on the antibacterial activity.      
The MICs of PCH against S. aureus and S. epidermidis were 256 and 128?g/ml 
respectively which were in agreement or in good correlation with the IZ values showed in 
the DDA (Table 5.1), however, this correlation between MIC and IZ is not true for other 
microorganisms such as B. cereus and B. subtilis.   
B. cereus and B. subtilis showed very high sensitivity to PCH from alamar blue microplate 
assay (MICs = 16 ?g/ml) compared to only moderate antibacterial effects shown by DDA. 
Such results without significant correlations were recognized before, for example, when
Wedelia chinensis methanolic extract showed IZ against B. cereus, B. subtilis and S. 
aureus equal to 14, 12 and 15 mm respectively and MIC equal to 3.13, 6.25 and 6.25 
mg/ml respectively (Darah, Lim et al. 2013). However, no explanation for this has been 
mentioned.  
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B. cereus and B. subtilis have the ability to form endospores when nutrients levels are 
decreased. When the microorganisms are subjected to various stress conditions, these 
endospores can reactivate again when the conditions are appropriate. The reactivation 
process occurs, and endospores can germinate again into vegetative cells when the 
nutrients, organic metabolites and moisture become available (Wijnands, Dufrenne et al. 
2006, von Stetten, Mayr et al. 1999), the early destructed bacterial cells on the agar plate 
offer an enrich source of decomposable organic metabolites essentials for spores 
reactivation.  
The uncorrelated results could be attributed to the slow release of the oil active constituents 
into the agar plate and possible reactivation of some of Bacillus spores leading to decrease 
the IZ compared to the direct contact with the active constituents of Pogostemon cablin in 
broth microdilution method which may kill both the endospores and vegetative cells. The 
other explanation of this result deduced from the fact that B. cereus grew very fast in the 
disk diffusion assay on agar plate (Chang, Lee et al. 1998) which may lead to increasing 
the bacterial population facing the limited quantity of the antibacterial extract, however, 
more experiments need to be conducted to confirm these explanation. 
Alcaligenes faecalis showed moderate sensitivity to PCH using alamar blue microplate 
assay (MIC 512 ?g/ml) compared to the strong inhibition of growth recorded by DDA (IZ 
= 15 mm) indicating that the DDA could provide enough information about the boundary 
of antibacterial activity/inactivity of nonpolar extracts. However, the determination of MIC 
using microplate assay is crucial to evaluate the extent of the antibacterial activities.        
The antibacterial activity of PCH against B. cereus was strong compared to ampicillin and 
it showed moderate effect against E. coli (MIC 512 ?g/ml).  
Patchouli oil in general showed less antibacterial activities compared to PCH against all of 
the bacterial isolates used in this study, which could be attributed to the difference in 
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metabolites types and quantity. Pogostone abundance in patchouli oil is very low compared 
to that in PCH, which could be a major reason for the decrease in antibacterial activities of 
the oil. Similarly, the hexane extract of nonpolar compounds showed better antibacterial 
activities than its corresponding essential oil extracted by fractional distillation 
(Packiyasothy, Kyle 2002). 
It is well-accepted that the MIC of oil against microorganism could be recorded by ?l/ml 
unit in addition to the ?g/ml unit that is why we included MICs in ?l/ml as a second 
column in (Table 5.3), (Abu-Darwish, Cabral et al. 2016, Knezevic, Aleksic et al. 2016, 
Bouzabata, Bazzali et al. 2013).  
Patchouli essential oil from leaves of Pogostemon cablin showed weak antibacterial 
activities MIC 5 ?l/ml against Candida albicans, 1.2 ?l/ml against Enterococcus facecalis, 
2.5 ?l/ml against S. aureus ???? ???? ?????? ???????? E. coli, K. pneumoniae and P. 
aeruginosa (Hammer, Carson et al. 1999). Patchouli oil from Guangdong, China showed 
????? ???????? ????? ???? ??? ??/ml against Staphylococcus aureus, Escherichia coli, 
Pseudomonas aeruginosa, Bacillus proteus and Shigella dysenteriae (Yang, Zhang et al. 
2013). The main constituent patchouli alcohol showed MIC equal to 1mg/ml against E.
coli, 2 mg/ml against S. aureus while pogostone showed MIC equal to 0.45 mg/ml against 
E. coli and 1 mg/ml against S. aureus (Yang, Zhang et al. 2013), which are much higher 
than the MICs obtained in this study.  
In the current study, the composition of PCH was characterized by GC-MS and it was 
characterised to contain patchouli alcohol and pogostone as major compounds together 
with a number of other monoterpenes and sesquiterpenes, which were also found in the 
previous reports (Hu, Li et al. 2006, Wu, Lu et al. 2004).  
Terpenes ????? ???? ?-pinene, ?-pinene and ?-caryophyllene in PCH all showed weak 
???????????????????????????? ?????????????????????????S. aureus, S. epidermidis, E. coli and 
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E. cloacae, h???????? ?-pinene showed strong growth inhibition against E. coli and A.
faecalis with MIC values of 256 and 64 ?g/ml respectively. The positive enantiomers of 
?????- ?????-isomers of pinene were active compared to the negatives against MRSA with 
MICs being 4150 and 6250 ?g/ml respectively (Rivas, Lopes et al. 2012). 
The bicyclic sesquiterpene ?-caryophyllene showed some antimicrobial activity against E.
coli, S. aureus, K. pneumoniae, P. aeruginosa and C. albicans (Goren, Piozzi et al. 2011). 
MI???????-caryophyllene and ?-caryophyllene against specific P. acnes were found to be 
15.6 and 7.8 ?g/ml, respectively. MIC of ?-caryophyllene against E. faecalis was found to 
be 6 ppm (~6 ?g/ml) (Schmidt, Bail et al. 2010). The weak antimicrobi??? ????????? ??? ?-
caryophyllene (MICs > 1000 ?g/ml) against S. aureus and E. coli (Kang, Helms et al. 
1992) were consistent with our results (MICs > 2048 ?g/ml). 
Interestingly, patchouli alcohol showed MICs equal to 256, 64 and 256 ?g/ml against S.
epidermidis, B. subtilis and E. coli, respectively. 2,4-bis(1,1-dimethylethyl)-phenol which 
constituted about 5 % of PCH, showed weak to moderate antibacterial activities with the 
best effect recorded against S. epidermidis with MIC equal to 512 ?g/ml. 
Previously the extract of Pogostemon cablin and its components (patchouli alcohol and 
pogostone) showed antibacterial activity against periodontopathic bacteria, including 
Actinobacillus, Capnocytophaga, Fusobacterium, Eikenella and Bacteroides species 
(Osawa, Matsumoto et al. 1990).  
The results demonstrated the moderate antibacterial properties of pogostone against E. coli, 
MIC 512 ?g/ml and moderate to strong antibacterial action against S. aureus and S.
epidermidis with MIC equal to 256 and 128 ?g/ml respectively. Pogostone showed 
inhibition against a fungus Candida albicans with MICs ranging from 12 to 97 ?g/ml 
against all strains and moderate inhibition against bacteria including Shigella flexneri, 
Pneumococcus and S. aureus (MIC 250 ?g/ml) but weak effect against E. coli,  Salmonella 
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typhi, S. enteritidis, P. aeruginosa, and Pneumococcus (MICs > 2000 ?g/ml) (Yi, He et al. 
2013). Pogostone was recorded with rapid absorption from the gut of the mice after oral 
administration (Li, Liang et al. 2012). Recently pogostone was also reported to show 
strong antibacterial activity against Corynebacterium xerosis and Chryseobacterium 
indologenes (MIC < 0.098 ?g/ml) and moderate activities (MIC 200-800 ?g/ ml) against 
different E. coli isolates (Peng, Wan et al. 2014). Patchouli alcohol has been shown to 
possess selective antibacterial activity against Helicobacter pylori (Yu, Xie et al. 2015), 
anti-influenza virus A/PR/8/34 (H1N1) (Kiyohara, Ichino et al. 2012) and also exhibited 
cytotoxic activity in human colorectal cancer cells (Jeong, Choi et al. 2013). 
5.2.3. Time-kill assay 
Time-kill kinetic study of the S. aureus and E. coli after treatment by patchouli alcohol and 
pogostone also demonstrated a rapid killing of these bacteria. To the best of current 
knowledge this is the first time to show the kinetics of those bacteria after exposure to the 
pure components from Pogostone cablin. 
5.2.4. SEM analysis
PCH caused ????????? ??? ??????? ?? ??????????? ??????? ???? ???? ???????? ?? cell contents as 
compared to the control sample which showed well defined S. aureus cells. PBPs, DHFS, 
dihydrofolate reductase (DHFR), RNA polymerase and DNA gyrase, are essential enzymes 
for bacterial biosynthesis; the two main constituents of Patchouli: patchouli alcohol and 
pogostone may show multi-target activity on these enzymes. Patchouli alcohol and 
pogostone were documented to interact with PBPs and DHFS, respectively (Yang, Zhang 
et al. 2013).  
?????????????????????????????????????-shaped cells with massive destruction to the cells 
but without the change in permeability, which is probably due to the interaction of 
?????????????????????????????????????????????????????????????????????????? (Yang, Zhang 
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et al. 2013). The bacterial cells subjected to pogostone looked well defined with 
continuous division; however, pogostone produced cell wall roughness which comes in 
agreement with the time-kill assay results, i.e. pogostone at its 2 MIC level approaches 
bactericidal level only after 6 h which indicates a slow onset of action. 
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Chapter 6 : Results and discussion of antibacterial 
activity of Perilla frutescens (PF) 
6.1. Results  
6.1.1 Antibacterial effects of PF 
6.1.1.1. Disk diffusion assay (DDA) 
The hexane and ethanol extracts of PF antibacterial activities were assayed according to 
section 2.16, using DDA. The mean diameters of (IZ)s against five gram-positive and four 
gram-negative microorganisms at four concentrations of PF hexane extract (PFH), and PF 
ethanol extract (PFE) were measured (Table 6.1). In general, increasing the quantity of 
extracts increased the IZs for the susceptible bacteria strains tested and PFH showed 
stronger antibacterial activities than PFE. PFH also showed moderate antibacterial activity 
against both gram positive and negative bacteria. 
6.1.1.2. Determination of MIC of the extracts and pure components 
The MICs of PFH along with an ampicillin control, against seven bacterial isolates which 
showed positive results to PFH by DDA were determined (Table 6.2) according to section 
2.17. 
Furthermore, the MICs of pure components of PFH including limonene (both isomers R 
and L), eucalyptol and linalool (Table 6.2) were determined. Linalool showed only weak 
effect against E. cloacae with MIC equal to 1024 ?g/ml, against E. coli and Alcaligenes 
faecalis with MICs equal to 2048 ?g/ml???????????????????????????????????????????????? ?????
2048 ?g/ml. MICs of limonene and eucalyptol were ? 2048 ?g/ml against all bacterial 
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isolates tested.  Perilla ketone and several fatty acids detected in PF extracts are important 
to check for their antibacterial activities.      
 
Table ?6.1: Antimicrobial activity of the hexane (PFH) and ethanol (PFE) extracts of 
Perilla frutescens by disk diffusion assay. +/-: indicates gram positive and negative 
staining; NC: Not calculated due to the growth of some colonies throughout the IZ; Neg: 
negative, assay has been done according to section 2.16, in triplicate n=3. 
 
 
Microorganism 
strain 
Extracts Mean diameter of inhibition zone (IZ) ± SD (n =3) 
(mm) 
2 mg  1 mg  0.5 mg  0.25 mg  
S. aureus (+) PFH 9.5 ± 0.5 7.0 ± 0.5 NC NC 
PFE 7.0 ± 0.5 Neg. Neg. Neg. 
S. epidermidis (+) PFH 10.5 ± 0.6 9.5 ± 0.5 8.0 ± 0.5 7.0 ± 0.6 
PFE 8.0 ± 0.6 7.0 ± 0.5 7.0 ± 0.4 6.5 ± 0.4 
B. cereus (+) PFH 8.5 ± 0.5 8.0 ± 0.4 7.0 ± 0.5 Neg. 
PFE NC Neg. Neg. Neg. 
B. subtilis (+) PFH 8.5 ± 0.5 8.0 ± 0.4 7.5 ± 0.5 Neg. 
PFE NC Neg. Neg. Neg. 
E. faecalis (+) PFH Neg. Neg. Neg. Neg. 
PFE Neg. Neg. Neg. Neg. 
E. coli (-) PFH 7.5 ± 0.5 7.0 ± 0.4 6.5 ± 0.4 6.4 ± 0.4 
PFE 7.0 ± 0.5 7.5 ± 0.5 6.5 ± 0.4 6.5 ± 0.4 
E. cloacae (-) PFH 8.5 ± 0.5 8.0 ± 0.4 7.5 ± 0.6 7.0 ± 0.6 
PFE Neg. Neg. Neg. Neg. 
P. aeruginosa (-) PFH Neg. Neg. Neg. Neg. 
PFE Neg. Neg. Neg. Neg. 
A. faecalis (-) PFH 10.5 ± 0.5 9.5 ± 0.4 8.0 ± 0.4 7.5 ± 0.5 
PFE 15.0 ± 1.0 13.5 ± 1.5 11.5 ± 1.0 9.0 ± 1.5 
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Table ?6.2: MICs in ?g/ml of PFH and linalool against seven bacterial isolates, shown to be 
sensitive in the previous DDA, section 2.17, assay has been done in quadruplicate n=4.  
 
 
 
 
 
 
 
 
 
6.1.1.3. Scanning Electron Microscopy (SEM) 
(Figure 6.1) shows the SEM images of S. aureus after exposure to medium (control) and 
2MIC of PFH for 1hour according to section 2.19.  There is significant change of their 
morphology such as the damage of cell wall of S. aureus by PFH. 
 
Figure ?6.1: SEM images of S. aureus after exposure to medium as control (A) and PFH 
(B) for 1h at a concentration of 2 MIC level. The study has been done according to section 
2.19. 
Microorganism strain PFH Linalool Ampicillin 
S. aureus (+) 1024 ? 2048 ???? 
S. epidermidis (+) 256 ? 2048 ???? 
B. cereus (+) 64 ? 2048 ?64 
B. subtilis (+) 128 ? 2048 ???? 
E. coli (-) ?2048 2048 ???? 
E. cloacae (-) 1024 1024 ???? 
A. faecalis (-) 1024 2048 16 
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6.1.2. Chemical analysis of PFH and PFE using GC-MS 
PFH was prepared according to section 2.8.5.1. PFE was prepared according to section 
2.8.5.2.  Samples were injected according to method mentioned in section 2.8.1 method A. 
(Table 6.3 and 6.4) list the compounds detected in PFH and PFE respectively. (Figure 6.2 
and 6.3) show the TIC of the PFH and PFE using GC-MS, respectively. 
 
Table ?6.3: Compounds detected in the hexane extract of Perilla frutescens (PFH) by GC-
MS. The analysis has been done according to section 2.8.1, n=3. 
 
RT = Retention time, SD= Standard deviation, n= Number of experiment replication, RI= 
Retention index. 
no. RT (min) Compound  percentages ±SD (n=3) RI 
1 6.88 D-Limonene 0.12±0.004 1033 
2 6.94 Eucalyptol 0.04±0.01 1037 
3 8.08 Linalool 0.42±0.08 1103 
4 9.14 Isoborneol 0.09±0.01 1167 
5 9.29 Endo-Borneol 0.16±0.04 1176 
6 10.54 1-(3-Furyl)-4-methyl-1-pentanone (Perilla ketone) 6.86±1.53 1256 
7 10.68 2-Isopropyl-5-methyl-3-cyclohexen-1-one 0.7±0.18 1265 
8 12.53 Copaene 0.09±0.02 1391 
9 13.20 ?-Caryophyllene 1.15±0.25 1439 
10 13.40 ?-Guaiene 0.21±0.02 1454 
11 13.58 Seychellene 0.18±0.003 1467 
12 13.68 Humulene 0.14±0.01 1474 
13 14.02 (Z,E)-?-Farnesene 0.58±0.1 1499 
14 14.11 1,2-Dimethoxy-4-(1-propenyl)-benzene  0.41±0.04 1506 
15 14.29 2,4-Bis(1,1-dimethylethyl)-phenol 0.25±0.09 1520 
16 14.50 Myristicin 1.37±0.19 1536 
17 14.84 Elemicin 1.85±0.29 1563 
18 15.43 Caryophyllene oxide 1.18±0.09 1610 
19 16.06 Asarone (isoelemicin) 0.38±0.02 1661 
20 19.09 Hexadecanoic acid methyl ester 0.29±0.14 1929 
21 19.60 E-11-Hexadecenoic acid ethyl ester 0.58±0.24 1978 
22 19.81 Hexadecanoic acid ethyl ester 11.7±1.3 1997 
23 21.51 Linoleic acid ethyl ester 15.7±0.95 - 
24 21.59 Linolenic acid ethyl ester 38.2±0.62 - 
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Figure ?6.2: GC-MS chromatogram of compounds of the hexane extract of Perilla
frutescens (PFH). The analysis has been done according to section 2.8.1, n=3.   
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Figure ?6.3: GC-MS chromatogram of compounds of PFE. The assay has been done 
according to section 2.8.1, n=3. 
 
6.2. Discussion 
6.2.1. Disk diffusion assay 
PFH showed stronger antibacterial activity than PFE by using disk diffusion assay, which 
provided a fast and cheap method to determine the bacterial susceptibility of plant extracts 
before the more expensive and time-consuming determination of their MICs. PFE showed 
weak activity against most bacterial strains, however, the PFE showed interesting and good 
antibacterial activities against Alcaligenes faecalis with an IZ of 15 mm. Investigation of 
this extract by GC-MS showed the existence of gallic acid and caffeic acid in PFE which 
showed moderate to good antibacterial effects (Chapter III and IV). Previous report also 
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showed that the aqueous leave extract of PF contained gallic acid and caffeic acid (Asif 
2012).  
Caffeic acid showed good anti-staphylococcal activity against MSSA and MRSA with 
MICs equal to 62 and 250 ?g/ml, respectively (Luís, Silva et al. 2014). In another study 
caffeic acid showed an MIC equal to 625 ?g/ml against S. aureus and S. epidermidis, while 
it showed weak effect against K. pneumonia with MIC equal to 5000 ?g/ml (Pinho, 
Ferreira et al. 2014). These phenolics or other unknown compounds might contribute to the 
inhibition of A. faecalis, which need to be investigated in the future. 
6.2.2. MIC of PFH and metabolites profile 
The MICs of PFH extract along with ampicillin as positive control were recorded against 
seven bacterial isolates which were recorded moderately sensitive to PFH by DDA (Table 
6.1 and 6.2). E. faecalis and P. aeruginosa were not tested for MIC determination, as there 
was no inhibition of growth for these two screened by DDA.  
PFH showed stronger activity against B. cereus with MIC of 64 ?g/ml compared to the 
MIC of 128 ?g/ml against B. subtilis. PFH generally recorded better activity against gram 
positive isolates used compared to the negative ones used in this study. PFH showed 
moderate antibacterial activity against S. aureus and S. epidermidis and weak activity 
against E. coli.  
Limonene, eucalyptol and ?-caryophyllene in PFH all showed weak antibacterial activity 
????? ????? ?? ????? ?????? ???????? S. aureus, S. epidermidis, E. coli and E. cloacae. 
Limonene showed a strong inhibition of S. aureus with MIC of 125 ?g/ml (Kang, Helms et 
al. 1992), which contradicted the results of current research. The results indicated that both 
L-limonene and D-limonene showed very weak activity against S. aureus as also reported 
(Van Vuuren, Viljoen 2007).  
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Linalool a terpene alcohol detected from PFH showed an MIC equal to 1024 ?g/ml against 
E. cloacae, which has been previously shown to exhibit a strong antibacterial activity 
against periodontopathic and cariogenic bacteria (Park, Lim et al. 2012). The MICs against 
Porphylomonas gingivalis ATCC 49417 and Prevotella intermedia ATCC 49046 were 
determined to be 100 ?g/ml and 1600 ?g/ml, respectively (Park, Lim et al. 2012). Linalool 
???? ?????????????????????????S. aureus, S. mutans and E. coli (Kang, Helms et al. 1992).  
The antimicrobial activity of the methanol and steam distillate leaves extracts of Perilla 
frutescens and its components against some bacterial strains including Propionibacterium 
acnes and S. aureus, two of fungus Mucor mucedo, and Penicillium chrysogenum and a 
yeast, Saccharomyces cerevisiae ???????????????? ?????????????????????????????????????
respectively against all mentioned isolates (Kang, Helms et al. 1992).  
Caffeic acid and gallic acid were two of the phenolic compounds present in the defatted 
ethanol extract of Perilla seeds, they showed MIC 100-200 ?g/ml and 50-800 ?g/ml 
respectively against several Porphyromonas gingivalis strains (Yamamoto, Ogawa 2002). 
The results also indicated that PFH had antibacterial activity against S. aureus as well as 
other species such as B. subtilis, E. cloacae and A. facecalis, which are reported here for 
the first time. 
Furthermore, the chemical composition of essential oils obtained by steam 
distillation/extraction has been well characterized as volatile compounds such as perilla 
ketone, linalool and ?-caryophyllene (Kang, Helms et al. 1992, Seo, Baek 2009, Huang, 
Lei et al. 2011, Liu, Wan et al. 2013). Leaves of Korean Perilla frutescens were extracted 
using solvent-assisted flavour evaporation, liquid-liquid continuous and hydrodistillation 
extraction ????????? ???????? ??????? ??? ?? ?????? ??????????? ??????? ????????? ????? ???? ????
percentage (6%) present in the sample assayed in current research. 
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6.2.3. SEM analysis
PFH also caused dramatic change of cellular shape, the peeling of the cell wall and leakage 
of cell contents shown by SEM (Figure 6.1) for the first time. Perilla oil effectively 
decreased ???????????????????-toxin, enterotoxin A and B, and toxic shock syndrome toxin 
1, in MRSA and MSSA (Qiu, Zhang et al. 2011). This encouraged the use of Perilla oil in 
combination ??????-lactam to increase the antibacterial activities and to incorporate this oil 
to many food products for their protection (Qiu, Zhang et al. 2011). 
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Chapter 7 : Results and discussion of Antibacterial 
activities of the essential oil and lignans from 
flower buds of Magnolia biondii Pamp. 
7.1. Results 
Flower buds of Magnolia biondii Pamp (MB), family Magnoliaceae were recorded in 
Chinese Pharmacopoeia to treat various ailments like allergy, inflammation, rhinosinusitis, 
and accumulation of pus in the respiratory system. This study was designed to evaluate the 
antibacterial activity and to characterize the metabolites of MB. 
In this study, the essential oil and lignans from the flower buds of MB were analysed using 
GC-MS and nuclear magnetic resonance (NMR) spectroscopy. The antibacterial activities 
against S. aureus and other bacteria on the basis of the MIC were evaluated. Furthermore, 
time-kill kinetics of S. aureus and E. coli in the presence of the Magnolia essential oil was 
also investigated. The micrography of Magnolia oil effects against S. aureus was studied 
using SEM. 
7.1.1. Antibacterial activity 
7.1.1.1. Determination of MIC using microplate method 
MICs were determined according to the method detailed in section 2.17; the results are 
shown in (Table 7.1) where the IC50s were calculated using GraphPad prism software 
(v6.0). 
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Table ?7.1: MICs of the essential oil and lignan-rich chloroform extract from flower buds 
of Magnolia biondii Pamp. The assay has been done according to section 2.17, n=4. 
 
 
 
7.1.1.2. Time-kill assay  
Magnolia essential oil killing kinetics against S. aureus and E. coli was determined using 
the method mentioned in section 2.18; (Figure 7.1) shows the time kill assay results. Four 
concentrations (1000 ?g/ml (2 MIC), 500 ?g/ml (1 MIC), 250 ?g/ml (1/2 MIC) and 0 
(control) ?g/ml) of the Magnolia oil were used for the time-kill kinetics assay in both S. 
aureus and E. coli. The oil at 1 MIC and ½ MIC level was not efficient to achieve the 
bactericidal effect after 24 hours. At 3-h exposure using 1000 ?g/ml of the oil 5% and 9 % 
of live cells for S. aureus and E. coli were observed, respectively. After 24 hours less than 
0.1% of viable cells (99.9 % or 3 log reduction in viable cells) for both of bacteria were 
observed, which indicated bactericidal effects. 
 
 
Bacterium MIC MIC (?g/ml) IC50 (?g/ml) MIC (?g/ml) 
essential oil chloroform extract essential oil Ampicillin 
?g/ml ?l/ml  
B. cereus 500 0.5 >1000 260 ?64 
B. subtilis 250 0.25 >1000 210 ???? 
S. aureus 500 0.5 >1000 320 ???? 
S. epidermidis 500 0.5 >1000 280 ???? 
E. coli 500 0.5 >1000 360 ???? 
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Figure ?7.1: Time-kill kinetics of the Magnolia biondii Pamp essential oil at four different 
concentrations. (0 (control), 250 (½ MIC), 500 (MIC) and 1000 ?g/ml (2 MIC)) against S. 
aureus (A) and E. coli (B), the assay has been done according to section 2.18, in duplicate. 
7.1.1.3. Effects of MB oil on S. aureus cell wall 
Effects of Magnolia oil against S. aureus cell wall were studied using SEM and the images 
are shown in (Figures 7.2 and 7.3). The cells fixed within one hour after exposure to the oil 
showed cell wall damage, leakage of contents and some cells were completely empty and 
appeared like empty shells, while the 24 hours sample showed complete destruction of the 
cells. 
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Figure ?7.2: Magnolia oil against S. aureus cell wall (exposure time to the oil is 1 hr). A 
and B: SEM micrograph of S. aureus control after 1 hour of incubation at 37°C. C and D: 
Micrographs show the effects of Magnolia oil against S. aureus cell wall within 1 hr of 
exposure to the oil, arrows pointing the sites of cellular contents leakage and collapsed 
cells. The study has been done according to section 2.19. 
A B 
D C 
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Figure ?7.3: Magnolia oil against S. aureus cell wall (exposure time to the oil is 24 hr). A. 
Micrograph of S. aureus control after 24 hours of incubation at 37°C. Micrograph B shows 
the effects of Magnolia oil against S. aureus cells. We can see the destruction of cells and 
complete death of the culture after 24 hr of contact with oil. The study has been done 
according to section 2.19. 
 
7.1.2. Spectroscopical analysis 
7.1.2.1. GC-MS
The essential oil and lignan fractions of MB were prepared according to section 2.8.5.1 and 
injected into the system to identify their metabolites, using GC-MS method C mentioned in 
section 2.8.3. The compounds detected are shown in (Table 7.2) and (Table 7.3) for the 
materials detected in MB oil and lignan fraction respectively. (Figure 7.4) and (Figure 7.5), 
show the GC-MS chromatograms of the oil and chloroform extract respectively. 
 
A B 
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Table ?7.2: Compounds identified in the essential oil of Magnolia biondii Pamp. by GC-
MS. *Trace, less than 0.1 %. References: (Qu, Qi et al. 2009, Zeng, Xie et al. 2011) which 
represent (a, b) respectively, samples prepared according to section 2.8.5.1 and analysed 
according to section 2.8.3 in triplicate n=3. 
No. RT 
(min) 
Compound name percentages 
±SD (n=3) 
Reference 
1 5.39 ?-Pinene trace* [a] 
2 5.73 Camphene trace [a,b] 
3 6.27 Sabinene trace  
4 6.36 ?-Pinene trace  
5 6.66 ?-Myrcene trace  
6 6.84 Decane trace  
7 7.01 ?-Phellandrene trace [a] 
8 7.30 (+)-3-carene trace [a] 
9 7.59 D-limonene 0.27 ± 0.02 [b] 
10 7.76 Eucalyptol (1,8-cineol) 25.00 ± 1.60  
11 8.34 ?-terpinene trace [b] 
12 8.71 Linalool oxide trace [b] 
13 8.74 Ethyl-2-(5-methyl-5-vinyltetrahydrofuran-2-yl)propan-2-yl 
carbonate 
trace  
14 9.12 Trans-2-menthen-1-ol trace  
15 9.13 Fenchone trace [a] 
16 9.31 Undecane trace  
17 9.47 3,7-dimethyl-1,6-Octadien-3-ol (linalool) 5.80 ± 0.30 [a,b] 
18 9.67 Tetrahydro-4-methyl-2-(2-methyl-1-propenyl)-2H-Pyran 0.17 ± 0.02 [a] 
19 10.01 Cis-2-menthenol 0.50 ± 0.02  
20 10.49 Cis-1-methyl-4-(1-methylethyl)-2-cyclohexen-1-ol trace  
21 10.64 Camphor ( (+)-2-Bornanone) 10.60 ± 0.20 [a,b] 
22 10.71 Fenchol 0.87 ± 0.03 [a] 
23 11.49 Terpinen-4-ol 8.40 ± 0.30 [a,b] 
24 11.91 ?-terpineol 19.80 ± 1.80 [a] 
25 12.70 Citronellol 2.90 ± 0.10 [a] 
26 13.34 Geraniol 2.30 ± 0.10 [b] 
27 14.05 Bornyl acetate trace  
28 15.55 (3R-trans)-4-Ethenyl-4-methyl-3-(1-methylethenyl)-1-(1-
methylethyl)-,  cyclohexene  
trace  
29 15.89  1,3,3-trimethyl- 2-oxabicyclo[2.2.2]octan-6-ol acetate trace [a] 
30 16.20 ?-Copaene trace [b] 
32 17.23 Caryophyllene 1.20 ± 0.05 [a,b] 
33 17.92 (E)-?-farnesene 0.38 ± 0.16  
34 17.98 Humulene 0.15  ± 0.02  
35 18.14 Alloaromadendrene trace  
36 18.38  1,2,3,4,4a,5,6,8a-octahydro-7-methyl-4-methylene-1-(1-
methylethyl)-(1.alpha.,4a.beta.,8a.alpha)- naphthalene 
trace [a] 
37 18.46 1,2,4a,5,6,8a-hexahydro-4,7-dimethyl-1-(1-methylethyl)- 
naphthalene 
0.20 ± 0.03 [b] 
38 18.59 ?-Copaene 0.54 ± 0.20   
39 18.75 (Z,Z)-alpha-Farnesene trace [a] 
40 18.82 ?-Cubebene trace [a,b] 
41 18.97 Ioledene  0.57 ± 0.02 [a] 
42 19.29 ?-Muurolene  0.58 ± 0.02  [b] 
43 19.47 1,2,3,5,6,8a-hexahydro-4,7-dimethyl-1-(1-methylethyl)-(1S-
cis)-naphthalene 
2.40 ± 0.20  [a] 
44 19.67 1,2,3,4,4a,7-hexahydro-1,6-dimethyl-4-(1-methylethyl)- 
naphthalene 
trace [a] 
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45 19.77 1,2,4a,5,6,8a-hexahydro-4,7-dimethyl-1-(1-methylethyl)- 
[1S-(1.alpha.,4a.beta.,8a.alpha.)]- naphthalene 
trace [a] 
46 20.26 3,7,11-Trimethyl-1,6,10-dodecatrien-3-ol  0.25 ± 0.03 [a] 
47 20.69 (-)-Spathulenol trace [a,b] 
48 20.80 Caryophyllene oxide trace [a] 
49 21.98 tau-Muurolol 2.30 ± 0.20  [b] 
50 22.05 1,2,3,4,4a,7,8,8a-octahydro-1,6-dimethyl-4-(1-methylethyl)-
[1R-(1.alpha.,4.beta.,4a.beta.,8a.beta.)]-1-naphthalenol 
1.70 ± 0.90 [a] 
51 22.26 ?-Cadinol 3.30  ± 0.40 [a,b] 
52 23.49 trans-Farnesol 8.70  ± 1.20 [a,b] 
53 23.93 7-Acetyl-2-hydroxy-2-methyl-5-
isopropylbicyclo[4.3.0]nonane (= oplopanone) 
0.64  ± 0.09 [a] 
54 24.25 trans-Geranylgeraniol trace  
55 25.52 trans-Longipinocarveol  trace [b] 
56 25.57 3,7,11-Trimethyl-[S-(Z)]-1,6,10-dodecatrien-3-ol (Nerolidol) trace  
 
 
 
Figure ?7.4: GC-MS chromatogram of the essential oil from flower buds of Magnolia 
biondii Pamp. 56 compounds (99.1 % of the total oil composition) were identified. 
Sections 2.8.5.1 and 2.8.3 in triplicate n=3.   
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Table ?7.3: Lignans identified in the chloroform extract of MB Pamp. by GC-MS. Samples 
prepared according to section 2.8.5.1 and analysed according to section 2.8.3 in triplicate 
n=3 
 
 
 
 
 
 
 
 
 
RT = Retention time in min, SD= Standard deviation, n= Number of the experiment replication, 
RI= Retention index. 
 
 
 
Figure ?7.5: GC-MS chromatogram of the lignans from the chloroform extract of flower 
buds of Magnolia biondii Pamp. Two unknown compound a (MW = 646.5) and b (MW = 
662.5) were also detected. Assay according to 2.8.3 in triplicate n=3.    
 
no. RT (min) Lignans % of abundance ± SD 
(n=3) 
1 25.08 demethoxyaschantin 2.7 ± 0.2 
2 25.26 fargesin 2.0 ± 0.1 
3 25.73 epieudesmin 1.0 ± 0.1 
4 25.97 eudesmin 21.2 ± 0.3 
5 27.33 aschantin < 0.1 
6 28.30 magnolin 55.9 ± 2.9 
7 30.71 yangambin 5.5 ± 0.1 
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7.1.2.2. NMR results
1H NMR and 13C NMR spectrum of the chloroform extract was done according to section 
2.14. (Figure 7.6) shows the 1H NMR spectrums of MB chloroform extract.  
 
Figure ?7.6: 1H NMR of the chloroform extract of flower buds of Magnolia biondii Pamp. 
The analysis has been done according to section 2.14.  
 
The 1H NMR literature data of four lignans magnolin, eudesmin, fargesin and yangambin 
(Figure 7.7) are shown in (Table 7.4), they were in agreement with current research results 
as shown in the proton NMR chromatogram magnified at the areas corresponding to the 
proton shifts detailed in (Table 7.4), the magnified areas are shown in Appendix E, 
(Figures E-(1-6)). (Figure 7.8) shows the 13C NMR spectra with assignment of yangambin 
carbon chemical shifts, which was identical with literature data.13C NMR data of  
yangambin was as follows 153.4 (C-???????????? ?????? ??-??????? ?????? ??-??????? ?????? ??-
2,6?????????????? ??-??????? ????? ??-???????????? ?????-???????????? ??????????-OCH3), 54.3 (C-
?????? 
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Figure ?7.7: The chemical structures of four lignans magnolin, eudesmin, fargesin and 
yangambin detected from Magnolia Biondii. 
 
Table 7.4: 1H-NMR data of several lignans detected in MB. Magnolin, eudesmin and 
fargesin (Kakisawa, Kusumi et al. 1970) and of yangambin (Tulake, Jiang et al. 2012). 
Structures of the lignans are shown above in (Figure 7.7). 
 
protons magnolin eudesmin fargesin yangambin 
8-H 3.15 m (2H) 3.15 m (2H) 3.35 m ????? ?????????? 
??-H 2.90 m 
7-H 4.8 d 4.75 d 4.88 d ???????????????? 
??-H 4.45 d 
9-H 4.2-4.5 m (2H) 3.8-4.0 m (2H) 3.25-3.45 m  ???????????????-???? 
??-H 3.8-4.0 m (2H) 4.2-4.4 m (2H) 3.7-4.0 m (2H) 3.94 dd ???????-???? 
   4.1-4.25 m  
OCH3 3.85,3.90 3.86,3.88 3.90 ???????????????????? 
?????????????? 
-OCH2O- - - 5.95  
Aromatic 6.61, 6.90 6.8-7.0 6.8-6.95 ??????????????????? 
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Figure ?7.8: 13C-NMR chart of Magnolia biondii chloroform extract , the chemical 
structure of magnolin shows the numbering system, chemical shifts are recorded in ppm 
and they are as follows. 153.4 (C-???????????? ?????? ??-??????? 137.5 (C-??????? ?????? ??-
????????????????? ??-??????? ????? ??-???????????? ?????-???????????? ??????????-OCH3), 54.3 (C-
?????? The analysis has been done according to section 2.14. 
 
7.2. Discussion
7.2.1. Antibacterial activities  
The Magnolia oil and lignan-rich chloroform extract were tested for their antibacterial 
activities against B. cereus, B. subtilis, S. aureus, S. epidermidis and E. coli by 
determination of their MICs using microplate alamar blue assay. The oil showed moderate 
antibacterial activity with MICs ranging from 250-500 ?g/ml (0.25-0.5 ?l/ml) against the 
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bacterial isolates used in this study with the most prominent effect against B. subtilis with 
MIC of 250 ?g/ml (0.25 ?l/ml).  
The IC50s of the essential oil against the five bacteria were also determined using Graph 
Pad software for more detailed comparison. The EO of Magnolia was more effective 
against B. cereus and B. subtilis (IC50 260 and 210 ?g/ml respectively) than its effect 
against S. aureus and S. apidermidis with the least effect on E. coli (IC50 360 ?g/ml), 
which is attributed to the nature of non-polar compounds from the oil. However, the 
lignan-rich extract showed weaker antibacterial activity than the essential oil, which 
suggested that the lignans played a less important antibacterial role than those terpenes and 
terpenoids in the essential oil. 
The antibacterial activity of the essential oil observed above is probably due to the 
monoterpenoids such as linalool, alpha-terpineol, citronellol, geraniol, and trans-farnesol 
(Cerca, Gomes et al. 2013, Togashi, Inoue et al. 2008) which are some of the main parts of 
the essential oil. Caryophyllene oxide, borneol, camphor and 1,8-cineole revealed no 
antibacterial activities against several plant pathogenic bacteria (Dadasoglu, Kotan et al. 
2015). Lippia multiflora Moldenke oil which contains 1,8-cineole (60.5%) shows weak 
antibacterial activities 1250 ?g/ml against S. aureus, B. cereus and E. coli (Owolabi, 
Ogundajo et al. 2009). 
In addition, geraniol and geranyl geraniol (both present in the Magnolia oil) could enhance 
the antibacterial activity of farnesol (Togashi, Inoue et al. 2008). Farnesol was found to 
induce the S. epidermidis biofilm detachment (Cerca, Gomes et al. 2013). In addition, 
??????????? ?????????? ????? ??? ??????? ????????? ?-?????????????? ?-????????? ?-murrolene 
???? ?-murrolene could exert antibacterial effects in synergy with the major bioactive 
compounds (Bajpai, Rahman et al. 2008). 
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The essential oil antibacterial activities of another plant species of the genus Magnolia 
(Magnolia liliiflora Desr.) have been evaluated against several food borne pathogenic 
bacteria to show MIC values equal to 125 ?g/ml against S. aureus , B. subtilis and P.
aeruginosa and weaker effects against E. coli (MIC 500-1000 ?g/ml) (Bajpai, Rahman et 
al. 2008).  
The lignans detected still have important biological activities: magnolin from Magnolia 
fargesii showed inhibition of cancerous cell metastasis (Cheol-Jung Lee, Mee-Hyun Lee et 
al. 2015), yangambin showed antihypertensive activities (Albuquerque Araújo, Silva et al. 
2014) and eudesmin showed anticonvulsant and sedative activities (Liu, Song et al. 2015). 
Eudesmin, magnolin and yangambin previously showed inhibitory effects on TNF-alpha 
production in LPS-stimulated murine macrophage cell line, and eudesmin showed the 
strongest activity (Chae, Kim et al. 1998). They also inhibited the NO production in LPS-
activated microglia, suggesting a role in the treatment of neurodegenerative diseases (Kim, 
Lim et al. 2009). 
Functional groups on the essential oil structure are essential for antibacterial activities, 
hydroxyl groups on the structure of carvacrol and thymol have key role in antimicrobial 
behavior (Knobloch, Weigand et al. 1986, Ultee, Bennink et al. 2002). Bacterial cell 
contains many targets susceptible for activity of volatile oil (Skandamis, Koutsoumanis et 
al. 2001, Skandamis, Nychas 2001, Carson, Mee et al. 2002). The hydrophobicity of the 
oils enables them to partition into the lipids of the bacterial cell membrane, affecting their 
structures and leaving them more permeable (Knobloch, Weigand et al. 1986, Sikkema, De 
Bont et al. 1994). Leakage of ions and cell materials is the second step (Oosterhaven, 
Poolman et al. 1995, Cox, Mann et al. 2000). The massive leakage of cell contents 
definitely leads to cell death (Denyer, Hugo 1991a). 
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Citronellol could show significant inhibition against S. aureus and E. coli by acting on the 
cell surface and causing the disruption of cell membrane (Lopez-Romero, Gonzalez-Rios 
et al. 2015). Farnesol may induce leakage of potassium ion by acting on membrane of S.
aureus (Inoue, Shiraishi et al. 2004).  
Many lipophilic compounds have been reported to increase membrane permeability 
(Trombetta, Castelli et al. 2005) and therefore potentiate the antibacterial potential of 
antibiotics that interact with intracellular targets. 
7.2.2. GC-MS results
GC-MS revealed the presence of 56 volatile and semi-volatile compounds (99.1% of the 
total oil composition) from MB essential oil. The main composition of this oil is similar to 
the oil of MB reported previously (Qu, Qi et al. 2009, Zeng, Xie et al. 2011), however, 
some metabolites were detected here in this species for the first time which could be 
attributed to the difference in the collection time or place of collection. GC-MS analysis of 
the chloroform extract of MB indicated the presence of an abundance of lignans.  
Four peaks were deduced for two pairs of stereoisomeric (epimeric) tetrahydrofurofuran 
lignans fargesin and demethoxyaschantin; eudesmin ((+)-pinoresinol dimethyl ether) and 
epieudesmin. The peaks were assigned based on the assumption that the trans-diaryl (epi-) 
isomers were eluted earlier than their cis-counterparts on the given stationary phase (5 % 
phenyl-methylpolysiloxane) (Yamamoto, Otto et al. 2004, Radulovic, Mladenovic et al. 
2012).  
The other three lignans were aschantin, magnolin, and yangambin (lirioresinol-B dimethyl 
ether) (Schuhly, Skarbina et al. 2009, Zhao, Zhou et al. 2007, Ma, Han 1995). These 
compounds were initially identified based on the NIST library comparison and previous 
phytochemical studies on this plant (Ma, Han 1995, Schuhly, Skarbina et al. 2009, Zhao, 
Zhou et al. 2007).  
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Further 1H NMR (Figure 7.6) analysis of the total chloroform extract confirmed the 
presence of magnolin, eudesmin, fargesin (Kakisawa, Kusumi et al. 1970, Tulake, Jiang et 
al. 2012) and yangambin (Tulake, Jiang et al. 2012). The presence of yangambin was also 
confirmed by 13C NMR in comparison with their reported data (Tulake, Jiang et al. 2012). 
Two unknown compounds detected with molecule weights of 646.5 and 662.5 (Figure 
7.10) were not confirmed by NIST library indicating the probability to be novel, however, 
their separation and identification is needed to confirm their chemical identities. 
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Figure ?7.9: EI-MS of fargesin (a), eudesmin (b), magnolin (c), and yangambin (d) from 
the chloroform extract of flower buds of Magnolia biondii Pamp. Their chemical 
structures, chemical formula, and exact masses are shown in inset. 
 
Figure ?7.10: EI-MS of two unknown compounds (a) with RT, 28.691 min (a), and 
compound b with RT, 33.185 min (b). 
196 
 
Chapter 8 : General discussion, conclusion and 
future studies 
8.1. General discussion 
8.1.1. Microbial resistance  
Bacteria, parasites, viruses and fungi have the abilities to develop resistance to 
antimicrobials. The encoding for the resistance can be transferred between microorganisms 
aggravating the problem; some microorganisms are multidrug resistance and called 
superbugs, prescribing the antibiotics using uncontrolled system contributes negatively to 
the resistance tragedy (Maisnier-Patin, Andersson 2004). Infection by resistant strains may 
lead to death and it is increasing the cost of treatment. The mortality number of resistant 
bacterial infections is around 25000 per year and the cost of treatment of the causative 
agents in Europe is exceeding one billion euros (Blair, Webber et al. 2015).    
In 2015 the World Health Organization (WHO) estimated, that there were some 214 
million new cases of malaria globally, resulting in approximately 438,000 deaths. Of these 
deaths, some 90% occur within Sub-Saharan Africa, over the last decade, the mortality 
rates are falling significantly, but the development and spread of resistance was the 
opponent of this success  (Guantai, Chibale 2011, Ginsburg, Deharo 2011, World Health 
Organization 2015). 
Bacterial resistance in general is developed when the bacterial cell wall permeability is 
changed, the antibacterial compounds are pumped out of the cells, bacterial enzymes 
destroy the antibacterial compounds and the receptor of the antibacterial material has been 
changed and becomes not accessible anymore for the antibacterial compound (Abreu, 
McBain et al. 2012). On the other hand, decrease the accumulation of drugs in the parasite 
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and affinity to some of the specific drug targets are the two major mechanisms of 
resistance to anti-malarial drugs (White 1999). In Introduction, brief explanations of 
resistance mechanisms and the role of natural compounds in controlling bacteria and 
parasites were presented.  
Plant extracts, fractions and pure compounds prove themselves as important resistance 
modification agents, effectively modify the resistance mechanisms of the microbe and 
synergise the antimicrobials activities (Chlez, Hohmann et al. 2010, Sibanda, Okoh 2007). 
The inhibition of ?-lactamase and PBP2a by gallate derivatives, to potentiate the drug 
activity against MRSA is an important example, epigallocatechin gallate decreases the 
concentration of imipenem required to inhibit the growth of several MRSA strains to 16% 
of its original concentration (Hu et al., 2002). Epigallocatechin gallate potentiates the 
effect of tetracycline by inhibition of Tet (K) pump (Sudano Roccaro et al., 2004). In the 
same direction, several esters of gallic acid synergise the antibacterial activities of ?-lactam 
antibiotics against MRSA by inactivation of PBP2a (Shibata et al., 2005). Targeting more 
than one site of action in the microorganism is one of the important strategies to control 
microbial resistance (Wagner, Ulrich-Merzenich 2009).  
8.1.2. The medicinal role of natural antimicrobials and challenges facing the bioguided- 
extraction procedure.  
Natural products from plants play a role in controlling diseases particularly in Asia. Many 
peoples are dependent on natural therapy for wellbeing and controlling of various illnesses 
(Prabuseenivasan, Jayakumar et al. 2006). An organized system of medicinal plants 
recording dated back 2600 BC in Mesopotamia (Atanasov, Waltenberger et al. 2015).  
The best way to find new antibacterial molecules with new mode of action is the following 
of an organized bioguided extraction method.  
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The starting of the bioguided extraction studies faced many challenges. The limited 
quantities of some active metabolites in the plant species in addition to limitation of the 
collected plant quantity due to protection rights of some plant, is one of these challenges 
(David, Wolfender et al. 2015).  
The problem of shortage in medicinal plants is serious and must be put in the circle of care, 
therefore the European Medicines Agency launched the controlled agricultural and 
collection code of practice to ensure a sustainable plants collection (Atanasov, 
Waltenberger et al. 2015). In addition to the previously mentioned challenges, only very 
few numbers of natural products are successful to reach experiments circle beyond the in 
vitro assays.   
Drug discovery of compounds from natural sources is hindered by the complexity of the 
chemical structures of natural molecules which have complex stereochemistry and 
functional groups. This makes their synthesis in laboratories a tedious task compared to 
pharmaceutical compounds produced by medicinal chemistry (Henrich, Beutler 2013), 
however, the complex stereochemistry of natural compounds could be advantageous from 
another side of view. Synthetic compounds have less chiral centres, more flexible bonds, 
and small molecule weights which produce low biological activities and less specific 
pharmacological action (Feher, Schmidt 2003), while the natural products have more 
complex structures and chirality and specifically bind proteins on the target cells (Koehn, 
Carter 2005). This brings the attention of pharmaceutical companies, back to the natural 
medicines. Pharmaceutical sector recognises that the synthesised molecules lack the 
special stereochemistry which natural products can offer and an increase in investments in 
natural products sector is expected (Gibbons 2008).  
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8.1.3. Selection of the plant species for the phytochemical study 
There are several selection methods of plants for phytochemical studies. The random 
screening of plant extracts, fractions and pure compounds may lead to discovery of 
unexpected pharmacological activities, however, this strategy is suffering from low hit rate 
due to the limitation of pharmacological assays can be applied (Henrich, Beutler 2013).  
Ethnopharmacology is a collection of treatment reports raised from local communities, 
botanical descriptions, plants pharmacopeia and other printed materials. Plants can be 
selected according to ethnopharmacological reports with a high possibility to find pure 
chemicals with pharmacological activities identical to the activities reported for the plants 
with ethnopharmacological background. Selection of the plant utilizing the 
chemotaxnomical information is another approach which phytochemist can use, certain 
plant species contains certain metabolites form its chemotaxnomical character (Atanasov, 
Waltenberger et al. 2015).  
8.1.4. The selection of plants under research 
The selection of Cylicodiscus gabunensis, Pogostemon cablin, Perilla frutescens, and 
Magnolia biondii was depending on ethnopharmacological reports.  About 80% of 122 
natural molecules used as medicines were extracted from plants with 
ethnopharmacological indication identical to the indication of the purified drugs 
(Farnsworth, Akerele et al. 1985). 
8.1.5. Extraction of the active principles from plants under research 
In most phytochemical studies, the active metabolites are unknown and the scientist needs 
a solvent able to extract most of the active constituents, 70% aqueous methanol or ethanol, 
is the solvent of choice in this case (Atanasov, Waltenberger et al. 2015). In this study we 
used an alternative method by extraction of active constituents using more than one solvent 
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of increasing polarity, which gives us extracts with small number of metabolites and 
almost uniform in polarity (Liu 2008). 
The active plant extract is subjected to cascade of bioguided fractionation steps starting 
with liquid-liquid chromatography (in current study we used ethyl acetate and butanol) to 
get several fractions of different polarities (Liu 2008). Different kinds of chromatography 
were used for separation of active metabolites and purification of chemicals. The benzoate 
derivatives were identified by different kinds of chromatography and spectroscopy. 
8.1.6. Evaluation of the antibacterial activities 
To evaluate the antibacterial activities, we utilized the disk diffusion assay which is a 
routine technique in microbiology laboratories. To ensure reproducibility microbiologist 
needs to do up to the standards of official protocols (Matuschek, Brown et al. 2013). Disk 
diffusion assay is usually conducted to evaluate the antibacterial activities before using 
other techniques like broth microdilution, time kill kinetics and SEM (Burt 2004, Boire, 
Zhang et al. 2016, Jr.Valle, Cabrera et al. 2016).  
In broth microdilution using alamar blue as an indicator, active cells have the reducing 
system able to convert resazurin (safe compound, enter cells freely) from blue colour to a 
red coloured material called resorufin. Resorufin is a fluorescent material and its emitted 
fluorescent energy can be quantified using spectrofluorometric apparatus such as GloMax-
plus® Multi Detection System used in Keele University laboratories. This method is very 
sensitive and can quantify cells down to 50 cells (Léguillier, Lecsö-Bornet et al. 2015, 
Westhrin, Xie et al. 2015). 
The time kill assay or time kill kinetics is used to determine whether the antibacterial of the 
extract, fraction, or pure compound is bactericidal or bacteriostatic (Igbinosa, Idemudia 
2016, El-Azizi 2016). The bactericidal concentration reduces the initial number of the live 
colonies 99.9% or 3 log10 cfu/ml (Olajuyigbe, Afolayan 2015). The drug is bactericidal, 
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when the minimum bactericidal concentration (MBC) is no more than double of the MIC 
and the drug is bacteriostatic if the MBC is eight times more than the MIC (Coqueiro, 
Regasini et al. 2014). In the current research we developed the study in 96 well plates to 
conserve the active compounds and to ensure the required replications of experiment. 
8.1.7. Assessment of the detection facilities used in the study 
The detection systems of plant secondary products changed radically during the previous 
years, many characters like detection limit, analysis time and separation effectiveness have 
been changed dramatically. Gas chromatography is sensitive and has ability to detect many 
compounds in the complex plant extracts and using of mass spectrometry as a detector 
increases its efficacy compared to LC-MS which does not contain the required compounds 
data bases like the National Institute of Standards and Technology/Gaithersburg, MD, 
USA (Rohloff 2015). 
The silylation step in this research was essential to detect polar and high boiling points 
metabolites (Lisec, Schauer et al. 2015), and the compounds detected in this study were not 
limited to sugars (monosaccharides), fatty acids, phenolics, and terpenoids. LC-MS is 
suitable for identification of more polar materials and high molecule weight materials of up 
to 2000 Da (Halket, Waterman et al. 2005). The glycosylated polyphenols and 
hydrolysable tannins have high molecular weight and need LC-MS for detection (Rohloff 
2015) as used for the analysis of antiplasmodial and antibacterial compounds from CG 
plant in this study. 
8.1.8. The antibacterial potential of the plants under study 
Analysing the results revealed from C. gabunensis study showed that the gram positive 
isolates used in this study were more sensitive than the gram negative bacteria except 
Alcaligenes faecalis which is a non-pathogenic bacterium.    
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Several benzoic acid derivatives have been detected in the most active fraction of C.
gabunensis which are probably the compounds responsible for the antibacterial activities. 
Gallic acid, one of the active metabolite detected in CG showed weak antibacterial activity 
against S. aureus and S. epidermidis, however, the esterification of carboxylic moiety in 
gallic acid increases the antibacterial activity against those bacteria drastically. In 
particular, lauryl gallate showed MIC of (8 ?g/ml) against S. aureus and S. epidermidis, 
indicating that the carboxylic acid moiety may hinder the penetration of benzoic acid 
derivatives into the gram positive bacterial cells.  
The EO of Pogostemon cablin showed less antibacterial activities compared to its hexane 
extract which was attributed to the less quantity of pogostone in the oil. The compounds 
extracted by hexane have been shown to exhibit better antimicrobial activity than the 
corresponding EOs obtained by steam distillation (Packiyasothy, Kyle 2002). 
S. aureus is a microorganism with abilities to cause serious infections for patients in 
hospitals and vulnerable persons of community. S. aureus infects the skin producing boils 
and skin abscess. Other infections caused by S. aureus are endocarditis and pneumonia 
(Smith, Gould et al. 2010, Waryah, Gogoi-Tiwari et al. 2016). S. aureus causes food 
poisoning and the control of its activity is one of the important challenges to food suppliers 
and consumers (Tong, Chen et al. 2012, Aires, Marrinhas et al. 2016).  
S. epidermidis is causing hospital-acquired infection, by lodging the medical devices like 
vascular catheter (Otto 2009, National Nosocomial Infections Surveillance System 2004). 
Treatment of these kinds of infection presents a challenge for the medical sector in 
hospitals since S. epidermidis cells are forming biofilms and may express resistance genes 
to certain treatment protocols (Carvalhais, Cerveira et al. 2015). S. epidermidis ranked the 
second after S. aureus in infecting prosthetic valve which leads to prosthetic valve 
endocarditis (Chu, Miro et al. 2009). 
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B. cereus causes food adulteration and food poisoning among consumers (Eneroth, 
Svensson et al. 2001, Ghelardi, Celandroni et al. 2002). B. cereus produces ?-lactamases 
and can resists third generation cephalosporins (Cormican, Jones 1995). Ampicillin, 
????????????????????????????????? ??????????????????????B. cereus (Schlegelova, Brychta 
et al. 2003).  Food stuffs of plant origin and products of milk especially become rotten by 
B. cereus (Zhang, Feng et al. 2016, Zhang, Tao et al. 2016). A serious consequences 
caused by B. cereus after seeding the catheters is the biofilm formation which is usually 
difficult to treat by conventional antibiotics (Kuroki, Kawakami et al. 2009, Celandroni, 
Salvetti et al. 2016).  
PCH showed strong antibacterial activities against B. cereus with MIC of (16 ?g/ml); 
however its main components showed less activity indicating a possible synergism 
between individual compounds.    
B. subtilis used in biotechnology to produce different proteins (???????????????-amylases), 
vitamins, and antibiotics. This kind of bacteria is safe to human and free of any toxin (van 
Dijl, Hecker 2013, Ploss, Reilman et al. 2016). E. coli cell wall is impermeable to some 
materials and it has pumps to expel unwanted compounds. The exposure to ?-lactam 
antibiotics promotes selection of resistant strains (Gibbons 2008, Sanchez, Master et al. 
2012). E. coli has polar properties (Borges, Ferreira et al. 2013), which prevents 
compounds like lauryl gallate from exerting its antibacterial activities.  
After contact angle measurement, gallic acid increases the hydrophilicity of E. coli and 
decreases the hydrophilicity of S. aureus, this effect in addition to several physicochemical 
effects of gallic acid on E. coli and S. aureus studied by Borges et al. 2013 indicated that 
gallic acid can interact with the cell membrane of both types of bacteria (Borges, Ferreira 
et al. 2013). Gallic acid increases the permeability of S. aureus cell wall and induces the 
leakage of contents (Borges, Ferreira et al. 2013).  
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Simple phenols inactivate some bacterial enzymes by nonspecific interaction (Mason, 
Wasserman 1987). Ethyl gallate and other alk??????????????????????????-lactam antibiotics 
against both MRSA and MSSA. The structure of the benzoates enable them to dwelling the 
external part of the bacterial cell membrane, disrupt its fluidity and decrease binding to 
PBP2a (Shibata, Kondo et al. 2005). Gallic acid potentiates the effects of tetracyclines 
against P.aerognosa (Jayaraman, Sakharkar et al. 2010) and with streptomycin against E.
coli and P.aerognosa (Saavedra, Borges et al. 2010).  
Essential oil from Enteromorpha linza L. exerts its activity by increasing the cell wall 
permeability and leakage of K+, resulting in cell destruction and death (Patra, Baek 2016). 
Patchouli alcohol and pogostone showed multi-target antibacterial activities on penicillin 
binding proteins (PBPs), dihydrofolate synthetase (DHFS), dihydrofolate reductase 
(DHFR), RNA polymerase and DNA gyrase. The best effect of patchouli alcohol and 
pogostone was recorded by interaction with PBPs and DHFS respectively (Yang, Zhang et 
al. 2013). 
Plant extracts contain more than one compound which can work synergistically by 
targeting more than one site of action (Wagner, Ulrich-Merzenich 2009). Sesquiterpenoid 
lactones are working by disrupting the bacterial cell wall integrity (Chadwick, Trewin et al. 
2013). Other research reported that the nonpolar properties of terpenoids enable them to 
host the bacterial cell wall and increase the wall permeability (Gershenzon, Dudareva 
2007). As we mentioned previously, patchouli alcohol targets PBPs to a high degree 
among the four proteins used (Yang, Zhang et al. 2013) which gives terpenoids more than 
single site of action.  
Pencillin binding protein has a crucial role in peptidoglycan biosynthesis, and initiates 
several reactions (transpeptidation, transglucosylation and carboxypeptidation) essential 
for cell wall synthesis. ?-lactam antibiotic interrupt all these steps by binding PBPs (Alves, 
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Froufe et al. 2014). The molecular docking system showed that the fitting score of 
patchouli alcohol is comparable to benzyl penicillin on PBPs (Yang, Zhang et al. 2013).  
The antibacterial combination we used in this study consists of patchouli alcohol and gallic 
acid which could work on two targets in the bacterial cells and showed a synergism 
between the two components in most combinations.  
8.1.9. The anti-malarial potential of the plants under the study. 
The other important issue we need to cover in current research is Malaria, which is one of 
the most dangerous diseases in the world and it is one of the major health problems in the 
developing countries (Garcia-Alvarez, Moussa et al. 2013). The need for new 
antiplasmodials is raised up again and nature is the place where we need to search for the 
new antiplasmodial  candidates. Phenolic acids and gallic acid oligosaccharides conjugates 
could play a vital role in the antiplasmodial activities of CG. Gallic acid and 
protocatechuic acid were isolated from Sebastiania chamaelea which showed IC 50 ? 10 
?g/ml against the chloroquine resistant strain, P. falciparum W2 (Garcia-Alvarez, Moussa 
et al. 2013).  
Ellagic, gentisic, and gallic acids were isolated from Anogeissus leiocarpus,  and showed 
moderate to potent in vitro antiplasmodial  activities against P. falciparum 3D7 with IC50 
of 2.88-11.74 ?M, in which the most potent compound was ellagic acid (IC50 ???????? 
(Ndjonka, Bergmann et al. 2012). Gallic acid and ?-glucogallin were isolated from 
Phyllanthus niruri and their IC50 were (14.8 ?g/ml and 4.6 ?g/ml) respectively, indicating 
that attachment of glucose molecule to gallic acid increases the anti-malarial activities 
(Subeki, Matsuura et al. 2005). 
8.1.10. The benzoates compounds used in this study 
Current results showed that alkyl or alkenyl benzoates are more potent than gallic acid 
against Plasmodium parasite. Previous report on Sorindeia juglandifolia showed that 
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esterification of the carboxylic functional group in benzoic acid derivatives increased its 
antiplasmodial activities. 2,3,6-Trihydroxy benzoic acid showed IC50 of ????????against P.
falciparum W2 while its methyl ester derivative 2,3,6-trihydroxy methyl benzoate showed 
IC50 of 13 ?? (Kamkumo, Ngoutane et al. 2012).    
8.2. Conclusions 
The results of this research support the ethnobotanical use of Cylicodiscus gabunensis as a 
treatment of malaria, the most active fraction CGEBUF-10-7 showed most potent 
antiplasmodial activities (IC50 4.7 ?g/ml) against P. falciparum Dd2. The active 
constituents were benzoic acid derivatives which act as antibacterial and antiplasmodial 
agents.    
The improved method for 3,4,5-trihydroxy benzoates synthesis offer a fast, clean and 
single step of purification and it was successful to synthesise esters from primary alcohols 
and secondary alcohols. Those compounds have a better activity than gallic acid against S. 
aureus, S. epidermidis, E. coli, B. subtilis and B. cereus. The products synthesised here are 
promising for further studies to prove their role as antibacterials with probability to use as 
food additives.  
The hexane and ethanol extracts of both Pogostemon cablin and Perilla frutescens (the two 
key compounds of the traditional medicine Huo-Xiang-Zhen-Qi-Wan), have been 
characterized by GC-MS, and they both showed antibacterial activities against a range of 
gram-positive and negative strains using DDA and alamar blue microplate assay. In 
particular, patchouli alcohol in Pogostemon cablin shows promising antibacterial activity 
against S. epidermidis and E. coli. The anti-bacillus activity of those two extracts present a 
chance for further developments of them as possible food additives or as resistant 
modifying agents as it is supported by the SEM results.   
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The tetrahydrofurofuran lignans in Magnolia biondii were readily detected by GC-MS for 
the first time without prior trimethylsilylation as usually required for the analysis of 
lignans (Li, Barz 2006), which could offer a simple method for the quantification of these 
lignans from MB, alternative to the HPLC method (Zhao, Zhou et al. 2007).  
The combination usage of GC-MS and NMR techniques allowed the identification of 56 
volatile compounds and 7 non-volatile lignans present in the extracts of MB. The Magnolia 
essential oil showed antibacterial and bactericidal activity, which could provide a scientific 
basis for the treatment of rhinosinusitis caused by S. aureus infection (Redinbo 2014) and 
suggested its potential use as antibacterial agents. Magnolia oil showed activity toward S. 
aureus, E. coli and B. cereus which are the major causes of food poisoning, therefore 
providing a chance of using this oil in food preservation. 
8.3. Future work 
The future work is suggested to investigate the antibacterial activities of the benzoate 
derivatives against antibiotic resistant bacterial strains alone and in combination with 
antibiotics. LC-MS-MS study of the most antiplasmodial fraction from Cylicodiscus
gabunensis (CGEBU-F10-7) is highly recommended to elucidate their detailed chemical 
structure including the linkages between the sugars and gallic acid. It would be interesting 
to check any synergism between this active antiplasmodial fraction of Cylicodiscus
gabunensis and chloroquine against chloroquine resistant Plasmodium strains.  
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Figure A-1: The positive mode ESI-MS of CGEEA-F5-8 by qualitative analysis mass 
hunter work station software. 
12 
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Figure A-2: the positive ESI-MS of five compounds picked as masses from CGEBU-F10-
7 by qualitative analysis mass hunter work station software. Masses detected are 1: 
1260.5497; 2: 1436.6116 and 1406.6074; 3: 1044.5522; 4: 1244.5487. 
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Figure A-3: Positive ion ESI-MS [M+H] + for 1, 2, 3, 4, and [M+Na] + for 5. 2-
methylpropyl 3,4,5-trihydroxybenzoate, 1; 2- methylbutyl 3,4,5-trihydroxybenzoate, 2; 3-
methylbut-2-en-1-yl 3,4,5-trihydroxybenzoate, 3; 3-methylbutyl 3,4,5-trihydroxybenzoate, 
4; propan-2-yl 3,4,5-trihydroxybenzoate, 5. 
247 
 
 
 
 
 
 
 
 
1-TMSi 2-TMSi 
3-TMSi 4-TMSi 
5-TMSi 
Figure A-4: EI-MS of trimethylsilyl derivatives of the synthesised esters, arrows pointing 
to the molecular ions, 1-TMSi= 442.3; 2-TMSi= 456.3; 3-TMSi= 454.2; 4-TMSi= 456.3
and 5-TMSi= 428.2. 
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Figure B-1: GC-MS chromatogram of Cylicodiscus gabunensis harms 
ethanol aqueous fraction (CGEAQ) 
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Table B-2: Compounds detected in CGH by GC-MS 
 
 
 
 
RT = Retention time, SD= Standard deviation, n= Number of experiment replication 
†Previous research showed that, the methanolic extract of the Cylicodiscus gabunensis 
stem bark and after fractionation by chloroform yielded, lupeol, the reduced form of Lup-
20(29)-en-3-one (Tane, Bergqust et al. 1995). The EI-Mass chromatogram (Figure B-3) of 
Lup-20(29)-en-3-one deprived from the peak of trimethyl silyl (Si (CH3)3.), which has 
molecular weight equal to (73.1); the detection of the Lup-20(29)-en-3-one molecular peak 
of 424.4 was clear.  
 
 
 
no. RT (min) Compound name Percentage ±SD (n=3) 
1 10.62 Benzene, 1,3-bis(1,1-dimethylethyl)- 11.66± 1.31 
2 14.28 Phenol, 2,4-bis(1,1-dimethylethyl)- 25.91± 1.74 
3 28.11 Lup-20(29)-en-3-one† 36.00± 1.39 
4 29.88 Stigmast-4-en-3-one 26.42± 3.38 
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Figure B-3: EI- Mass spectrum of Lup-20(29)-en-3-one 
Figure B-2: GC-MS chromatogram of Cylicodiscus gabunensis harms hexane 
extract, CGH.  
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Appendix C 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure C-1: 1H NMR (300MHz, METHANOL-d4) δ = 7.08 (2H, s, H-2, 6), 4.02 (2H, d, J = 6.6 Hz, H-8, 8), 
2.04 (1H, m, H-9), 1.03 (6H, d, J = 6.6 Hz, H-10, 11). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure C-2: 13C NMR of 2-methylpropyl 3, 4, 5-trihydroxybenzoate; 13C NMR (101MHz, METHANOL-d4) 
δ = 167.2 (C-7), 145.1 (C-3, 5), 138.3 (C-4),120.3 (C-1), 108.6 (C-2, 6), 70.3 (C-8), 27.8 (C-9), 18.1 (C-10, 
11). 
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Figure C-3: 1H NMR (300MHz, METHANOL-d4) δ = 7.07 (2H, s, H-2, 6), 4.02 - 4.16 (2H, m, H-8, 8), 1.79 
- 1.87 (1H, m, H-9), 1.45-1.55 (1H, m, H-10), 1.26 - 1.34 (1H, m, H-10), 1.02 (3H, d, J = 6.8 Hz, H-12), 0.95 
(3H, t, J=7.45 Hz, H-11). 
 
Figure C-4: 13C NMR of 2- methylbutyl 3, 4, 5-trihydroxybenzoate;13C NMR (101MHz, METHANOL-d4) δ 
= 167.2 (C-7), 145.1 (C-3, 5), 138.3 (C-4),120.3 (C-1), 108.6 (C-2, 6), 68.8 (C-8), 34.3 (C-9), 25.8 (C-10), 
15.5 (C-12), 10.3 (C-11). 
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Figure C-5: 1H NMR (300MHz, METHANOL-d4) δ = 7.05 (2H, s, H-2, 6), 5.45 (1H, m, H-9), 4.74 (2H, d, J 
= 7.2 Hz, H-8, 8), 1.79 (3H, s, H-11), 1.82 (3H, s, H-12). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure C-6: 13C NMR of 3-methylbut-2-en-1-yl 3,4,5-trihydroxybenzoate; 13C NMR (101MHz, 
METHANOL-d4) δ = 167.1 (C-7), 145.1 (C-3, 5), 138.6 (C-10), 138.3 (C-4), 120.4 (C-1), 118.7 (C-9), 108.6 
(C-2, 6), 61.0 (C-8), 24.5 (C-11), 16.7 (C-12). 
255 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure C-7: 1H NMR of 3-methylbutyl 3,4,5-trihydroxybenzoate; 1H NMR (300MHz, METHANOL-d4) δ = 
7.06 (2H, s, H-2, 6), 4.27 (2H, t, J = 6.6 Hz, H-8), 1.64 (2H, q, J = 6.7 Hz, H-9), 1.25 (1H, m, H-10), 0.99 
(6H, d, J = 6.6 Hz, H-11, 12).   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure C-8: 13C NMR of 3-methylbutyl 3,4,5-trihydroxybenzoate; 13C NMR (101MHz, METHANOL-d4) δ 
= 167.2 (C-7), 145.1 (C-3, 5), 138.3 (C-4), 120.3 (C-1), 108.6 (C-2, 6), 62.8 (C-8), 37.3 (C-9), 25.0 (C-10), 
21.5 (C-11, 12). 
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Figure C-9: 1C NMR propan-2-yl 3,4,5-trihydroxybenzoate; 1H NMR (300MHz, METHANOL-d4) δ = 7.06 
(2H, s, H-2, 6), 5.09 - 5.17 (1H, m, H-8), 1.34 (6H, d, J = 6.4 Hz, H-10, 11). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure C-10: 13C NMR propan-2-yl 3,4,5-trihydroxybenzoate; 13C NMR (101MHz, METHANOL-d4) δ = 
166.7 (C-7), 145.0 (C-3, 5), 138.2 (C-4), 120.8 (C-1), 108.6 (C-2,6), 67.8 (C-8), 20.8 (C-9,10).
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Figure D-1: GC-MS chromatogram of compounds of PCE 
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Chemical shift 3.25-4.5 ppm: m (2H) 9,9′ 
Appendix E 
 
 
 
 
 
 
Chemical shift 2.9-3.35 ppm: m (2H) 8,8′ 
Figure 1-E: The proton NMR of lignans mixture from Magnolia Biondii, the area
shown is related to the two protons of the Tetrahydrofuran Bridge. Yangambin
structure is included here as an example of lignans, the numbering system is clear on 
the structure for correlation purposes.   
Figure 2-E: The proton NMR of lignans mixture from Magnolia Biondii, the area
shown is related to the two aliphatic protons 9 and 9′.  
261 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chemical shift 3.8-3.9 ppm: OCH3 (3,3′,4,4′,5,5′) 
Chemical shift 4.45-4.9 ppm: d (2H) 7,7′ 
Figure 3-E: The proton NMR of lignans mixture from Magnolia Biondii, the area 
shown is related to the methoxy groups protons at carbons 3,3′,4,4′,5,5′. 
Figure 4-E: The proton NMR of lignans mixture from Magnolia Biondii, the area 
shown is related to the two aliphatic protons 7 and 7′. 
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Chemical shift 5.9 ppm: -OCH2O- 
Chemical shift 6.6-7 ppm: aromatic  
Figure 5-E: The proton NMR of lignans mixture from Magnolia Biondii, the area 
shown is related to the two protons of -OCH2O-. 
Figure 6-E: The proton NMR of lignans mixture from Magnolia Biondii, the area 
shown is related to aromatic protons. 
